antibodytarget,cellline,tissue,cid,compound,concentration,concordancetable,datasetid,factor,level1,level2,libraryid,lincspertid,nCtrSamples,nTrtSamples,peaktype,platform,signatureid,lincsSigID,organism,clueIoCompound,integratedMoas,GeneTargets,time,treatment,perturbagenID,stitchID,pubChemID,is_exemplar,pert_type
,MCF7,breast,cID_1000,primaquine,8.8uM,concordanceLib2,,perturbagen,primaquine_0.0000088,control,LIB_2,LSM-1649,11.0,2.0,,,CMAP_1000,,,,Antimalarial agent|DNA inhibitor,,,primaquine,,CID4908,4908,,
,MCF7,breast,cID_102,amitriptyline,12.8uM,concordanceLib2,,perturbagen,amitriptyline_0.0000128,control,LIB_2,LSM-3190,11.0,2.0,,,CMAP_102,,,,Serotonin transporter inhibitor|Norepinephrine transporter inhibitor,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HTR6|SLC6A2|SLC6A4,,amitriptyline,,CID2160,2160,,
,MCF7,breast,cID_1022,mefloquine,9.6uM,concordanceLib2,,perturbagen,mefloquine_0.0000096,control,LIB_2,LSM-5525,12.0,2.0,,,CMAP_1022,,,,Adenosine receptor antagonist|Hemoglobin antagonist,,,mefloquine,,CID40692,40692,,
,PC3,prostate,cID_1023,mefloquine,9.6uM,concordanceLib2,,perturbagen,mefloquine_0.0000096,control,LIB_2,LSM-5525,12.0,2.0,,,CMAP_1023,,,,Adenosine receptor antagonist|Hemoglobin antagonist,,,mefloquine,,CID40692,40692,,
,MCF7,breast,cID_1028,astemizole,8.8uM,concordanceLib2,,perturbagen,astemizole_0.0000088,control,LIB_2,LSM-5502,12.0,2.0,,,CMAP_1028,,,,Histamine H1 receptor antagonist,HRH1|KCNH2,,astemizole,,CID2247,2247,,
,PC3,prostate,cID_1029,astemizole,8.8uM,concordanceLib2,,perturbagen,astemizole_0.0000088,control,LIB_2,LSM-5502,12.0,2.0,,,CMAP_1029,,,,Histamine H1 receptor antagonist,HRH1|KCNH2,,astemizole,,CID2247,2247,,
,PC3,prostate,cID_103,amitriptyline,12.8uM,concordanceLib2,,perturbagen,amitriptyline_0.0000128,control,LIB_2,LSM-3190,12.0,2.0,,,CMAP_103,,,,Serotonin transporter inhibitor|Norepinephrine transporter inhibitor,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HTR6|SLC6A2|SLC6A4,,amitriptyline,,CID2160,2160,,
,MCF7,breast,cID_1034,ivermectin,4.6uM,concordanceLib2,,perturbagen,ivermectin_0.0000046,control,LIB_2,LSM-42824,12.0,2.0,,,CMAP_1034,,,,GABA receptor agonist,,,ivermectin,,CID45114068,45114068,,
,MCF7,breast,cID_1046,disulfiram,13.4uM,concordanceLib2,,perturbagen,disulfiram_0.0000134,control,LIB_2,LSM-5467,12.0,2.0,,,CMAP_1046,,,,Aldehyde dehydrogenase inhibitor,ALDH2,,disulfiram,,CID3117,3117,,
,PC3,prostate,cID_1047,disulfiram,13.4uM,concordanceLib2,,perturbagen,disulfiram_0.0000134,control,LIB_2,LSM-5467,12.0,2.0,,,CMAP_1047,,,,Aldehyde dehydrogenase inhibitor,ALDH2,,disulfiram,,CID3117,3117,,
,MCF7,breast,cID_1062,isoconazole,9.6uM,concordanceLib2,,perturbagen,isoconazole_0.0000096,control,LIB_2,LSM-6515,12.0,2.0,,,CMAP_1062,,,,,,,isoconazole,,CID3760,3760,,
,PC3,prostate,cID_1063,isoconazole,9.6uM,concordanceLib2,,perturbagen,isoconazole_0.0000096,control,LIB_2,LSM-6515,12.0,2.0,,,CMAP_1063,,,,,,,isoconazole,,CID3760,3760,,
,MCF7,breast,cID_1074,nicergoline,8.2uM,concordanceLib2,,perturbagen,nicergoline_0.0000082,control,LIB_2,LSM-3720,12.0,2.0,,,CMAP_1074,,,,Adrenergic receptor antagonist,ADRA1A,,nicergoline,,CID34040,34040,,
,MCF7,breast,cID_1108,spironolactone,9.6uM,concordanceLib2,,perturbagen,spironolactone_0.0000096,control,LIB_2,LSM-4018,12.0,2.0,,,CMAP_1108,,,,Mineralocorticoid receptor antagonist,NR3C2,,spironolactone,,CID5833,5833,,
,MCF7,breast,cID_1114,terfenadine,8.4uM,concordanceLib2,,perturbagen,terfenadine_0.0000084,control,LIB_2,LSM-1273,12.0,2.0,,,CMAP_1114,,,,Histamine receptor antagonist,HRH1|KCNH2,,terfenadine,,CID5405,5405,,
,PC3,prostate,cID_1125,mianserin,13.2uM,concordanceLib2,,perturbagen,mianserin_0.0000132,control,LIB_2,LSM-1374,12.0,2.0,,,CMAP_1125,,,,Serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7,,mianserin,,CID4184,4184,,
,MCF7,breast,cID_1154,thioproperazine,6.2uM,concordanceLib2,,perturbagen,thioproperazine_0.0000062,control,LIB_2,LSM-2170,12.0,2.0,,,CMAP_1154,,,,Dopamine receptor antagonist,,,thioproperazine,,CID9429,9429,,
,MCF7,breast,cID_118,15-delta prostaglandin J2,10uM,concordanceLib2,,perturbagen,15-delta prostaglandin J2_0.00001,control,LIB_2,LSM-43081,43.0,8.0,,,CMAP_118,,,,PPAR receptor agonist,PPARG,,15-delta prostaglandin J2,,CID5311211,5311211,,
,HL60,haematopoietic and lymphoid tissue,cID_119,15-delta prostaglandin J2,10uM,concordanceLib2,,perturbagen,15-delta prostaglandin J2_0.00001,control,LIB_2,LSM-43081,17.0,3.0,,,CMAP_119,,,,PPAR receptor agonist,PPARG,,15-delta prostaglandin J2,,CID5311211,5311211,,
,MCF7,breast,cID_1190,dihydroergotamine,3uM,concordanceLib2,,perturbagen,dihydroergotamine_0.000003,control,LIB_2,LSM-3619,12.0,2.0,,,CMAP_1190,,,,Serotonin 1d (5-HT1d) receptor agonist (Serotonin 1d,HTR1B|HTR1D,,dihydroergotamine,,CID10531,10531,,
,PC3,prostate,cID_120,15-delta prostaglandin J2,10uM,concordanceLib2,,perturbagen,15-delta prostaglandin J2_0.00001,control,LIB_2,LSM-43081,13.0,3.0,,,CMAP_120,,,,PPAR receptor agonist,PPARG,,15-delta prostaglandin J2,,CID5311211,5311211,,
,MCF7,breast,cID_1266,antimycin A,7.2uM,concordanceLib2,,perturbagen,antimycin A_0.0000072,control,LIB_2,LSM-5076,12.0,2.0,,,CMAP_1266,,,,ATP synthase inhibitor,CYCS,,antimycin A,,CID16218979,16218979,,
,PC3,prostate,cID_1267,antimycin A,7.2uM,concordanceLib2,,perturbagen,antimycin A_0.0000072,control,LIB_2,LSM-5076,11.0,2.0,,,CMAP_1267,,,,ATP synthase inhibitor,CYCS,,antimycin A,,CID16218979,16218979,,
,MCF7,breast,cID_127,raloxifene,7.8uM,concordanceLib2,,perturbagen,raloxifene_0.0000078,control,LIB_2,LSM-3425,11.0,2.0,,,CMAP_127,,,,Estrogen receptor beta modulator,ESR1|ESR2,,raloxifene,,CID5035,5035,,
,MCF7,breast,cID_128,raloxifene,"0.1uM,7.8uM",concordanceLib2,,perturbagen,"raloxifene_0.0000001,0.0000078",control,LIB_2,LSM-3425,12.0,3.0,,,CMAP_128,,,,Estrogen receptor beta modulator,ESR1|ESR2,,raloxifene,,CID5035,5035,,
,MCF7,breast,cID_1282,tranylcypromine,23.6uM,concordanceLib2,,perturbagen,tranylcypromine_0.0000236,control,LIB_2,LSM-5578,12.0,2.0,,,CMAP_1282,,,,Monoamine oxidase inhibitor,KDM1A|MAOA|MAOB,,tranylcypromine,,CID19493,19493,,
,MCF7,breast,cID_132,nordihydroguaiaretic acid,1uM,concordanceLib2,,perturbagen,nordihydroguaiaretic acid_0.000001,control,LIB_2,LSM-6507,43.0,8.0,,,CMAP_132,,,,,,,nordihydroguaiaretic acid,,CID4534,4534,,
,PC3,prostate,cID_1417,cimetidine,15.8uM,concordanceLib2,,perturbagen,cimetidine_0.0000158,control,LIB_2,LSM-2404,11.0,2.0,,,CMAP_1417,,,,Histamine receptor antagonist,HRH2,,cimetidine,,CID2756,2756,,
,MCF7,breast,cID_1474,ticlopidine,13.4uM,concordanceLib2,,perturbagen,ticlopidine_0.0000134,control,LIB_2,LSM-1986,12.0,2.0,,,CMAP_1474,,,,Purinergic receptor P2Y12 antagonist,P2RY12,,ticlopidine,,CID5472,5472,,
,MCF7,breast,cID_1484,miconazole,9.6uM,concordanceLib2,,perturbagen,miconazole_0.0000096,control,LIB_2,LSM-5165,11.0,2.0,,,CMAP_1484,,,,Cytochrome P450 51 inhibitor,,,miconazole,,CID4189,4189,,
,MCF7,breast,cID_1520,dicycloverine,11.6uM,concordanceLib2,,perturbagen,dicycloverine_0.0000116,control,LIB_2,LSM-3534,12.0,2.0,,,CMAP_1520,,,,Muscarinic acetylcholine receptor M3 antagonist|Muscarinic acetylcholine receptor M1 antagonist,CHRM1|CHRM2|CHRM3,,dicycloverine,,CID3042,3042,,
,PC3,prostate,cID_1521,dicycloverine,11.6uM,concordanceLib2,,perturbagen,dicycloverine_0.0000116,control,LIB_2,LSM-3534,12.0,2.0,,,CMAP_1521,,,,Muscarinic acetylcholine receptor M3 antagonist|Muscarinic acetylcholine receptor M1 antagonist,CHRM1|CHRM2|CHRM3,,dicycloverine,,CID3042,3042,,
,MCF7,breast,cID_158,tanespimycin,1uM,concordanceLib2,,perturbagen,tanespimycin_0.000001,control,LIB_2,LSM-43238,64.0,35.0,,,CMAP_158,,,,Heat shock protein HSP90 inhibitor,HSP90AA1|HSP90AB1,,tanespimycin,,CID6505803,6505803,,
,HL60,haematopoietic and lymphoid tissue,cID_159,tanespimycin,1uM,concordanceLib2,,perturbagen,tanespimycin_0.000001,control,LIB_2,LSM-43238,17.0,12.0,,,CMAP_159,,,,Heat shock protein HSP90 inhibitor,HSP90AA1|HSP90AB1,,tanespimycin,,CID6505803,6505803,,
,PC3,prostate,cID_160,tanespimycin,1uM,concordanceLib2,,perturbagen,tanespimycin_0.000001,control,LIB_2,LSM-43238,16.0,12.0,,,CMAP_160,,,,Heat shock protein HSP90 inhibitor,HSP90AA1|HSP90AB1,,tanespimycin,,CID6505803,6505803,,
,MCF7,breast,cID_1600,niclosamide,12.2uM,concordanceLib2,,perturbagen,niclosamide_0.0000122,control,LIB_2,LSM-2787,11.0,2.0,,,CMAP_1600,,,,DNA replication inhibitor|STAT inhibitor,STAT3,,niclosamide,,CID4477,4477,,
,PC3,prostate,cID_1601,niclosamide,12.2uM,concordanceLib2,,perturbagen,niclosamide_0.0000122,control,LIB_2,LSM-2787,11.0,2.0,,,CMAP_1601,,,,DNA replication inhibitor|STAT inhibitor,STAT3,,niclosamide,,CID4477,4477,,
,MCF7,breast,cID_161,tanespimycin,"0.1uM,1uM",concordanceLib2,,perturbagen,"tanespimycin_0.0000001,0.000001",control,LIB_2,LSM-43238,65.0,36.0,,,CMAP_161,,,,Heat shock protein HSP90 inhibitor,HSP90AA1|HSP90AB1,,tanespimycin,,CID6505803,6505803,,
,PC3,prostate,cID_1631,metronidazole,23.4uM,concordanceLib2,,perturbagen,metronidazole_0.0000234,control,LIB_2,LSM-5628,11.0,2.0,,,CMAP_1631,,,,DNA inhibitor,CYP2C9|CYP3A4,,metronidazole,,CID4173,4173,,
,MCF7,breast,cID_168,tretinoin,1uM,concordanceLib2,,perturbagen,tretinoin_0.000001,control,LIB_2,LSM-42854,56.0,11.0,,,CMAP_168,,,,Retinoic acid receptor agonist,RARA|RARB|RARG|RORB,,tretinoin,,CID444795,444795,,
,MCF7,breast,cID_1684,amoxapine,12.8uM,concordanceLib2,,perturbagen,amoxapine_0.0000128,control,LIB_2,LSM-2021,12.0,2.0,,,CMAP_1684,,,,Serotonin transporter inhibitor|Norepinephrine transporter inhibitor|Dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR2A|HTR6|SLC6A2|SLC6A4,,amoxapine,,CID2170,2170,,
,HL60,haematopoietic and lymphoid tissue,cID_169,tretinoin,1uM,concordanceLib2,,perturbagen,tretinoin_0.000001,control,LIB_2,LSM-42854,18.0,4.0,,,CMAP_169,,,,Retinoic acid receptor agonist,RARA|RARB|RARG|RORB,,tretinoin,,CID444795,444795,,
,MCF7,breast,cID_17,valproic acid,1000uM,concordanceLib2,,perturbagen,valproic acid_0.001,control,LIB_2,LSM-4620,43.0,8.0,,,CMAP_17,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_1706,dipyridamole,8uM,concordanceLib2,,perturbagen,dipyridamole_0.000008,control,LIB_2,LSM-3927,18.0,3.0,,,CMAP_1706,,,,"Equilibrative nucleoside transporter 1 inhibitor|3',5'-cyclic phosphodiesterase inhibitor",ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,,dipyridamole,,CID3108,3108,,
,MCF7,breast,cID_172,tretinoin,13.4uM,concordanceLib2,,perturbagen,tretinoin_0.0000134,control,LIB_2,LSM-42854,11.0,2.0,,,CMAP_172,,,,Retinoic acid receptor agonist,RARA|RARB|RARG|RORB,,tretinoin,,CID444795,444795,,
,MCF7,breast,cID_1724,azacyclonol,15uM,concordanceLib2,,perturbagen,azacyclonol_0.000015,control,LIB_2,LSM-4191,11.0,2.0,,,CMAP_1724,,,,Histamine receptor antagonist,,,azacyclonol,,CID15723,15723,,
,PC3,prostate,cID_1725,azacyclonol,15uM,concordanceLib2,,perturbagen,azacyclonol_0.000015,control,LIB_2,LSM-4191,11.0,2.0,,,CMAP_1725,,,,Histamine receptor antagonist,,,azacyclonol,,CID15723,15723,,
,MCF7,breast,cID_173,tretinoin,"1uM,13.4uM",concordanceLib2,,perturbagen,"tretinoin_0.000001,0.0000134",control,LIB_2,LSM-42854,67.0,13.0,,,CMAP_173,,,,Retinoic acid receptor agonist,RARA|RARB|RARG|RORB,,tretinoin,,CID444795,444795,,
,MCF7,breast,cID_1730,cyproheptadine,12.4uM,concordanceLib2,,perturbagen,cyproheptadine_0.0000124,control,LIB_2,LSM-5419,12.0,2.0,,,CMAP_1730,,,,Histamine H1 receptor antagonist,HRH1,,cyproheptadine,,CID2913,2913,,
,PC3,prostate,cID_1731,cyproheptadine,12.4uM,concordanceLib2,,perturbagen,cyproheptadine_0.0000124,control,LIB_2,LSM-5419,12.0,2.0,,,CMAP_1731,,,,Histamine H1 receptor antagonist,HRH1,,cyproheptadine,,CID2913,2913,,
,HL60,haematopoietic and lymphoid tissue,cID_174,tretinoin,"1uM,13.4uM",concordanceLib2,,perturbagen,"tretinoin_0.000001,0.0000134",control,LIB_2,LSM-42854,23.0,5.0,,,CMAP_174,,,,Retinoic acid receptor agonist,RARA|RARB|RARG|RORB,,tretinoin,,CID444795,444795,,
,MCF7,breast,cID_1754,chlorhexidine,8uM,concordanceLib2,,perturbagen,chlorhexidine_0.000008,control,LIB_2,LSM-5633,11.0,2.0,,,CMAP_1754,,,,Membrane integrity inhibitor,,,chlorhexidine,,CID2713,2713,,
,PC3,prostate,cID_1755,chlorhexidine,8uM,concordanceLib2,,perturbagen,chlorhexidine_0.000008,control,LIB_2,LSM-5633,11.0,2.0,,,CMAP_1755,,,,Membrane integrity inhibitor,,,chlorhexidine,,CID2713,2713,,
,MCF7,breast,cID_178,LY-294002,10uM,concordanceLib2,,perturbagen,LY-294002_0.00001,control,LIB_2,LSM-2597,47.0,26.0,,,CMAP_178,,,,MTOR inhibitor|DNA dependent protein kinase inhibitor|Phosphodiesterase inhibitor|PLK inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKDC,,LY-294002,,CID3973,3973,,
,PC3,prostate,cID_1789,diltiazem,8.8uM,concordanceLib2,,perturbagen,diltiazem_0.0000088,control,LIB_2,LSM-2523,12.0,2.0,,,CMAP_1789,,,,Voltage-gated L-type calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,,diltiazem,,CID39186,39186,,
,HL60,haematopoietic and lymphoid tissue,cID_179,LY-294002,10uM,concordanceLib2,,perturbagen,LY-294002_0.00001,control,LIB_2,LSM-2597,18.0,10.0,,,CMAP_179,,,,MTOR inhibitor|DNA dependent protein kinase inhibitor|Phosphodiesterase inhibitor|PLK inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKDC,,LY-294002,,CID3973,3973,,
,MCF7,breast,cID_1794,loperamide,7.8uM,concordanceLib2,,perturbagen,loperamide_0.0000078,control,LIB_2,LSM-3365,18.0,3.0,,,CMAP_1794,,,,Mu opioid receptor agonist,OPRD1|OPRM1,,loperamide,,CID3955,3955,,
,HL60,haematopoietic and lymphoid tissue,cID_18,valproic acid,1000uM,concordanceLib2,,perturbagen,valproic acid_0.001,control,LIB_2,LSM-4620,18.0,4.0,,,CMAP_18,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,PC3,prostate,cID_180,LY-294002,10uM,concordanceLib2,,perturbagen,LY-294002_0.00001,control,LIB_2,LSM-2597,16.0,10.0,,,CMAP_180,,,,MTOR inhibitor|DNA dependent protein kinase inhibitor|Phosphodiesterase inhibitor|PLK inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKDC,,LY-294002,,CID3973,3973,,
,MCF7,breast,cID_1812,lynestrenol,14uM,concordanceLib2,,perturbagen,lynestrenol_0.000014,control,LIB_2,LSM-6592,12.0,2.0,,,CMAP_1812,,,,,,,lynestrenol,,CID5857,5857,,
,MCF7,breast,cID_1822,perphenazine,10uM,concordanceLib2,,perturbagen,perphenazine_0.00001,control,LIB_2,LSM-2224,11.0,2.0,,,CMAP_1822,,,,Dopamine D2 receptor antagonist,DRD2,,perphenazine,,CID4748,4748,,
,PC3,prostate,cID_1823,perphenazine,10uM,concordanceLib2,,perturbagen,perphenazine_0.00001,control,LIB_2,LSM-2224,12.0,2.0,,,CMAP_1823,,,,Dopamine D2 receptor antagonist,DRD2,,perphenazine,,CID4748,4748,,
,MCF7,breast,cID_185,LY-294002,"10uM,0.1uM",concordanceLib2,,perturbagen,"LY-294002_0.00001,0.0000001",control,LIB_2,LSM-2597,48.0,34.0,,,CMAP_185,,,,MTOR inhibitor|DNA dependent protein kinase inhibitor|Phosphodiesterase inhibitor|PLK inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKDC,,LY-294002,,CID3973,3973,,
,MCF7,breast,cID_1856,albendazole,15uM,concordanceLib2,,perturbagen,albendazole_0.000015,control,LIB_2,LSM-3782,10.0,2.0,,,CMAP_1856,,,,Tubulin inhibitor,,,albendazole,,CID2082,2082,,
,HL60,haematopoietic and lymphoid tissue,cID_186,LY-294002,"10uM,0.1uM",concordanceLib2,,perturbagen,"LY-294002_0.00001,0.0000001",control,LIB_2,LSM-2597,18.0,13.0,,,CMAP_186,,,,MTOR inhibitor|DNA dependent protein kinase inhibitor|Phosphodiesterase inhibitor|PLK inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKDC,,LY-294002,,CID3973,3973,,
,MCF7,breast,cID_1864,oxybutynin,10.2uM,concordanceLib2,,perturbagen,oxybutynin_0.0000102,control,LIB_2,LSM-5111,10.0,2.0,,,CMAP_1864,,,,Muscarinic acetylcholine receptor M3 antagonist|Muscarinic acetylcholine receptor M2 antagonist,CHRM1|CHRM2|CHRM3,,oxybutynin,,CID4634,4634,,
,PC3,prostate,cID_187,LY-294002,"10uM,0.1uM",concordanceLib2,,perturbagen,"LY-294002_0.00001,0.0000001",control,LIB_2,LSM-2597,16.0,12.0,,,CMAP_187,,,,MTOR inhibitor|DNA dependent protein kinase inhibitor|Phosphodiesterase inhibitor|PLK inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKDC,,LY-294002,,CID3973,3973,,
,MCF7,breast,cID_1896,pimozide,8.6uM,concordanceLib2,,perturbagen,pimozide_0.0000086,control,LIB_2,LSM-2001,10.0,2.0,,,CMAP_1896,,,,Dopamine receptor antagonist|Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a,DRD1|DRD2|DRD3|DRD4|DRD5|HTR2A,,pimozide,,CID16362,16362,,
,PC3,prostate,cID_19,valproic acid,1000uM,concordanceLib2,,perturbagen,valproic acid_0.001,control,LIB_2,LSM-4620,14.0,4.0,,,CMAP_19,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_1908,clomipramine,11.4uM,concordanceLib2,,perturbagen,clomipramine_0.0000114,control,LIB_2,LSM-3171,11.0,2.0,,,CMAP_1908,,,,Serotonin transporter inhibitor,SLC6A2|SLC6A4,,clomipramine,,CID2801,2801,,
,MCF7,breast,cID_192,ciclosporin,3.4uM,concordanceLib2,,perturbagen,ciclosporin_0.0000034,control,LIB_2,LSM-42883,11.0,2.0,,,CMAP_192,,,,Cyclophilin A modulator,PPIA|PPP3CA,,ciclosporin,,CID5284373,5284373,,
,MCF7,breast,cID_1920,mifepristone,9.4uM,concordanceLib2,,perturbagen,mifepristone_0.0000094,control,LIB_2,LSM-2822,10.0,2.0,,,CMAP_1920,,,,Glucocorticoid receptor antagonist|Progesterone receptor antagonist,AR|NR3C1|PGR,,mifepristone,,CID55245,55245,,
,MCF7,breast,cID_1924,amodiaquine,8.6uM,concordanceLib2,,perturbagen,amodiaquine_0.0000086,control,LIB_2,LSM-4042,11.0,2.0,,,CMAP_1924,,,,Histamine receptor agonist,HNMT,,amodiaquine,,CID2165,2165,,
,MCF7,breast,cID_193,ciclosporin,"1uM,3.4uM",concordanceLib2,,perturbagen,"ciclosporin_0.000001,0.0000034",control,LIB_2,LSM-42883,13.0,4.0,,,CMAP_193,,,,Cyclophilin A modulator,PPIA|PPP3CA,,ciclosporin,,CID5284373,5284373,,
,MCF7,breast,cID_1936,fendiline,11.4uM,concordanceLib2,,perturbagen,fendiline_0.0000114,control,LIB_2,LSM-5133,10.0,2.0,,,CMAP_1936,,,,Calcium channel blocker,,,fendiline,,CID3336,3336,,
,MCF7,breast,cID_2012,desipramine,13.2uM,concordanceLib2,,perturbagen,desipramine_0.0000132,control,LIB_2,LSM-3351,12.0,2.0,,,CMAP_2012,,,,Norepinephrine transporter inhibitor,SLC6A2|SLC6A4,,desipramine,,CID2995,2995,,
,MCF7,breast,cID_2020,methotrexate,8.8uM,concordanceLib2,,perturbagen,methotrexate_0.0000088,control,LIB_2,LSM-5690,17.0,3.0,,,CMAP_2020,,,,Dihydrofolate reductase inhibitor,DHFR,,methotrexate,,CID126941,126941,,
,HL60,haematopoietic and lymphoid tissue,cID_2021,methotrexate,8.8uM,concordanceLib2,,perturbagen,methotrexate_0.0000088,control,LIB_2,LSM-5690,12.0,2.0,,,CMAP_2021,,,,Dihydrofolate reductase inhibitor,DHFR,,methotrexate,,CID126941,126941,,
,PC3,prostate,cID_2022,methotrexate,8.8uM,concordanceLib2,,perturbagen,methotrexate_0.0000088,control,LIB_2,LSM-5690,17.0,3.0,,,CMAP_2022,,,,Dihydrofolate reductase inhibitor,DHFR,,methotrexate,,CID126941,126941,,
,MCF7,breast,cID_2044,clorgiline,13uM,concordanceLib2,,perturbagen,clorgiline_0.000013,control,LIB_2,LSM-5808,12.0,2.0,,,CMAP_2044,,,,Monoamine oxidase inhibitor,MAOA,,clorgiline,,CID4380,4380,,
,MCF7,breast,cID_2052,metergoline,10uM,concordanceLib2,,perturbagen,metergoline_0.00001,control,LIB_2,LSM-3265,12.0,2.0,,,CMAP_2052,,,,Dopamine receptor agonist|Serotonin receptor antagonist,HTR1A|HTR2A,,metergoline,,CID28693,28693,,
,MCF7,breast,cID_2076,hycanthone,11.2uM,concordanceLib2,,perturbagen,hycanthone_0.0000112,control,LIB_2,LSM-5614,11.0,2.0,,,CMAP_2076,,,,RNA synthesis inhibitor,,,hycanthone,,CID3634,3634,,
,MCF7,breast,cID_2084,metitepine,8.4uM,concordanceLib2,,perturbagen,metitepine_0.0000084,control,LIB_2,LSM-4320,11.0,2.0,,,CMAP_2084,,,,Anti-HCVE2,HTR5A|HTR6|HTR7,,metitepine,,CID4106,4106,,
,MCF7,breast,cID_2100,maprotiline,12.8uM,concordanceLib2,,perturbagen,maprotiline_0.0000128,control,LIB_2,LSM-2043,12.0,2.0,,,CMAP_2100,,,,Norepinephrine transporter inhibitor,SLC6A2,,maprotiline,,CID4011,4011,,
,MCF7,breast,cID_2104,adenosine phosphate,11uM,concordanceLib2,,perturbagen,adenosine phosphate_0.000011,control,LIB_2,LSM-5914,12.0,2.0,,,CMAP_2104,,,,Adenosine receptor agonist,ADCY1,,adenosine phosphate,,CID6083,6083,,
,MCF7,breast,cID_2112,clofazimine,8.4uM,concordanceLib2,,perturbagen,clofazimine_0.0000084,control,LIB_2,LSM-5669,18.0,3.0,,,CMAP_2112,,,,GK0582 inhibitor,,,clofazimine,,CID2794,2794,,
,MCF7,breast,cID_2116,vanoxerine,7.6uM,concordanceLib2,,perturbagen,vanoxerine_0.0000076,control,LIB_2,LSM-2703,11.0,2.0,,,CMAP_2116,,,,Dopamine uptake inhibitor,SLC6A3,,vanoxerine,,CID3455,3455,,
,MCF7,breast,cID_2120,etoposide,6.8uM,concordanceLib2,,perturbagen,etoposide_0.0000068,control,LIB_2,LSM-6348,12.0,2.0,,,CMAP_2120,,,,DNA topoisomerase II inhibitor,TOP2A|TOP2B,,etoposide,,CID36462,36462,,
,MCF7,breast,cID_2126,8-azaguanine,26.2uM,concordanceLib2,,perturbagen,8-azaguanine_0.0000262,control,LIB_2,LSM-6615,12.0,2.0,,,CMAP_2126,,,,,,,8-azaguanine,,CID8646,8646,,
,MCF7,breast,cID_2198,imipramine,12.6uM,concordanceLib2,,perturbagen,imipramine_0.0000126,control,LIB_2,LSM-2852,11.0,2.0,,,CMAP_2198,,,,Serotonin transporter inhibitor|Norepinephrine transporter inhibitor,CHRM2|SLC6A2|SLC6A4,,imipramine,,CID3696,3696,,
,MCF7,breast,cID_220,genistein,10uM,concordanceLib2,,perturbagen,genistein_0.00001,control,LIB_2,LSM-5549,44.0,9.0,,,CMAP_220,,,,Tyrosine kinase inhibitor,CFTR|ESR2,,genistein,,CID5280961,5280961,,
,HL60,haematopoietic and lymphoid tissue,cID_221,genistein,10uM,concordanceLib2,,perturbagen,genistein_0.00001,control,LIB_2,LSM-5549,17.0,3.0,,,CMAP_221,,,,Tyrosine kinase inhibitor,CFTR|ESR2,,genistein,,CID5280961,5280961,,
,MCF7,breast,cID_223,genistein,1uM,concordanceLib2,,perturbagen,genistein_0.000001,control,LIB_2,LSM-5549,1.0,2.0,,,CMAP_223,,,,Tyrosine kinase inhibitor,CFTR|ESR2,,genistein,,CID5280961,5280961,,
,MCF7,breast,cID_2238,noretynodrel,13.4uM,concordanceLib2,,perturbagen,noretynodrel_0.0000134,control,LIB_2,LSM-3807,12.0,2.0,,,CMAP_2238,,,,Progesterone receptor agonist,PGR,,noretynodrel,,CID6231,6231,,
,PC3,prostate,cID_2243,triamterene,15.8uM,concordanceLib2,,perturbagen,triamterene_0.0000158,control,LIB_2,LSM-4060,12.0,2.0,,,CMAP_2243,,,,"Amiloride-sensitive sodium channel, ENaC blocker",SCNN1A|SCNN1B|SCNN1G,,triamterene,,CID5546,5546,,
,MCF7,breast,cID_225,genistein,"1uM,10uM",concordanceLib2,,perturbagen,"genistein_0.000001,0.00001",control,LIB_2,LSM-5549,45.0,11.0,,,CMAP_225,,,,Tyrosine kinase inhibitor,CFTR|ESR2,,genistein,,CID5280961,5280961,,
,MCF7,breast,cID_2325,budesonide,9.2uM,concordanceLib2,,perturbagen,budesonide_0.0000092,control,LIB_2,LSM-1472,11.0,2.0,,,CMAP_2325,,,,Glucocorticoid receptor agonist,NR3C1,,budesonide,,CID5281004,5281004,,
,PC3,prostate,cID_233,fludrocortisone,9.4uM,concordanceLib2,,perturbagen,fludrocortisone_0.0000094,control,LIB_2,LSM-1510,12.0,2.0,,,CMAP_233,,,,Glucocorticoid receptor agonist|Mineralocorticoid receptor agonist,NR3C2,,fludrocortisone,,CID6710659,6710659,,
,MCF7,breast,cID_2347,propafenone,10.6uM,concordanceLib2,,perturbagen,propafenone_0.0000106,control,LIB_2,LSM-1416,11.0,2.0,,,CMAP_2347,,,,Beta-1 adrenergic receptor antagonist|Beta-2 adrenergic receptor antagonist|Sodium channel alpha subunit blocker,ADRB1|ADRB2|KCNH2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,propafenone,,CID4932,4932,,
,MCF7,breast,cID_2351,bromperidol,9.6uM,concordanceLib2,,perturbagen,bromperidol_0.0000096,control,LIB_2,LSM-5849,12.0,2.0,,,CMAP_2351,,,,Dopamine receptor antagonist,DRD2,,bromperidol,,CID2448,2448,,
,MCF7,breast,cID_2371,Prestwick-559,8.2uM,concordanceLib2,,perturbagen,Prestwick-559_0.0000082,control,LIB_2,LSM-5805,12.0,2.0,,,CMAP_2371,,,,,,,Prestwick-559,,,,,
,MCF7,breast,cID_2395,parthenolide,16.2uM,concordanceLib2,,perturbagen,parthenolide_0.0000162,control,LIB_2,LSM-43090,12.0,2.0,,,CMAP_2395,,,,NFkB pathway inhibitor,,,parthenolide,,CID7251185,7251185,,
,MCF7,breast,cID_2399,prenylamine,9.6uM,concordanceLib2,,perturbagen,prenylamine_0.0000096,control,LIB_2,LSM-4963,12.0,2.0,,,CMAP_2399,,,,Calcium channel blocker,,,prenylamine,,CID9801,9801,,
,MCF7,breast,cID_240,quercetin,11.8uM,concordanceLib2,,perturbagen,quercetin_0.0000118,control,LIB_2,LSM-4199,12.0,2.0,,,CMAP_240,,,,Polar auxin transport inhibitor,PIK3CG,,quercetin,,CID5280343,5280343,,
,MCF7,breast,cID_241,quercetin,"1uM,11.8uM",concordanceLib2,,perturbagen,"quercetin_0.000001,0.0000118",control,LIB_2,LSM-4199,19.0,4.0,,,CMAP_241,,,,Polar auxin transport inhibitor,PIK3CG,,quercetin,,CID5280343,5280343,,
,MCF7,breast,cID_2435,mometasone,7.6uM,concordanceLib2,,perturbagen,mometasone_0.0000076,control,LIB_2,LSM-3349,12.0,2.0,,,CMAP_2435,,,,Glucocorticoid receptor agonist,NR3C1,,mometasone,,CID441336,441336,,
,MCF7,breast,cID_2451,harmol,15.8uM,concordanceLib2,,perturbagen,harmol_0.0000158,control,LIB_2,LSM-6720,12.0,2.0,,,CMAP_2451,,,,,,,harmol,,CID6419938,6419938,,
,MCF7,breast,cID_2471,papaverine,10.6uM,concordanceLib2,,perturbagen,papaverine_0.0000106,control,LIB_2,LSM-2338,12.0,2.0,,,CMAP_2471,,,,Phosphodiesterase inhibitor,PDE10A,,papaverine,,CID4680,4680,,
,MCF7,breast,cID_248,fulvestrant,0.01uM,concordanceLib2,,perturbagen,fulvestrant_0.00000001,control,LIB_2,LSM-6504,37.0,7.0,,,CMAP_248,,,,Estrogen receptor antagonist,ESR1|ESR2,,fulvestrant,,CID104741,104741,,
,MCF7,breast,cID_2483,harmine,16uM,concordanceLib2,,perturbagen,harmine_0.000016,control,LIB_2,LSM-5451,12.0,2.0,,,CMAP_2483,,,,DYRK inhibitor,MAOA,,harmine,,CID5280953,5280953,,
,MCF7,breast,cID_2491,syrosingopine,6uM,concordanceLib2,,perturbagen,syrosingopine_0.000006,control,LIB_2,LSM-2297,12.0,2.0,,,CMAP_2491,,,,Vesicular monoamine transporter inhibitor,,,syrosingopine,,CID6769,6769,,
,MCF7,breast,cID_2495,dacarbazine,22uM,concordanceLib2,,perturbagen,dacarbazine_0.000022,control,LIB_2,LSM-5487,12.0,2.0,,,CMAP_2495,,,,DNA alkylating agent,,,dacarbazine,,CID5281007,5281007,,
,MCF7,breast,cID_2501,ellipticine,16.2uM,concordanceLib2,,perturbagen,ellipticine_0.0000162,control,LIB_2,LSM-4842,12.0,2.0,,,CMAP_2501,,,,Topoisomerase inhibitor,TOP2A|TOP2B,,ellipticine,,CID3213,3213,,
,MCF7,breast,cID_252,fulvestrant,1uM,concordanceLib2,,perturbagen,fulvestrant_0.000001,control,LIB_2,LSM-6504,49.0,14.0,,,CMAP_252,,,,Estrogen receptor antagonist,ESR1|ESR2,,fulvestrant,,CID104741,104741,,
,MCF7,breast,cID_2549,berberine,10.8uM,concordanceLib2,,perturbagen,berberine_0.0000108,control,LIB_2,LSM-6553,11.0,2.0,,,CMAP_2549,,,,,,,berberine,,CID2353,2353,,
,MCF7,breast,cID_255,fulvestrant,"0.01uM,1uM",concordanceLib2,,perturbagen,"fulvestrant_0.00000001,0.000001",control,LIB_2,LSM-6504,50.0,21.0,,,CMAP_255,,,,Estrogen receptor antagonist,ESR1|ESR2,,fulvestrant,,CID104741,104741,,
,MCF7,breast,cID_2577,(+)-chelidonine,10.8uM,concordanceLib2,,perturbagen,(+)-chelidonine_0.0000108,control,LIB_2,LSM-2715,12.0,2.0,,,CMAP_2577,,,,Tubulin inhibitor,,,(+)-chelidonine,,CID197810,197810,,
,MCF7,breast,cID_2585,vinburnine,13.6uM,concordanceLib2,,perturbagen,vinburnine_0.0000136,control,LIB_2,LSM-2891,11.0,2.0,,,CMAP_2585,,,,Adrenergic receptor antagonist,,,vinburnine,,CID71203,71203,,
,PC3,prostate,cID_2597,chloramphenicol,12.4uM,concordanceLib2,,perturbagen,chloramphenicol_0.0000124,control,LIB_2,LSM-5256,11.0,2.0,,,CMAP_2597,,,,Bacterial 70S ribosome inhibitor,,,chloramphenicol,,CID5959,5959,,
,MCF7,breast,cID_26,valproic acid,500uM,concordanceLib2,,perturbagen,valproic acid_0.0005,control,LIB_2,LSM-4620,37.0,7.0,,,CMAP_26,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_2609,ursolic acid,8.8uM,concordanceLib2,,perturbagen,ursolic acid_0.0000088,control,LIB_2,LSM-4889,11.0,2.0,,,CMAP_2609,,,,11-beta hydroxysteroid dehydrogenase inhibitor|Acetylcholinesterase inhibitor|Caspase inhibitor|HIV protease inhibitor|Lipid peroxidase inhibitor|Quorum sensing signaling modulator|Steryl sulfatase inhibitor|Tyrosine phosphatase inhibitor|ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PTPN1,,ursolic acid,,CID64945,64945,,
,MCF7,breast,cID_263,monastrol,"100uM,20uM",concordanceLib2,,perturbagen,"monastrol_0.0001,0.00002",control,LIB_2,LSM-1809,7.0,7.0,,,CMAP_263,,,,Kinesin inhibitor,KIF11,,monastrol,,CID2987927,2987927,,
,MCF7,breast,cID_2635,rescinnamine,6.4uM,concordanceLib2,,perturbagen,rescinnamine_0.0000064,control,LIB_2,LSM-42980,11.0,2.0,,,CMAP_2635,,,,Synaptic vesicular amine transporter inhibitor,ACE|SLC18A2,,rescinnamine,,CID5280954,5280954,,
,MCF7,breast,cID_2643,xylazine,18.2uM,concordanceLib2,,perturbagen,xylazine_0.0000182,control,LIB_2,LSM-2477,11.0,2.0,,,CMAP_2643,,,,Adrenergic receptor agonist,,,xylazine,,CID5707,5707,,
,MCF7,breast,cID_266,staurosporine,"1uM,0.1uM,0uM",concordanceLib2,,perturbagen,"staurosporine_0.000001,0.0000001,0.00000001",control,LIB_2,LSM-1103,3.0,3.0,,,CMAP_266,,,,PKC inhibitor,CDK2|GSK3B,,staurosporine,,CID44259,44259,,
,MCF7,breast,cID_2685,protoveratrine A,5uM,concordanceLib2,,perturbagen,protoveratrine A_0.000005,control,LIB_2,LSM-6392,10.0,2.0,,,CMAP_2685,,,,,,,protoveratrine A,,CID8931,8931,,
,MCF7,breast,cID_2689,emetine,7.2uM,concordanceLib2,,perturbagen,emetine_0.0000072,control,LIB_2,LSM-2041,11.0,2.0,,,CMAP_2689,,,,Protein synthesis inhibitor,RPS2,,emetine,,CID10219,10219,,
,HL60,haematopoietic and lymphoid tissue,cID_27,valproic acid,500uM,concordanceLib2,,perturbagen,valproic acid_0.0005,control,LIB_2,LSM-4620,17.0,3.0,,,CMAP_27,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_2711,quinisocaine,13uM,concordanceLib2,,perturbagen,quinisocaine_0.000013,control,LIB_2,LSM-3647,11.0,2.0,,,CMAP_2711,,,,Local anesthetic,,,quinisocaine,,CID6857,6857,,
,MCF7,breast,cID_2715,solanine,4.6uM,concordanceLib2,,perturbagen,solanine_0.0000046,control,LIB_2,LSM-3583,11.0,2.0,,,CMAP_2715,,,,Acetylcholinesterase inhibitor,,,solanine,,CID9549171,9549171,,
,MCF7,breast,cID_273,acetylsalicylic acid,100uM,concordanceLib2,,perturbagen,acetylsalicylic acid_0.0001,control,LIB_2,LSM-5288,43.0,8.0,,,CMAP_273,,,,Cyclooxygenase inhibitor,PTGS1|PTGS2|TP53,,acetylsalicylic acid,,CID2244,2244,,
,MCF7,breast,cID_2733,hydroxyachillin,14.2uM,concordanceLib2,,perturbagen,hydroxyachillin_0.0000142,control,LIB_2,,11.0,2.0,,,CMAP_2733,,,,,,,hydroxyachillin,,CID6419904,6419904,,
,MCF7,breast,cID_2775,flunisolide,9.2uM,concordanceLib2,,perturbagen,flunisolide_0.0000092,control,LIB_2,LSM-3089,16.0,3.0,,,CMAP_2775,,,,Glucocorticoid receptor agonist,NR3C1,,flunisolide,,CID82153,82153,,
,PC3,prostate,cID_2776,flunisolide,9.2uM,concordanceLib2,,perturbagen,flunisolide_0.0000092,control,LIB_2,LSM-3089,12.0,2.0,,,CMAP_2776,,,,Glucocorticoid receptor agonist,NR3C1,,flunisolide,,CID82153,82153,,
,MCF7,breast,cID_2787,solasodine,9.6uM,concordanceLib2,,perturbagen,solasodine_0.0000096,control,LIB_2,LSM-6427,16.0,3.0,,,CMAP_2787,,,,,,,solasodine,,CID442985,442985,,
,PC3,prostate,cID_28,valproic acid,500uM,concordanceLib2,,perturbagen,valproic acid_0.0005,control,LIB_2,LSM-4620,12.0,2.0,,,CMAP_28,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_2803,promazine,12.4uM,concordanceLib2,,perturbagen,promazine_0.0000124,control,LIB_2,LSM-2137,16.0,3.0,,,CMAP_2803,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor antagonist,CHRM5|DRD2|DRD3|DRD4|HTR2A,,promazine,,CID4926,4926,,
,PC3,prostate,cID_2804,promazine,12.4uM,concordanceLib2,,perturbagen,promazine_0.0000124,control,LIB_2,LSM-2137,12.0,2.0,,,CMAP_2804,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor antagonist,CHRM5|DRD2|DRD3|DRD4|HTR2A,,promazine,,CID4926,4926,,
,MCF7,breast,cID_2809,famprofazone,10.6uM,concordanceLib2,,perturbagen,famprofazone_0.0000106,control,LIB_2,LSM-4322,16.0,3.0,,,CMAP_2809,,,,Cyclooxygenase inhibitor,,,famprofazone,,CID3326,3326,,
,PC3,prostate,cID_2864,fludroxycortide,9.2uM,concordanceLib2,,perturbagen,fludroxycortide_0.0000092,control,LIB_2,LSM-1993,11.0,2.0,,,CMAP_2864,,,,Glucocorticoid receptor agonist,NR3C1,,fludroxycortide,,CID15209,15209,,
,MCF7,breast,cID_287,monorden,0.1uM,concordanceLib2,,perturbagen,monorden_0.0000001,control,LIB_2,LSM-43318,57.0,12.0,,,CMAP_287,,,,,,,monorden,,CID6323491,6323491,,
,PC3,prostate,cID_2870,halcinonide,8.8uM,concordanceLib2,,perturbagen,halcinonide_0.0000088,control,LIB_2,LSM-3832,11.0,2.0,,,CMAP_2870,,,,Glucocorticoid receptor agonist,NR3C1,,halcinonide,,CID443943,443943,,
,HL60,haematopoietic and lymphoid tissue,cID_288,monorden,0.1uM,concordanceLib2,,perturbagen,monorden_0.0000001,control,LIB_2,LSM-43318,18.0,4.0,,,CMAP_288,,,,,,,monorden,,CID6323491,6323491,,
,PC3,prostate,cID_289,monorden,0.1uM,concordanceLib2,,perturbagen,monorden_0.0000001,control,LIB_2,LSM-43318,15.0,5.0,,,CMAP_289,,,,,,,monorden,,CID6323491,6323491,,
,MCF7,breast,cID_2891,acacetin,14uM,concordanceLib2,,perturbagen,acacetin_0.000014,control,LIB_2,LSM-6662,16.0,3.0,,,CMAP_2891,,,,,,,acacetin,,CID5280442,5280442,,
,PC3,prostate,cID_2892,acacetin,14uM,concordanceLib2,,perturbagen,acacetin_0.000014,control,LIB_2,LSM-6662,12.0,2.0,,,CMAP_2892,,,,,,,acacetin,,CID5280442,5280442,,
,MCF7,breast,cID_2897,methylbenzethonium chloride,8.6uM,concordanceLib2,,perturbagen,methylbenzethonium chloride_0.0000086,control,LIB_2,LSM-5574,16.0,3.0,,,CMAP_2897,,,,,,,methylbenzethonium chloride,,CID4135,4135,,
,PC3,prostate,cID_2898,methylbenzethonium chloride,8.6uM,concordanceLib2,,perturbagen,methylbenzethonium chloride_0.0000086,control,LIB_2,LSM-5574,12.0,2.0,,,CMAP_2898,,,,,,,methylbenzethonium chloride,,CID4135,4135,,
,MCF7,breast,cID_2909,helveticoside,7.4uM,concordanceLib2,,perturbagen,helveticoside_0.0000074,control,LIB_2,LSM-42700,16.0,3.0,,,CMAP_2909,,,,,,,helveticoside,,CID441860,441860,,
,PC3,prostate,cID_2910,helveticoside,7.4uM,concordanceLib2,,perturbagen,helveticoside_0.0000074,control,LIB_2,LSM-42700,12.0,2.0,,,CMAP_2910,,,,,,,helveticoside,,CID441860,441860,,
,MCF7,breast,cID_2915,lanatoside C,4uM,concordanceLib2,,perturbagen,lanatoside C_0.000004,control,LIB_2,LSM-5496,16.0,3.0,,,CMAP_2915,,,,Cardiac glycoside,,,lanatoside C,,CID73707447,73707447,,
,PC3,prostate,cID_2916,lanatoside C,4uM,concordanceLib2,,perturbagen,lanatoside C_0.000004,control,LIB_2,LSM-5496,12.0,2.0,,,CMAP_2916,,,,Cardiac glycoside,,,lanatoside C,,CID73707447,73707447,,
,MCF7,breast,cID_2921,beta-escin,3.2uM,concordanceLib2,,perturbagen,beta-escin_0.0000032,control,LIB_2,LSM-43314,16.0,3.0,,,CMAP_2921,,,,,,,beta-escin,,CID16211024,16211024,,
,PC3,prostate,cID_2922,beta-escin,3.2uM,concordanceLib2,,perturbagen,beta-escin_0.0000032,control,LIB_2,LSM-43314,12.0,2.0,,,CMAP_2922,,,,,,,beta-escin,,CID16211024,16211024,,
,MCF7,breast,cID_2927,lycorine,12.4uM,concordanceLib2,,perturbagen,lycorine_0.0000124,control,LIB_2,LSM-6387,16.0,3.0,,,CMAP_2927,,,,,,,lycorine,,CID164943,164943,,
,MCF7,breast,cID_2931,ethotoin,19.6uM,concordanceLib2,,perturbagen,ethotoin_0.0000196,control,LIB_2,LSM-1440,16.0,3.0,,,CMAP_2931,,,,Sodium channel alpha subunit blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,ethotoin,,CID3292,3292,,
,MCF7,breast,cID_2937,chlorcyclizine,11.8uM,concordanceLib2,,perturbagen,chlorcyclizine_0.0000118,control,LIB_2,LSM-5088,16.0,3.0,,,CMAP_2937,,,,Histamine receptor antagonist,HRH1,,chlorcyclizine,,CID2710,2710,,
,PC3,prostate,cID_2938,chlorcyclizine,11.8uM,concordanceLib2,,perturbagen,chlorcyclizine_0.0000118,control,LIB_2,LSM-5088,12.0,2.0,,,CMAP_2938,,,,Histamine receptor antagonist,HRH1,,chlorcyclizine,,CID2710,2710,,
,MCF7,breast,cID_295,sirolimus,0.1uM,concordanceLib2,,perturbagen,sirolimus_0.0000001,control,LIB_2,LSM-42782,51.0,25.0,,,CMAP_295,,,,FK506-binding protein 1A inhibitor,FKBP1A|MTOR,,sirolimus,,CID5284616,5284616,,
,MCF7,breast,cID_2953,benzamil,11.2uM,concordanceLib2,,perturbagen,benzamil_0.0000112,control,LIB_2,LSM-3945,17.0,3.0,,,CMAP_2953,,,,Sodium channel blocker,PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,,benzamil,,CID108107,108107,,
,PC3,prostate,cID_2954,benzamil,11.2uM,concordanceLib2,,perturbagen,benzamil_0.0000112,control,LIB_2,LSM-3945,11.0,2.0,,,CMAP_2954,,,,Sodium channel blocker,PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,,benzamil,,CID108107,108107,,
,HL60,haematopoietic and lymphoid tissue,cID_296,sirolimus,0.1uM,concordanceLib2,,perturbagen,sirolimus_0.0000001,control,LIB_2,LSM-42782,18.0,10.0,,,CMAP_296,,,,FK506-binding protein 1A inhibitor,FKBP1A|MTOR,,sirolimus,,CID5284616,5284616,,
,MCF7,breast,cID_2965,gossypol,7.8uM,concordanceLib2,,perturbagen,gossypol_0.0000078,control,LIB_2,LSM-6229,17.0,3.0,,,CMAP_2965,,,,BCL inhibitor|MCL1 inhibitor,BCL2|BCL2L1|MCL1,,gossypol,,CID3503,3503,,
,PC3,prostate,cID_2966,gossypol,7.8uM,concordanceLib2,,perturbagen,gossypol_0.0000078,control,LIB_2,LSM-6229,11.0,2.0,,,CMAP_2966,,,,BCL inhibitor|MCL1 inhibitor,BCL2|BCL2L1|MCL1,,gossypol,,CID3503,3503,,
,PC3,prostate,cID_297,sirolimus,0.1uM,concordanceLib2,,perturbagen,sirolimus_0.0000001,control,LIB_2,LSM-42782,14.0,8.0,,,CMAP_297,,,,FK506-binding protein 1A inhibitor,FKBP1A|MTOR,,sirolimus,,CID5284616,5284616,,
,MCF7,breast,cID_30,valproic acid,200uM,concordanceLib2,,perturbagen,valproic acid_0.0002,control,LIB_2,LSM-4620,36.0,6.0,,,CMAP_30,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,PC3,prostate,cID_3008,griseofulvin,11.2uM,concordanceLib2,,perturbagen,griseofulvin_0.0000112,control,LIB_2,LSM-5259,11.0,2.0,,,CMAP_3008,,,,Tubulin inhibitor,,,griseofulvin,,CID441140,441140,,
,MCF7,breast,cID_3013,dilazep,6uM,concordanceLib2,,perturbagen,dilazep_0.000006,control,LIB_2,LSM-3068,11.0,2.0,,,CMAP_3013,,,,Adenosine reuptake inhibitor,SLC29A1,,dilazep,,CID3074,3074,,
,PC3,prostate,cID_3014,dilazep,6uM,concordanceLib2,,perturbagen,dilazep_0.000006,control,LIB_2,LSM-3068,11.0,2.0,,,CMAP_3014,,,,Adenosine reuptake inhibitor,SLC29A1,,dilazep,,CID3074,3074,,
,PC3,prostate,cID_3038,metaraminol,8.6uM,concordanceLib2,,perturbagen,metaraminol_0.0000086,control,LIB_2,LSM-6000,11.0,2.0,,,CMAP_3038,,,,Adrenergic receptor alpha-1 agonist,ADRA1A|ADRA1B|ADRA1D,,metaraminol,,CID5906,5906,,
,MCF7,breast,cID_3043,kawain,17.4uM,concordanceLib2,,perturbagen,kawain_0.0000174,control,LIB_2,LSM-42869,11.0,2.0,,,CMAP_3043,,,,Calcium channel modulator|MTOR inhibitor|Sodium channel blocker,MTOR,,kawain,,CID5281565,5281565,,
,MCF7,breast,cID_3049,mebendazole,13.6uM,concordanceLib2,,perturbagen,mebendazole_0.0000136,control,LIB_2,LSM-3749,11.0,2.0,,,CMAP_3049,,,,Tubulin inhibitor,,,mebendazole,,CID4030,4030,,
,PC3,prostate,cID_3050,mebendazole,13.6uM,concordanceLib2,,perturbagen,mebendazole_0.0000136,control,LIB_2,LSM-3749,11.0,2.0,,,CMAP_3050,,,,Tubulin inhibitor,,,mebendazole,,CID4030,4030,,
,MCF7,breast,cID_307,trichostatin A,0.1uM,concordanceLib2,,perturbagen,trichostatin A_0.0000001,control,LIB_2,LSM-43005,386.0,69.0,,,CMAP_307,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,HL60,haematopoietic and lymphoid tissue,cID_308,trichostatin A,0.1uM,concordanceLib2,,perturbagen,trichostatin A_0.0000001,control,LIB_2,LSM-43005,172.0,31.0,,,CMAP_308,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,PC3,prostate,cID_3086,salbutamol,16.8uM,concordanceLib2,,perturbagen,salbutamol_0.0000168,control,LIB_2,LSM-5178,11.0,2.0,,,CMAP_3086,,,,Beta-2 adrenergic receptor agonist,ADRB2,,salbutamol,,CID2083,2083,,
,PC3,prostate,cID_309,trichostatin A,0.1uM,concordanceLib2,,perturbagen,trichostatin A_0.0000001,control,LIB_2,LSM-43005,221.0,39.0,,,CMAP_309,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,HL60,haematopoietic and lymphoid tissue,cID_31,valproic acid,200uM,concordanceLib2,,perturbagen,valproic acid_0.0002,control,LIB_2,LSM-4620,17.0,3.0,,,CMAP_31,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_311,trichostatin A,1uM,concordanceLib2,,perturbagen,trichostatin A_0.000001,control,LIB_2,LSM-43005,68.0,23.0,,,CMAP_311,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,HL60,haematopoietic and lymphoid tissue,cID_312,trichostatin A,1uM,concordanceLib2,,perturbagen,trichostatin A_0.000001,control,LIB_2,LSM-43005,17.0,3.0,,,CMAP_312,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,PC3,prostate,cID_313,trichostatin A,1uM,concordanceLib2,,perturbagen,trichostatin A_0.000001,control,LIB_2,LSM-43005,26.0,16.0,,,CMAP_313,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,MCF7,breast,cID_314,trichostatin A,"0.1uM,1uM",concordanceLib2,,perturbagen,"trichostatin A_0.0000001,0.000001",control,LIB_2,LSM-43005,412.0,92.0,,,CMAP_314,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,HL60,haematopoietic and lymphoid tissue,cID_315,trichostatin A,"0.1uM,1uM",concordanceLib2,,perturbagen,"trichostatin A_0.0000001,0.000001",control,LIB_2,LSM-43005,172.0,34.0,,,CMAP_315,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,MCF7,breast,cID_3159,camptothecin,11.4uM,concordanceLib2,,perturbagen,camptothecin_0.0000114,control,LIB_2,LSM-4611,11.0,2.0,,,CMAP_3159,,,,Topoisomerase inhibitor,TOP1,,camptothecin,,CID24360,24360,,
,PC3,prostate,cID_316,trichostatin A,"0.1uM,1uM",concordanceLib2,,perturbagen,"trichostatin A_0.0000001,0.000001",control,LIB_2,LSM-43005,235.0,55.0,,,CMAP_316,,,,HDAC inhibitor|CDK expression enhancer|ID1 expression inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8,,trichostatin A,,CID444732,444732,,
,MCF7,breast,cID_3193,flutamide,14.4uM,concordanceLib2,,perturbagen,flutamide_0.0000144,control,LIB_2,LSM-2621,11.0,2.0,,,CMAP_3193,,,,Androgen Receptor antagonist,AR,,flutamide,,CID3397,3397,,
,PC3,prostate,cID_3199,fenbendazole,13.4uM,concordanceLib2,,perturbagen,fenbendazole_0.0000134,control,LIB_2,LSM-3134,12.0,2.0,,,CMAP_3199,,,,Tubulin inhibitor,TUBB,,fenbendazole,,CID3334,3334,,
,MCF7,breast,cID_3231,trazodone,9.8uM,concordanceLib2,,perturbagen,trazodone_0.0000098,control,LIB_2,LSM-3580,12.0,2.0,,,CMAP_3231,,,,Serotonin transporter inhibitor|Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c,HTR2A|HTR2C|SLC6A4,,trazodone,,CID5533,5533,,
,MCF7,breast,cID_3239,flunarizine,8.4uM,concordanceLib2,,perturbagen,flunarizine_0.0000084,control,LIB_2,LSM-42878,11.0,2.0,,,CMAP_3239,,,,Calcium channel blocker,CACNA1G|CACNA1H,,flunarizine,,CID941361,941361,,
,MCF7,breast,cID_3253,cortisone,11uM,concordanceLib2,,perturbagen,cortisone_0.000011,control,LIB_2,LSM-2965,12.0,2.0,,,CMAP_3253,,,,Glucocorticoid receptor agonist,,,cortisone,,CID222786,222786,,
,MCF7,breast,cID_3257,homochlorcyclizine,10.4uM,concordanceLib2,,perturbagen,homochlorcyclizine_0.0000104,control,LIB_2,LSM-1394,12.0,2.0,,,CMAP_3257,,,,Antihistamine,HRH1,,homochlorcyclizine,,CID3627,3627,,
,MCF7,breast,cID_3273,nortriptyline,13.4uM,concordanceLib2,,perturbagen,nortriptyline_0.0000134,control,LIB_2,LSM-4039,12.0,2.0,,,CMAP_3273,,,,Serotonin transporter inhibitor|Norepinephrine transporter inhibitor,KCNJ10|SLC6A2|SLC6A4,,nortriptyline,,CID4543,4543,,
,MCF7,breast,cID_3277,dyclonine,12.2uM,concordanceLib2,,perturbagen,dyclonine_0.0000122,control,LIB_2,LSM-5801,11.0,2.0,,,CMAP_3277,,,,Sodium channel alpha subunit blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,dyclonine,,CID3180,3180,,
,MCF7,breast,cID_328,nifedipine,11.6uM,concordanceLib2,,perturbagen,nifedipine_0.0000116,control,LIB_2,LSM-4176,12.0,2.0,,,CMAP_328,,,,Voltage-gated L-type calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,,nifedipine,,CID4485,4485,,
,MCF7,breast,cID_3285,pimethixene,9.8uM,concordanceLib2,,perturbagen,pimethixene_0.0000098,control,LIB_2,LSM-5936,12.0,2.0,,,CMAP_3285,,,,Antihistamine,,,pimethixene,,CID4822,4822,,
,MCF7,breast,cID_3289,econazole,9uM,concordanceLib2,,perturbagen,econazole_0.000009,control,LIB_2,LSM-1617,12.0,2.0,,,CMAP_3289,,,,Cytochrome P450 51 inhibitor,,,econazole,,CID3198,3198,,
,PC3,prostate,cID_329,nifedipine,11.6uM,concordanceLib2,,perturbagen,nifedipine_0.0000116,control,LIB_2,LSM-4176,12.0,2.0,,,CMAP_329,,,,Voltage-gated L-type calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,,nifedipine,,CID4485,4485,,
,MCF7,breast,cID_33,valproic acid,"1000uM,10000uM,2000uM,0uM",concordanceLib2,,perturbagen,"valproic acid_0.001,0.01,0.002,0.0005,0.00005,0.0002",control,LIB_2,LSM-4620,44.0,31.0,,,CMAP_33,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_3309,fenofibrate,11uM,concordanceLib2,,perturbagen,fenofibrate_0.000011,control,LIB_2,LSM-3107,12.0,2.0,,,CMAP_3309,,,,Peroxisome proliferator-activated receptor alpha agonist,PPARA,,fenofibrate,,CID3339,3339,,
,MCF7,breast,cID_3329,isotretinoin,13.4uM,concordanceLib2,,perturbagen,isotretinoin_0.0000134,control,LIB_2,LSM-42855,12.0,2.0,,,CMAP_3329,,,,Retinoic acid receptor agonist,RARA|RARB|RARG,,isotretinoin,,CID5282379,5282379,,
,MCF7,breast,cID_3333,disopyramide,11.8uM,concordanceLib2,,perturbagen,disopyramide_0.0000118,control,LIB_2,LSM-1439,11.0,2.0,,,CMAP_3333,,,,Sodium channel alpha subunit blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,disopyramide,,CID3114,3114,,
,MCF7,breast,cID_334,nitrendipine,11uM,concordanceLib2,,perturbagen,nitrendipine_0.000011,control,LIB_2,LSM-1246,11.0,2.0,,,CMAP_334,,,,Calcium channel blocker,CACNA1C|CACNA1D|CACNA2D1,,nitrendipine,,CID4507,4507,,
,MCF7,breast,cID_3341,perhexiline,10.2uM,concordanceLib2,,perturbagen,perhexiline_0.0000102,control,LIB_2,LSM-4353,12.0,2.0,,,CMAP_3341,,,,Carnitine palmitoyltransferase inhibitor,CPT1A|CPT2,,perhexiline,,CID4746,4746,,
,MCF7,breast,cID_3349,clemastine,8.6uM,concordanceLib2,,perturbagen,clemastine_0.0000086,control,LIB_2,LSM-2655,12.0,2.0,,,CMAP_3349,,,,Histamine H1 receptor antagonist,HRH1,,clemastine,,CID26987,26987,,
,MCF7,breast,cID_3353,digoxin,5.2uM,concordanceLib2,,perturbagen,digoxin_0.0000052,control,LIB_2,LSM-2511,12.0,2.0,,,CMAP_3353,,,,Sodium/potassium-transporting ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,,digoxin,,CID2724385,2724385,,
,MCF7,breast,cID_3357,meclozine,8.6uM,concordanceLib2,,perturbagen,meclozine_0.0000086,control,LIB_2,LSM-1607,18.0,3.0,,,CMAP_3357,,,,Histamine H1 receptor antagonist,HRH1|NR1I3,,meclozine,,CID4034,4034,,
,MCF7,breast,cID_3365,progesterone,12.8uM,concordanceLib2,,perturbagen,progesterone_0.0000128,control,LIB_2,LSM-3452,12.0,2.0,,,CMAP_3365,,,,Progesterone receptor agonist,CYP17A1|NR3C2|PGR,,progesterone,,CID5994,5994,,
,MCF7,breast,cID_3369,butoconazole,8.4uM,concordanceLib2,,perturbagen,butoconazole_0.0000084,control,LIB_2,LSM-1344,11.0,2.0,,,CMAP_3369,,,,Cytochrome P450 51 inhibitor,,,butoconazole,,CID47472,47472,,
,MCF7,breast,cID_337,felodipine,10uM,concordanceLib2,,perturbagen,felodipine_0.00001,control,LIB_2,LSM-1447,13.0,3.0,,,CMAP_337,,,,Mineralocorticoid receptor antagonist|Voltage-gated L-type calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|NR3C2,,felodipine,,CID3333,3333,,
,MCF7,breast,cID_3375,cephaeline,6uM,concordanceLib2,,perturbagen,cephaeline_0.000006,control,LIB_2,LSM-3808,18.0,3.0,,,CMAP_3375,,,,Protein synthesis inhibitor,,,cephaeline,,CID442195,442195,,
,MCF7,breast,cID_3391,amiodarone,5.8uM,concordanceLib2,,perturbagen,amiodarone_0.0000058,control,LIB_2,LSM-2379,18.0,3.0,,,CMAP_3391,,,,HERG blocker,KCNH2,,amiodarone,,CID2157,2157,,
,MCF7,breast,cID_3395,bisacodyl,11uM,concordanceLib2,,perturbagen,bisacodyl_0.000011,control,LIB_2,LSM-2883,11.0,2.0,,,CMAP_3395,,,,Laxative,,,bisacodyl,,CID2391,2391,,
,HL60,haematopoietic and lymphoid tissue,cID_34,valproic acid,"1000uM,10000uM,200uM,0uM",concordanceLib2,,perturbagen,"valproic acid_0.001,0.01,0.0002,0.00005,0.0005",control,LIB_2,LSM-4620,18.0,14.0,,,CMAP_34,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_340,felodipine,10.4uM,concordanceLib2,,perturbagen,felodipine_0.0000104,control,LIB_2,LSM-1447,12.0,2.0,,,CMAP_340,,,,Mineralocorticoid receptor antagonist|Voltage-gated L-type calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|NR3C2,,felodipine,,CID3333,3333,,
,MCF7,breast,cID_341,felodipine,"10uM,10.4uM",concordanceLib2,,perturbagen,"felodipine_0.00001,0.0000104",control,LIB_2,LSM-1447,25.0,5.0,,,CMAP_341,,,,Mineralocorticoid receptor antagonist|Voltage-gated L-type calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|NR3C2,,felodipine,,CID3333,3333,,
,MCF7,breast,cID_3417,amphotericin B,4.4uM,concordanceLib2,,perturbagen,amphotericin B_0.0000044,control,LIB_2,LSM-5443,11.0,2.0,,,CMAP_3417,,,,Membrane permeability enhancer,,,amphotericin B,,CID73707460,73707460,,
,MCF7,breast,cID_3429,epiandrosterone,13.8uM,concordanceLib2,,perturbagen,epiandrosterone_0.0000138,control,LIB_2,LSM-5861,11.0,2.0,,,CMAP_3429,,,,Steroid,,,epiandrosterone,,CID11868648,11868648,,
,MCF7,breast,cID_3445,puromycin,7.4uM,concordanceLib2,,perturbagen,puromycin_0.0000074,control,LIB_2,LSM-2788,12.0,2.0,,,CMAP_3445,,,,Protein synthesis inhibitor,,,puromycin,,CID439530,439530,,
,MCF7,breast,cID_3453,metixene,11.6uM,concordanceLib2,,perturbagen,metixene_0.0000116,control,LIB_2,LSM-1467,12.0,2.0,,,CMAP_3453,,,,Muscarinic acetylcholine receptor M1 antagonist|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c,CHRM1|CHRM5|HTR2C,,metixene,,CID4167,4167,,
,MCF7,breast,cID_3459,fluoxetine,11.6uM,concordanceLib2,,perturbagen,fluoxetine_0.0000116,control,LIB_2,LSM-1449,12.0,2.0,,,CMAP_3459,,,,Serotonin transporter inhibitor,SLC6A4,,fluoxetine,,CID3386,3386,,
,MCF7,breast,cID_346,azathioprine,"100uM,14.4uM",concordanceLib2,,perturbagen,"azathioprine_0.0001,0.0000144",control,LIB_2,LSM-42936,19.0,4.0,,,CMAP_346,,,,Dehydrogenase inhibitor,PPAT,,azathioprine,,CID2265,2265,,
,MCF7,breast,cID_3467,pirenperone,10.2uM,concordanceLib2,,perturbagen,pirenperone_0.0000102,control,LIB_2,LSM-2550,18.0,3.0,,,CMAP_3467,,,,Serotonin receptor antagonist,HTR2A,,pirenperone,,CID4847,4847,,
,MCF7,breast,cID_3471,ciclopirox,15uM,concordanceLib2,,perturbagen,ciclopirox_0.000015,control,LIB_2,LSM-5307,12.0,2.0,,,CMAP_3471,,,,Membrane integrity inhibitor,ATP1A1,,ciclopirox,,CID2749,2749,,
,MCF7,breast,cID_3475,hexetidine,11.8uM,concordanceLib2,,perturbagen,hexetidine_0.0000118,control,LIB_2,LSM-4988,11.0,2.0,,,CMAP_3475,,,,Local anesthetic,,,hexetidine,,CID3607,3607,,
,MCF7,breast,cID_3495,thiostrepton,2.4uM,concordanceLib2,,perturbagen,thiostrepton_0.0000024,control,LIB_2,LSM-43142,12.0,2.0,,,CMAP_3495,,,,FOXM1 inhibitor|Protein synthesis inhibitor,FOXM1,,thiostrepton,,CID16129666,16129666,,
,PC3,prostate,cID_35,valproic acid,"1000uM,200uM,50uM",concordanceLib2,,perturbagen,"valproic acid_0.001,0.0002,0.00005,0.0005",control,LIB_2,LSM-4620,14.0,10.0,,,CMAP_35,,,,Succinate semialdehyde dehydrogenase inhibitor,ABAT|ALDH5A1|HDAC1|SCN1A|SCN3A,,valproic acid,,CID3121,3121,,
,MCF7,breast,cID_350,sodium phenylbutyrate,1000uM,concordanceLib2,,perturbagen,sodium phenylbutyrate_0.001,control,LIB_2,LSM-5751,1.0,2.0,,,CMAP_350,,,,HDAC inhibitor,,,sodium phenylbutyrate,,CID4775,4775,,
,MCF7,breast,cID_3523,norcyclobenzaprine,15.4uM,concordanceLib2,,perturbagen,norcyclobenzaprine_0.0000154,control,LIB_2,LSM-3403,12.0,2.0,,,CMAP_3523,,,,Adrenergic receptor agonist|Serotonin receptor antagonist,,,norcyclobenzaprine,,CID9918,9918,,
,MCF7,breast,cID_3539,benperidol,10.4uM,concordanceLib2,,perturbagen,benperidol_0.0000104,control,LIB_2,LSM-3792,12.0,2.0,,,CMAP_3539,,,,Dopamine receptor antagonist,DRD2,,benperidol,,CID16363,16363,,
,MCF7,breast,cID_3571,terconazole,7.6uM,concordanceLib2,,perturbagen,terconazole_0.0000076,control,LIB_2,LSM-3923,12.0,2.0,,,CMAP_3571,,,,Cytochrome P450 51 inhibitor,,,terconazole,,CID441383,441383,,
,MCF7,breast,cID_3595,nifuroxazide,14.6uM,concordanceLib2,,perturbagen,nifuroxazide_0.0000146,control,LIB_2,LSM-5405,12.0,2.0,,,CMAP_3595,,,,Bacterial DNA inhibitor,,,nifuroxazide,,CID13764,13764,,
,MCF7,breast,cID_3611,lovastatin,9.8uM,concordanceLib2,,perturbagen,lovastatin_0.0000098,control,LIB_2,LSM-2189,11.0,2.0,,,CMAP_3611,,,,HMG-CoA reductase inhibitor,HMGCR,,lovastatin,,CID53232,53232,,
,MCF7,breast,cID_3647,estropipate,9.2uM,concordanceLib2,,perturbagen,estropipate_0.0000092,control,LIB_2,LSM-3126,12.0,2.0,,,CMAP_3647,,,,Estrogen receptor alpha agonist,ESR1,,estropipate,,CID3001028,3001028,,
,MCF7,breast,cID_3655,benzethonium chloride,9uM,concordanceLib2,,perturbagen,benzethonium chloride_0.000009,control,LIB_2,LSM-5804,12.0,2.0,,,CMAP_3655,,,,Sodium channel blocker,SCN10A,,benzethonium chloride,,CID2335,2335,,
,MCF7,breast,cID_3659,fluorometholone,10.6uM,concordanceLib2,,perturbagen,fluorometholone_0.0000106,control,LIB_2,LSM-25624,12.0,2.0,,,CMAP_3659,,,,Glucocorticoid receptor agonist,NR3C1,,fluorometholone,,CID9878,9878,,
,PC3,prostate,cID_367,pirinixic acid,100uM,concordanceLib2,,perturbagen,pirinixic acid_0.0001,control,LIB_2,LSM-2015,2.0,2.0,,,CMAP_367,,,,PPAR receptor agonist,PPARA,,pirinixic acid,,CID5694,5694,,
,MCF7,breast,cID_3675,delsoline,8.6uM,concordanceLib2,,perturbagen,delsoline_0.0000086,control,LIB_2,LSM-6415,12.0,2.0,,,CMAP_3675,,,,,,,delsoline,,CID441727,441727,,
,MCF7,breast,cID_3683,hexestrol,14.8uM,concordanceLib2,,perturbagen,hexestrol_0.0000148,control,LIB_2,LSM-4300,12.0,2.0,,,CMAP_3683,,,,Synthetic estrogen,ESR1,,hexestrol,,CID3606,3606,,
,MCF7,breast,cID_3691,cefalotin,9.6uM,concordanceLib2,,perturbagen,cefalotin_0.0000096,control,LIB_2,LSM-15184,12.0,2.0,,,CMAP_3691,,,,Bacterial penicillin-binding protein inhibitor,,,cefalotin,,CID23675321,23675321,,
,MCF7,breast,cID_3695,abamectin,4.8uM,concordanceLib2,,perturbagen,abamectin_0.0000048,control,LIB_2,LSM-5805,12.0,2.0,,,CMAP_3695,,,,,,,abamectin,,,,,
,MCF7,breast,cID_3699,tetrandrine,6.4uM,concordanceLib2,,perturbagen,tetrandrine_0.0000064,control,LIB_2,LSM-6539,11.0,2.0,,,CMAP_3699,,,,,,,tetrandrine,,CID73078,73078,,
,MCF7,breast,cID_3715,strophanthidin,9.8uM,concordanceLib2,,perturbagen,strophanthidin_0.0000098,control,LIB_2,LSM-3891,11.0,2.0,,,CMAP_3715,,,,ATPase inhibitor,ATP1A1,,strophanthidin,,CID6185,6185,,
,PC3,prostate,cID_374,rosiglitazone,10uM,concordanceLib2,,perturbagen,rosiglitazone_0.00001,control,LIB_2,LSM-1949,13.0,3.0,,,CMAP_374,,,,Peroxisome proliferator-activated receptor gamma agonist,PPARG,,rosiglitazone,,CID77999,77999,,
,MCF7,breast,cID_3759,phenazopyridine,16uM,concordanceLib2,,perturbagen,phenazopyridine_0.000016,control,LIB_2,LSM-3705,12.0,2.0,,,CMAP_3759,,,,Sodium channel alpha subunit blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,phenazopyridine,,CID4756,4756,,
,MCF7,breast,cID_3771,podophyllotoxin,9.6uM,concordanceLib2,,perturbagen,podophyllotoxin_0.0000096,control,LIB_2,LSM-3055,11.0,2.0,,,CMAP_3771,,,,Microtubule inhibitor|Tubulin inhibitor,,,podophyllotoxin,,CID10607,10607,,
,PC3,prostate,cID_3788,medrysone,11.6uM,concordanceLib2,,perturbagen,medrysone_0.0000116,control,LIB_2,LSM-3259,11.0,2.0,,,CMAP_3788,,,,Glucocorticoid receptor agonist,NR3C1,,medrysone,,CID247839,247839,,
,MCF7,breast,cID_38,estradiol,0.1uM,concordanceLib2,,perturbagen,estradiol_0.0000001,control,LIB_2,LSM-2421,37.0,7.0,,,CMAP_38,,,,Estrogen receptor alpha agonist,ESR1|ESR2|NR1I2,,estradiol,,CID5757,5757,,
,MCF7,breast,cID_380,troglitazone,10uM,concordanceLib2,,perturbagen,troglitazone_0.00001,control,LIB_2,LSM-4890,42.0,7.0,,,CMAP_380,,,,Peroxisome proliferator-activated receptor gamma agonist,PPARG,,troglitazone,,CID5591,5591,,
,MCF7,breast,cID_3805,levonorgestrel,12.8uM,concordanceLib2,,perturbagen,levonorgestrel_0.0000128,control,LIB_2,LSM-2768,18.0,3.0,,,CMAP_3805,,,,Progesterone receptor agonist,PGR,,levonorgestrel,,CID13109,13109,,
,MCF7,breast,cID_3811,cloperastine,11uM,concordanceLib2,,perturbagen,cloperastine_0.000011,control,LIB_2,LSM-5161,18.0,3.0,,,CMAP_3811,,,,Antitussive,,,cloperastine,,CID2805,2805,,
,PC3,prostate,cID_3812,cloperastine,11uM,concordanceLib2,,perturbagen,cloperastine_0.000011,control,LIB_2,LSM-5161,11.0,2.0,,,CMAP_3812,,,,Antitussive,,,cloperastine,,CID2805,2805,,
,PC3,prostate,cID_382,troglitazone,10uM,concordanceLib2,,perturbagen,troglitazone_0.00001,control,LIB_2,LSM-4890,14.0,4.0,,,CMAP_382,,,,Peroxisome proliferator-activated receptor gamma agonist,PPARG,,troglitazone,,CID5591,5591,,
,PC3,prostate,cID_3822,flumetasone,9.8uM,concordanceLib2,,perturbagen,flumetasone_0.0000098,control,LIB_2,LSM-3369,11.0,2.0,,,CMAP_3822,,,,Glucocorticoid receptor agonist,NR3C1,,flumetasone,,CID16490,16490,,
,MCF7,breast,cID_3857,flecainide,8.4uM,concordanceLib2,,perturbagen,flecainide_0.0000084,control,LIB_2,LSM-1297,17.0,3.0,,,CMAP_3857,,,,Sodium channel protein type V alpha subunit blocker,SCN5A,,flecainide,,CID3356,3356,,
,MCF7,breast,cID_3911,diethylstilbestrol,15uM,concordanceLib2,,perturbagen,diethylstilbestrol_0.000015,control,LIB_2,LSM-42960,17.0,3.0,,,CMAP_3911,,,,Estrogen receptor alpha agonist,ESR1|ESR2|ESRRG,,diethylstilbestrol,,CID448537,448537,,
,MCF7,breast,cID_392,wortmannin,0.01uM,concordanceLib2,,perturbagen,wortmannin_0.00000001,control,LIB_2,LSM-3947,48.0,8.0,,,CMAP_392,,,,PI3K inhibitor,PIK3CA|PIK3CG|PLK1,,wortmannin,,CID312145,312145,,
,HL60,haematopoietic and lymphoid tissue,cID_393,wortmannin,0.01uM,concordanceLib2,,perturbagen,wortmannin_0.00000001,control,LIB_2,LSM-3947,18.0,4.0,,,CMAP_393,,,,PI3K inhibitor,PIK3CA|PIK3CG|PLK1,,wortmannin,,CID312145,312145,,
,PC3,prostate,cID_394,wortmannin,0.01uM,concordanceLib2,,perturbagen,wortmannin_0.00000001,control,LIB_2,LSM-3947,12.0,2.0,,,CMAP_394,,,,PI3K inhibitor,PIK3CA|PIK3CG|PLK1,,wortmannin,,CID312145,312145,,
,MCF7,breast,cID_3941,alpha-ergocryptine,7uM,concordanceLib2,,perturbagen,alpha-ergocryptine_0.000007,control,LIB_2,LSM-3664,17.0,3.0,,,CMAP_3941,,,,Dopamine agonist,,,alpha-ergocryptine,,CID134551,134551,,
,MCF7,breast,cID_395,wortmannin,1uM,concordanceLib2,,perturbagen,wortmannin_0.000001,control,LIB_2,LSM-3947,12.0,2.0,,,CMAP_395,,,,PI3K inhibitor,PIK3CA|PIK3CG|PLK1,,wortmannin,,CID312145,312145,,
,PC3,prostate,cID_3959,alexidine,6.8uM,concordanceLib2,,perturbagen,alexidine_0.0000068,control,LIB_2,LSM-4432,11.0,2.0,,,CMAP_3959,,,,Phosphatidylglycerophosphatase inhibitor,PTPMT1,,alexidine,,CID2090,2090,,
,MCF7,breast,cID_397,wortmannin,"1uM,0.01uM",concordanceLib2,,perturbagen,"wortmannin_0.000001,0.00000001",control,LIB_2,LSM-3947,60.0,10.0,,,CMAP_397,,,,PI3K inhibitor,PIK3CA|PIK3CG|PLK1,,wortmannin,,CID312145,312145,,
,MCF7,breast,cID_3989,vidarabine,15uM,concordanceLib2,,perturbagen,vidarabine_0.000015,control,LIB_2,LSM-5800,11.0,2.0,,,CMAP_3989,,,,Human herpesvirus 1 DNA polymerase inhibitor,ADA,,vidarabine,,CID21704,21704,,
,MCF7,breast,cID_3993,proadifen,10.2uM,concordanceLib2,,perturbagen,proadifen_0.0000102,control,LIB_2,LSM-3023,10.0,2.0,,,CMAP_3993,,,,Nitric oxide synthase inhibitor,NOS1,,proadifen,,CID4910,4910,,
,MCF7,breast,cID_4021,drofenine,11.4uM,concordanceLib2,,perturbagen,drofenine_0.0000114,control,LIB_2,LSM-4364,10.0,2.0,,,CMAP_4021,,,,,,,drofenine,,CID92806,92806,,
,MCF7,breast,cID_4049,cicloheximide,14.2uM,concordanceLib2,,perturbagen,cicloheximide_0.0000142,control,LIB_2,LSM-2791,11.0,2.0,,,CMAP_4049,,,,Protein synthesis inhibitor,RPL3,,cicloheximide,,CID6197,6197,,
,MCF7,breast,cID_4053,amrinone,21.4uM,concordanceLib2,,perturbagen,amrinone_0.0000214,control,LIB_2,LSM-6600,11.0,2.0,,,CMAP_4053,,,,Phosphodiesterase 3A inhibitor,PDE3A,,amrinone,,CID3698,3698,,
,MCF7,breast,cID_4073,securinine,18.4uM,concordanceLib2,,perturbagen,securinine_0.0000184,control,LIB_2,LSM-6733,11.0,2.0,,,CMAP_4073,,,,GABA receptor antagonist|TP53 activator,GABRA1,,securinine,,CID442872,442872,,
,MCF7,breast,cID_4137,mycophenolic acid,12.4uM,concordanceLib2,,perturbagen,mycophenolic acid_0.0000124,control,LIB_2,LSM-42933,11.0,2.0,,,CMAP_4137,,,,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor (Inosine-5'-monophosphate dehydrogenase,IMPDH1|IMPDH2,,mycophenolic acid,,CID446541,446541,,
,MCF7,breast,cID_416,thioridazine,10uM,concordanceLib2,,perturbagen,thioridazine_0.00001,control,LIB_2,LSM-1863,38.0,8.0,,,CMAP_416,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,HL60,haematopoietic and lymphoid tissue,cID_417,thioridazine,10uM,concordanceLib2,,perturbagen,thioridazine_0.00001,control,LIB_2,LSM-1863,17.0,3.0,,,CMAP_417,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,PC3,prostate,cID_418,thioridazine,10uM,concordanceLib2,,perturbagen,thioridazine_0.00001,control,LIB_2,LSM-1863,13.0,3.0,,,CMAP_418,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,MCF7,breast,cID_4187,fluvoxamine,9.2uM,concordanceLib2,,perturbagen,fluvoxamine_0.0000092,control,LIB_2,LSM-3625,11.0,2.0,,,CMAP_4187,,,,Selective serotonin reuptake inhibitor (SSRI),SLC6A4,,fluvoxamine,,CID3404,3404,,
,MCF7,breast,cID_42,estradiol,0.01uM,concordanceLib2,,perturbagen,estradiol_0.00000001,control,LIB_2,LSM-2421,45.0,10.0,,,CMAP_42,,,,Estrogen receptor alpha agonist,ESR1|ESR2|NR1I2,,estradiol,,CID5757,5757,,
,MCF7,breast,cID_420,thioridazine,9.8uM,concordanceLib2,,perturbagen,thioridazine_0.0000098,control,LIB_2,LSM-1863,12.0,2.0,,,CMAP_420,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,PC3,prostate,cID_421,thioridazine,9.8uM,concordanceLib2,,perturbagen,thioridazine_0.0000098,control,LIB_2,LSM-1863,11.0,2.0,,,CMAP_421,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,MCF7,breast,cID_4211,tracazolate,11.8uM,concordanceLib2,,perturbagen,tracazolate_0.0000118,control,LIB_2,LSM-2745,11.0,2.0,,,CMAP_4211,,,,GABA receptor modulator,GABRA1,,tracazolate,,CID5522,5522,,
,MCF7,breast,cID_4215,proscillaridin,7.6uM,concordanceLib2,,perturbagen,proscillaridin_0.0000076,control,LIB_2,LSM-1476,12.0,2.0,,,CMAP_4215,,,,ATPase inhibitor,ATP1A1,,proscillaridin,,CID9828429,9828429,,
,MCF7,breast,cID_422,thioridazine,"10uM,1uM,0uM",concordanceLib2,,perturbagen,"thioridazine_0.00001,0.000001,0.0000098",control,LIB_2,LSM-1863,51.0,11.0,,,CMAP_422,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,MCF7,breast,cID_4221,epitiostanol,13uM,concordanceLib2,,perturbagen,epitiostanol_0.000013,control,LIB_2,LSM-45392,12.0,2.0,,,CMAP_4221,,,,,,,epitiostanol,,CID443935,443935,,
,HL60,haematopoietic and lymphoid tissue,cID_423,thioridazine,"10uM,9.8uM",concordanceLib2,,perturbagen,"thioridazine_0.00001,0.0000098",control,LIB_2,LSM-1863,23.0,4.0,,,CMAP_423,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,PC3,prostate,cID_424,thioridazine,"10uM,9.8uM",concordanceLib2,,perturbagen,"thioridazine_0.00001,0.0000098",control,LIB_2,LSM-1863,24.0,5.0,,,CMAP_424,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR2A|HTR2C,,thioridazine,,CID5452,5452,,
,MCF7,breast,cID_427,haloperidol,10uM,concordanceLib2,,perturbagen,haloperidol_0.00001,control,LIB_2,LSM-3512,44.0,16.0,,,CMAP_427,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor inverse agonist,DRD1|DRD2|DRD3|DRD4|HTR2A,,haloperidol,,CID3559,3559,,
,MCF7,breast,cID_4273,zuclopenthixol,9.2uM,concordanceLib2,,perturbagen,zuclopenthixol_0.0000092,control,LIB_2,LSM-42927,12.0,2.0,,,CMAP_4273,,,,Dopamine receptor antagonist,DRD1|DRD2,,zuclopenthixol,,CID5311507,5311507,,
,PC3,prostate,cID_4281,alprostadil,10uM,concordanceLib2,,perturbagen,alprostadil_0.00001,control,LIB_2,LSM-42979,2.0,2.0,,,CMAP_4281,,,,Prostanoid EP1 receptor agonist|Prostanoid EP2 receptor agonist,PTGER1|PTGER2,,alprostadil,,CID5280723,5280723,,
,PC3,prostate,cID_4285,alprostadil,"11.2uM,10uM",concordanceLib2,,perturbagen,"alprostadil_0.0000112,0.00001",control,LIB_2,LSM-42979,7.0,3.0,,,CMAP_4285,,,,Prostanoid EP1 receptor agonist|Prostanoid EP2 receptor agonist,PTGER1|PTGER2,,alprostadil,,CID5280723,5280723,,
,MCF7,breast,cID_431,haloperidol,10.6uM,concordanceLib2,,perturbagen,haloperidol_0.0000106,control,LIB_2,LSM-3512,18.0,3.0,,,CMAP_431,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor inverse agonist,DRD1|DRD2|DRD3|DRD4|HTR2A,,haloperidol,,CID3559,3559,,
,MCF7,breast,cID_4316,tribenoside,8.4uM,concordanceLib2,,perturbagen,tribenoside_0.0000084,control,LIB_2,LSM-1671,11.0,2.0,,,CMAP_4316,,,,Anti-inflammatory agent|Capillary stabilizing agent,,,tribenoside,,CID196122,196122,,
,MCF7,breast,cID_433,haloperidol,"10uM,10.6uM",concordanceLib2,,perturbagen,"haloperidol_0.00001,0.0000106",control,LIB_2,LSM-3512,62.0,19.0,,,CMAP_433,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor inverse agonist,DRD1|DRD2|DRD3|DRD4|HTR2A,,haloperidol,,CID3559,3559,,
,MCF7,breast,cID_4348,rimexolone,10.8uM,concordanceLib2,,perturbagen,rimexolone_0.0000108,control,LIB_2,LSM-2685,12.0,2.0,,,CMAP_4348,,,,Glucocorticoid receptor agonist,NR3C1,,rimexolone,,CID5311412,5311412,,
,MCF7,breast,cID_4402,procarbazine,15.6uM,concordanceLib2,,perturbagen,procarbazine_0.0000156,control,LIB_2,LSM-2272,11.0,2.0,,,CMAP_4402,,,,Monoamine oxidase inhibitor,,,procarbazine,,CID4915,4915,,
,MCF7,breast,cID_4406,penbutolol,5.8uM,concordanceLib2,,perturbagen,penbutolol_0.0000058,control,LIB_2,LSM-43256,12.0,2.0,,,CMAP_4406,,,,Adrenergic receptor antagonist,ADRB2,,penbutolol,,CID4724,4724,,
,MCF7,breast,cID_4414,naftifine,12.4uM,concordanceLib2,,perturbagen,naftifine_0.0000124,control,LIB_2,LSM-43018,11.0,2.0,,,CMAP_4414,,,,Squalene monooxygenase inhibitor,,,naftifine,,CID47641,47641,,
,MCF7,breast,cID_442,chlorpromazine,11.2uM,concordanceLib2,,perturbagen,chlorpromazine_0.0000112,control,LIB_2,LSM-4017,12.0,2.0,,,CMAP_442,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,,chlorpromazine,,CID2726,2726,,
,PC3,prostate,cID_443,chlorpromazine,11.2uM,concordanceLib2,,perturbagen,chlorpromazine_0.0000112,control,LIB_2,LSM-4017,11.0,2.0,,,CMAP_443,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,,chlorpromazine,,CID2726,2726,,
,PC3,prostate,cID_446,chlorpromazine,"1uM,11.2uM",concordanceLib2,,perturbagen,"chlorpromazine_0.000001,0.0000112",control,LIB_2,LSM-4017,23.0,4.0,,,CMAP_446,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|D2-like dopamine receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,,chlorpromazine,,CID2726,2726,,
,MCF7,breast,cID_449,trifluoperazine,10uM,concordanceLib2,,perturbagen,trifluoperazine_0.00001,control,LIB_2,LSM-4010,37.0,7.0,,,CMAP_449,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,trifluoperazine,,CID5566,5566,,
,MCF7,breast,cID_4492,tetroquinone,21uM,concordanceLib2,,perturbagen,tetroquinone_0.000021,control,LIB_2,LSM-5953,12.0,2.0,,,CMAP_4492,,,,,,,tetroquinone,,CID36689751,36689751,,
,HL60,haematopoietic and lymphoid tissue,cID_450,trifluoperazine,10uM,concordanceLib2,,perturbagen,trifluoperazine_0.00001,control,LIB_2,LSM-4010,17.0,3.0,,,CMAP_450,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,trifluoperazine,,CID5566,5566,,
,MCF7,breast,cID_4502,simvastatin,9.6uM,concordanceLib2,,perturbagen,simvastatin_0.0000096,control,LIB_2,LSM-2492,12.0,2.0,,,CMAP_4502,,,,HMG-CoA reductase inhibitor,HMGCR,,simvastatin,,CID54454,54454,,
,MCF7,breast,cID_4508,trimipramine,9.8uM,concordanceLib2,,perturbagen,trimipramine_0.0000098,control,LIB_2,LSM-1371,12.0,2.0,,,CMAP_4508,,,,Histamine H1 receptor antagonist|Dopamine D2 receptor antagonist|Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|Norepinephrine transporter inhibitor|Adrenergic receptor alpha-1 antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,,trimipramine,,CID5584,5584,,
,PC3,prostate,cID_451,trifluoperazine,10uM,concordanceLib2,,perturbagen,trifluoperazine_0.00001,control,LIB_2,LSM-4010,12.0,2.0,,,CMAP_451,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,trifluoperazine,,CID5566,5566,,
,MCF7,breast,cID_4524,mestranol,12.8uM,concordanceLib2,,perturbagen,mestranol_0.0000128,control,LIB_2,LSM-2693,12.0,2.0,,,CMAP_4524,,,,Estrogen receptor alpha agonist,ESR1,,mestranol,,CID6291,6291,,
,MCF7,breast,cID_453,trifluoperazine,8.4uM,concordanceLib2,,perturbagen,trifluoperazine_0.0000084,control,LIB_2,LSM-4010,11.0,2.0,,,CMAP_453,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,trifluoperazine,,CID5566,5566,,
,MCF7,breast,cID_4536,chloropyramine,12.2uM,concordanceLib2,,perturbagen,chloropyramine_0.0000122,control,LIB_2,LSM-5896,12.0,2.0,,,CMAP_4536,,,,Histamine receptor antagonist,HRH1,,chloropyramine,,CID25295,25295,,
,MCF7,breast,cID_454,trifluoperazine,"10uM,8.4uM",concordanceLib2,,perturbagen,"trifluoperazine_0.00001,0.0000084",control,LIB_2,LSM-4010,48.0,9.0,,,CMAP_454,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,trifluoperazine,,CID5566,5566,,
,HL60,haematopoietic and lymphoid tissue,cID_455,trifluoperazine,"10uM,8.4uM",concordanceLib2,,perturbagen,"trifluoperazine_0.00001,0.0000084",control,LIB_2,LSM-4010,23.0,4.0,,,CMAP_455,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,trifluoperazine,,CID5566,5566,,
,PC3,prostate,cID_456,trifluoperazine,"10uM,8.4uM",concordanceLib2,,perturbagen,"trifluoperazine_0.00001,0.0000084",control,LIB_2,LSM-4010,18.0,3.0,,,CMAP_456,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,trifluoperazine,,CID5566,5566,,
,MCF7,breast,cID_4576,lasalocid,6.6uM,concordanceLib2,,perturbagen,lasalocid_0.0000066,control,LIB_2,LSM-2214,11.0,2.0,,,CMAP_4576,,,,Bacterial permeability inducer,,,lasalocid,,CID5360807,5360807,,
,MCF7,breast,cID_459,iloprost,1uM,concordanceLib2,,perturbagen,iloprost_0.000001,control,LIB_2,LSM-43147,2.0,2.0,,,CMAP_459,,,,Prostanoid IP receptor agonist,PTGER1|PTGER2|PTGIR,,iloprost,,CID5311181,5311181,,
,MCF7,breast,cID_4622,phthalylsulfathiazole,10uM,concordanceLib2,,perturbagen,phthalylsulfathiazole_0.00001,control,LIB_2,LSM-5730,18.0,3.0,,,CMAP_4622,,,,Dihydropteroate synthetase inhibitor,,,phthalylsulfathiazole,,CID4806,4806,,
,MCF7,breast,cID_4630,sulconazole,8.6uM,concordanceLib2,,perturbagen,sulconazole_0.0000086,control,LIB_2,LSM-1751,12.0,2.0,,,CMAP_4630,,,,Cytochrome P450 51 inhibitor,,,sulconazole,,CID5318,5318,,
,MCF7,breast,cID_4634,aminophylline,9.6uM,concordanceLib2,,perturbagen,aminophylline_0.0000096,control,LIB_2,LSM-6010,11.0,2.0,,,CMAP_4634,,,,Adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE3A|PDE4A|PDE4B,,aminophylline,,CID2153,2153,,
,MCF7,breast,cID_4642,profenamine,11.4uM,concordanceLib2,,perturbagen,profenamine_0.0000114,control,LIB_2,LSM-1342,12.0,2.0,,,CMAP_4642,,,,Muscarinic acetylcholine receptor M1 antagonist,CHRM1,,profenamine,,CID3290,3290,,
,MCF7,breast,cID_4646,equilin,15uM,concordanceLib2,,perturbagen,equilin_0.000015,control,LIB_2,LSM-2063,18.0,3.0,,,CMAP_4646,,,,Estrogen receptor agonist,HSD17B1,,equilin,,CID223368,223368,,
,MCF7,breast,cID_4654,luteolin,14uM,concordanceLib2,,perturbagen,luteolin_0.000014,control,LIB_2,LSM-5229,12.0,2.0,,,CMAP_4654,,,,Glucosidase inhibitor,,,luteolin,,CID5280445,5280445,,
,MCF7,breast,cID_4682,propofol,22.4uM,concordanceLib2,,perturbagen,propofol_0.0000224,control,LIB_2,LSM-3847,12.0,2.0,,,CMAP_4682,,,,GABA-A receptor; anion channel positive allosteric modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,,propofol,,CID4943,4943,,
,MCF7,breast,cID_4690,crotamiton,19.6uM,concordanceLib2,,perturbagen,crotamiton_0.0000196,control,LIB_2,LSM-42989,11.0,2.0,,,CMAP_4690,,,,Antipruritic,,,crotamiton,,CID688020,688020,,
,MCF7,breast,cID_47,estradiol,14.6uM,concordanceLib2,,perturbagen,estradiol_0.0000146,control,LIB_2,LSM-2421,11.0,2.0,,,CMAP_47,,,,Estrogen receptor alpha agonist,ESR1|ESR2|NR1I2,,estradiol,,CID5757,5757,,
,MCF7,breast,cID_4704,monobenzone,20uM,concordanceLib2,,perturbagen,monobenzone_0.00002,control,LIB_2,LSM-5642,12.0,2.0,,,CMAP_4704,,,,Tyrosinase inhibitor,TYR,,monobenzone,,CID7638,7638,,
,MCF7,breast,cID_4724,digoxigenin,10.2uM,concordanceLib2,,perturbagen,digoxigenin_0.0000102,control,LIB_2,LSM-2405,18.0,3.0,,,CMAP_4724,,,,Steroid,,,digoxigenin,,CID15478,15478,,
,MCF7,breast,cID_475,prochlorperazine,10uM,concordanceLib2,,perturbagen,prochlorperazine_0.00001,control,LIB_2,LSM-2436,37.0,7.0,,,CMAP_475,,,,Dopamine D2 receptor antagonist,DRD2,,prochlorperazine,,CID4917,4917,,
,HL60,haematopoietic and lymphoid tissue,cID_476,prochlorperazine,10uM,concordanceLib2,,perturbagen,prochlorperazine_0.00001,control,LIB_2,LSM-2436,17.0,3.0,,,CMAP_476,,,,Dopamine D2 receptor antagonist,DRD2,,prochlorperazine,,CID4917,4917,,
,MCF7,breast,cID_4760,butyl hydroxybenzoate,20.6uM,concordanceLib2,,perturbagen,butyl hydroxybenzoate_0.0000206,control,LIB_2,LSM-2161,18.0,3.0,,,CMAP_4760,,,,,,,butyl hydroxybenzoate,,CID7184,7184,,
,MCF7,breast,cID_4768,estrone,14.8uM,concordanceLib2,,perturbagen,estrone_0.0000148,control,LIB_2,LSM-3837,12.0,2.0,,,CMAP_4768,,,,Estrogen receptor alpha agonist,ESR1,,estrone,,CID5870,5870,,
,PC3,prostate,cID_477,prochlorperazine,10uM,concordanceLib2,,perturbagen,prochlorperazine_0.00001,control,LIB_2,LSM-2436,12.0,2.0,,,CMAP_477,,,,Dopamine D2 receptor antagonist,DRD2,,prochlorperazine,,CID4917,4917,,
,MCF7,breast,cID_479,prochlorperazine,6.6uM,concordanceLib2,,perturbagen,prochlorperazine_0.0000066,control,LIB_2,LSM-2436,11.0,2.0,,,CMAP_479,,,,Dopamine D2 receptor antagonist,DRD2,,prochlorperazine,,CID4917,4917,,
,MCF7,breast,cID_4792,lorglumide,8.4uM,concordanceLib2,,perturbagen,lorglumide_0.0000084,control,LIB_2,LSM-4389,18.0,3.0,,,CMAP_4792,,,,CCK receptor antagonist,CCKAR|CCKBR,,lorglumide,,CID3960,3960,,
,MCF7,breast,cID_4796,tonzonium bromide,6.8uM,concordanceLib2,,perturbagen,tonzonium bromide_0.0000068,control,LIB_2,LSM-5312,11.0,2.0,,,CMAP_4796,,,,ATPase inhibitor,,,tonzonium bromide,,CID5456,5456,,
,MCF7,breast,cID_48,estradiol,"0.01uM,0.1uM",concordanceLib2,,perturbagen,"estradiol_0.00000001,0.0000001,0.0000146",control,LIB_2,LSM-2421,57.0,19.0,,,CMAP_48,,,,Estrogen receptor alpha agonist,ESR1|ESR2|NR1I2,,estradiol,,CID5757,5757,,
,MCF7,breast,cID_480,prochlorperazine,"10uM,6.6uM",concordanceLib2,,perturbagen,"prochlorperazine_0.00001,0.0000066",control,LIB_2,LSM-2436,48.0,9.0,,,CMAP_480,,,,Dopamine D2 receptor antagonist,DRD2,,prochlorperazine,,CID4917,4917,,
,HL60,haematopoietic and lymphoid tissue,cID_481,prochlorperazine,"10uM,6.6uM",concordanceLib2,,perturbagen,"prochlorperazine_0.00001,0.0000066",control,LIB_2,LSM-2436,23.0,4.0,,,CMAP_481,,,,Dopamine D2 receptor antagonist,DRD2,,prochlorperazine,,CID4917,4917,,
,MCF7,breast,cID_4816,clioquinol,13uM,concordanceLib2,,perturbagen,clioquinol_0.000013,control,LIB_2,LSM-2186,18.0,3.0,,,CMAP_4816,,,,Chelating agent,,,clioquinol,,CID2788,2788,,
,PC3,prostate,cID_482,prochlorperazine,"10uM,6.6uM",concordanceLib2,,perturbagen,"prochlorperazine_0.00001,0.0000066",control,LIB_2,LSM-2436,18.0,3.0,,,CMAP_482,,,,Dopamine D2 receptor antagonist,DRD2,,prochlorperazine,,CID4917,4917,,
,MCF7,breast,cID_4824,fluspirilene,8.4uM,concordanceLib2,,perturbagen,fluspirilene_0.0000084,control,LIB_2,LSM-3748,12.0,2.0,,,CMAP_4824,,,,Dopamine receptor antagonist,DRD2|HTR2A,,fluspirilene,,CID3396,3396,,
,MCF7,breast,cID_4844,oxybenzone,17.6uM,concordanceLib2,,perturbagen,oxybenzone_0.0000176,control,LIB_2,LSM-3309,11.0,2.0,,,CMAP_4844,,,,Lipase inhibitor,,,oxybenzone,,CID4632,4632,,
,MCF7,breast,cID_4858,prasterone,12.2uM,concordanceLib2,,perturbagen,prasterone_0.0000122,control,LIB_2,LSM-4181,12.0,2.0,,,CMAP_4858,,,,GABA receptor modulator,,,prasterone,,CID14709,14709,,
,MCF7,breast,cID_4870,dioxybenzone,16.4uM,concordanceLib2,,perturbagen,dioxybenzone_0.0000164,control,LIB_2,LSM-2493,11.0,2.0,,,CMAP_4870,,,,Topical sunscreen agent,,,dioxybenzone,,CID8569,8569,,
,MCF7,breast,cID_4874,etynodiol,10.4uM,concordanceLib2,,perturbagen,etynodiol_0.0000104,control,LIB_2,,12.0,2.0,,,CMAP_4874,,,,,,,etynodiol,,CID9270,9270,,
,MCF7,breast,cID_4888,chrysin,15.8uM,concordanceLib2,,perturbagen,chrysin_0.0000158,control,LIB_2,LSM-6566,12.0,2.0,,,CMAP_4888,,,,,,,chrysin,,CID5281607,5281607,,
,MCF7,breast,cID_489,deferoxamine,100uM,concordanceLib2,,perturbagen,deferoxamine_0.0001,control,LIB_2,LSM-6541,2.0,2.0,,,CMAP_489,,,,,,,deferoxamine,,CID62881,62881,,
,MCF7,breast,cID_4934,protriptyline,13.4uM,concordanceLib2,,perturbagen,protriptyline_0.0000134,control,LIB_2,LSM-2936,11.0,2.0,,,CMAP_4934,,,,Serotonin transporter inhibitor|Norepinephrine transporter inhibitor,SLC6A2|SLC6A4,,protriptyline,,CID4976,4976,,
,PC3,prostate,cID_494,deferoxamine,"100uM,6uM",concordanceLib2,,perturbagen,"deferoxamine_0.0001,0.000006",control,LIB_2,LSM-6541,13.0,3.0,,,CMAP_494,,,,,,,deferoxamine,,CID62881,62881,,
,MCF7,breast,cID_495,calmidazolium,5uM,concordanceLib2,,perturbagen,calmidazolium_0.000005,control,LIB_2,LSM-5017,7.0,2.0,,,CMAP_495,,,,Calcium channel blocker|Calmodulin antagonist,ATP2B1|PDE1A,,calmidazolium,,CID2531,2531,,
,MCF7,breast,cID_4986,pizotifen,9.4uM,concordanceLib2,,perturbagen,pizotifen_0.0000094,control,LIB_2,LSM-3695,12.0,2.0,,,CMAP_4986,,,,Serotonin receptor antagonist,HTR2A|HTR2C,,pizotifen,,CID27400,27400,,
,MCF7,breast,cID_501,fluphenazine,10uM,concordanceLib2,,perturbagen,fluphenazine_0.00001,control,LIB_2,LSM-3226,43.0,8.0,,,CMAP_501,,,,Dopamine D2 receptor antagonist,DRD1|DRD2,,fluphenazine,,CID3372,3372,,
,MCF7,breast,cID_5022,deptropine,7.6uM,concordanceLib2,,perturbagen,deptropine_0.0000076,control,LIB_2,LSM-5115,12.0,2.0,,,CMAP_5022,,,,Histamine receptor antagonist,HRH1,,deptropine,,CID203911,203911,,
,PC3,prostate,cID_503,fluphenazine,10uM,concordanceLib2,,perturbagen,fluphenazine_0.00001,control,LIB_2,LSM-3226,12.0,2.0,,,CMAP_503,,,,Dopamine D2 receptor antagonist,DRD1|DRD2,,fluphenazine,,CID3372,3372,,
,MCF7,breast,cID_5030,clofilium tosylate,7.8uM,concordanceLib2,,perturbagen,clofilium tosylate_0.0000078,control,LIB_2,LSM-5214,11.0,2.0,,,CMAP_5030,,,,Potassium channel blocker,,,clofilium tosylate,,CID2798,2798,,
,MCF7,breast,cID_5042,mitoxantrone,7.8uM,concordanceLib2,,perturbagen,mitoxantrone_0.0000078,control,LIB_2,LSM-2481,12.0,2.0,,,CMAP_5042,,,,DNA topoisomerase II alpha inhibitor,TOP2A,,mitoxantrone,,CID4212,4212,,
,MCF7,breast,cID_5050,doxorubicin,6.8uM,concordanceLib2,,perturbagen,doxorubicin_0.0000068,control,LIB_2,LSM-4062,11.0,2.0,,,CMAP_5050,,,,DNA topoisomerase II alpha inhibitor,TOP2A,,doxorubicin,,CID31703,31703,,
,MCF7,breast,cID_5058,azacitidine,16.4uM,concordanceLib2,,perturbagen,azacitidine_0.0000164,control,LIB_2,LSM-5218,11.0,2.0,,,CMAP_5058,,,,DNA (cytosine-5)-methyltransferase 3A inhibitor (DNA|DNA (cytosine-5)-methyltransferase 1 inhibitor (DNA,DNMT1|DNMT3A,,azacitidine,,CID9444,9444,,
,MCF7,breast,cID_506,fluphenazine,"10uM,7.8uM",concordanceLib2,,perturbagen,"fluphenazine_0.00001,0.0000078",control,LIB_2,LSM-3226,54.0,10.0,,,CMAP_506,,,,Dopamine D2 receptor antagonist,DRD1|DRD2,,fluphenazine,,CID3372,3372,,
,PC3,prostate,cID_5063,fluocinonide,8uM,concordanceLib2,,perturbagen,fluocinonide_0.000008,control,LIB_2,LSM-19002,12.0,2.0,,,CMAP_5063,,,,Glucocorticoid receptor agonist,NR3C1,,fluocinonide,,CID9642,9642,,
,PC3,prostate,cID_508,fluphenazine,"10uM,7.8uM",concordanceLib2,,perturbagen,"fluphenazine_0.00001,0.0000078",control,LIB_2,LSM-3226,18.0,3.0,,,CMAP_508,,,,Dopamine D2 receptor antagonist,DRD1|DRD2,,fluphenazine,,CID3372,3372,,
,MCF7,breast,cID_5080,levomepromazine,9uM,concordanceLib2,,perturbagen,levomepromazine_0.000009,control,LIB_2,LSM-2778,12.0,2.0,,,CMAP_5080,,,,D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4,,levomepromazine,,CID72287,72287,,
,PC3,prostate,cID_5081,levomepromazine,9uM,concordanceLib2,,perturbagen,levomepromazine_0.000009,control,LIB_2,LSM-2778,11.0,2.0,,,CMAP_5081,,,,D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4,,levomepromazine,,CID72287,72287,,
,MCF7,breast,cID_5086,dienestrol,15uM,concordanceLib2,,perturbagen,dienestrol_0.000015,control,LIB_2,LSM-43043,11.0,2.0,,,CMAP_5086,,,,Estrogen receptor alpha agonist,ESR1,,dienestrol,,CID667476,667476,,
,MCF7,breast,cID_5120,cyproterone,9.6uM,concordanceLib2,,perturbagen,cyproterone_0.0000096,control,LIB_2,LSM-45961,12.0,2.0,,,CMAP_5120,,,,,,,cyproterone,,CID9880,9880,,
,MCF7,breast,cID_5136,saquinavir,5.2uM,concordanceLib2,,perturbagen,saquinavir_0.0000052,control,LIB_2,LSM-2205,12.0,2.0,,,CMAP_5136,,,,Human immunodeficiency virus type 1 protease inhibitor,,,saquinavir,,CID441243,441243,,
,MCF7,breast,cID_5140,sertaconazole,8uM,concordanceLib2,,perturbagen,sertaconazole_0.000008,control,LIB_2,LSM-1938,12.0,2.0,,,CMAP_5140,,,,Cytochrome P450 51 inhibitor,,,sertaconazole,,CID65863,65863,,
,MCF7,breast,cID_5162,verteporfin,2.8uM,concordanceLib2,,perturbagen,verteporfin_0.0000028,control,LIB_2,LSM-44934,12.0,2.0,,,CMAP_5162,,,,Photosensitizing agent,,,verteporfin,,CID91122153,91122153,,
,MCF7,breast,cID_5172,trifluridine,13.6uM,concordanceLib2,,perturbagen,trifluridine_0.0000136,control,LIB_2,LSM-5217,11.0,2.0,,,CMAP_5172,,,,DNA directed DNA polymerase inhibitor|Thymidylate synthase inhibitor,TYMS,,trifluridine,,CID6256,6256,,
,MCF7,breast,cID_5184,cycloserine,39.2uM,concordanceLib2,,perturbagen,cycloserine_0.0000392,control,LIB_2,LSM-5932,11.0,2.0,,,CMAP_5184,,,,D-alanylalanine synthetase inhibitor|Alanine racemase inhibitor,,,cycloserine,,CID6234,6234,,
,MCF7,breast,cID_5188,estriol,13.8uM,concordanceLib2,,perturbagen,estriol_0.0000138,control,LIB_2,LSM-2368,12.0,2.0,,,CMAP_5188,,,,Estrogen receptor agonist,ESR1|ESR2,,estriol,,CID5756,5756,,
,MCF7,breast,cID_5228,piperacetazine,9.8uM,concordanceLib2,,perturbagen,piperacetazine_0.0000098,control,LIB_2,LSM-2355,11.0,2.0,,,CMAP_5228,,,,Dopamine receptor antagonist,,,piperacetazine,,CID19675,19675,,
,MCF7,breast,cID_524,geldanamycin,1uM,concordanceLib2,,perturbagen,geldanamycin_0.000001,control,LIB_2,LSM-42789,50.0,10.0,,,CMAP_524,,,,HSP inhibitor,HSP90AA1,,geldanamycin,,CID5288382,5288382,,
,MCF7,breast,cID_5248,kaempferol,14uM,concordanceLib2,,perturbagen,kaempferol_0.000014,control,LIB_2,LSM-5304,11.0,2.0,,,CMAP_5248,,,,Bone resorption inhibitor|Estrogen-related receptor inverse agonist,,,kaempferol,,CID5280863,5280863,,
,HL60,haematopoietic and lymphoid tissue,cID_525,geldanamycin,1uM,concordanceLib2,,perturbagen,geldanamycin_0.000001,control,LIB_2,LSM-42789,17.0,3.0,,,CMAP_525,,,,HSP inhibitor,HSP90AA1,,geldanamycin,,CID5288382,5288382,,
,PC3,prostate,cID_526,geldanamycin,1uM,concordanceLib2,,perturbagen,geldanamycin_0.000001,control,LIB_2,LSM-42789,12.0,2.0,,,CMAP_526,,,,HSP inhibitor,HSP90AA1,,geldanamycin,,CID5288382,5288382,,
,MCF7,breast,cID_5260,oxyphenbutazone,12.4uM,concordanceLib2,,perturbagen,oxyphenbutazone_0.0000124,control,LIB_2,LSM-5029,12.0,2.0,,,CMAP_5260,,,,Cyclooxygenase inhibitor,PTGS1|PTGS2,,oxyphenbutazone,,CID4641,4641,,
,MCF7,breast,cID_5264,propoxycaine,12uM,concordanceLib2,,perturbagen,propoxycaine_0.000012,control,LIB_2,LSM-2397,11.0,2.0,,,CMAP_5264,,,,Sodium channel alpha subunit blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,propoxycaine,,CID6843,6843,,
,MCF7,breast,cID_5268,PNU-0230031,10uM,concordanceLib2,,perturbagen,PNU-0230031_0.00001,control,LIB_2,LSM-5805,12.0,2.0,,,CMAP_5268,,,,,,,PNU-0230031,,,,,
,PC3,prostate,cID_5269,PNU-0230031,10uM,concordanceLib2,,perturbagen,PNU-0230031_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5269,,,,,,,PNU-0230031,,,,,
,MCF7,breast,cID_5277,0179445-0000,10uM,concordanceLib2,,perturbagen,0179445-0000_0.00001,control,LIB_2,LSM-5805,12.0,2.0,,,CMAP_5277,,,,,,,0179445-0000,,,,,
,PC3,prostate,cID_5278,0179445-0000,10uM,concordanceLib2,,perturbagen,0179445-0000_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5278,,,,,,,0179445-0000,,,,,
,MCF7,breast,cID_5282,0179445-0000,"10uM,1uM",concordanceLib2,,perturbagen,"0179445-0000_0.00001,0.000001",control,LIB_2,LSM-5805,12.0,4.0,,,CMAP_5282,,,,,,,0179445-0000,,,,,
,PC3,prostate,cID_5283,0179445-0000,"10uM,1uM",concordanceLib2,,perturbagen,"0179445-0000_0.00001,0.000001",control,LIB_2,LSM-5805,11.0,4.0,,,CMAP_5283,,,,,,,0179445-0000,,,,,
,PC3,prostate,cID_5286,PNU-0251126,10uM,concordanceLib2,,perturbagen,PNU-0251126_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5286,,,,,,,PNU-0251126,,,,,
,PC3,prostate,cID_5290,PNU-0251126,"10uM,1uM",concordanceLib2,,perturbagen,"PNU-0251126_0.00001,0.000001",control,LIB_2,LSM-5805,11.0,4.0,,,CMAP_5290,,,,,,,PNU-0251126,,,,,
,PC3,prostate,cID_5293,0173570-0000,10uM,concordanceLib2,,perturbagen,0173570-0000_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5293,,,,,,,0173570-0000,,,,,
,PC3,prostate,cID_5295,0173570-0000,1uM,concordanceLib2,,perturbagen,0173570-0000_0.000001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5295,,,,,,,0173570-0000,,,,,
,MCF7,breast,cID_5296,0173570-0000,"10uM,1uM",concordanceLib2,,perturbagen,"0173570-0000_0.00001,0.000001",control,LIB_2,LSM-5805,6.0,2.0,,,CMAP_5296,,,,,,,0173570-0000,,,,,
,PC3,prostate,cID_5297,0173570-0000,"10uM,1uM",concordanceLib2,,perturbagen,"0173570-0000_0.00001,0.000001",control,LIB_2,LSM-5805,11.0,4.0,,,CMAP_5297,,,,,,,0173570-0000,,,,,
,PC3,prostate,cID_5300,0175029-0000,10uM,concordanceLib2,,perturbagen,0175029-0000_0.00001,control,LIB_2,LSM-5805,7.0,2.0,,,CMAP_5300,,,,,,,0175029-0000,,,,,
,PC3,prostate,cID_5302,0175029-0000,1uM,concordanceLib2,,perturbagen,0175029-0000_0.000001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5302,,,,,,,0175029-0000,,,,,
,MCF7,breast,cID_5303,0175029-0000,"10uM,1uM",concordanceLib2,,perturbagen,"0175029-0000_0.00001,0.000001",control,LIB_2,LSM-5805,6.0,2.0,,,CMAP_5303,,,,,,,0175029-0000,,,,,
,PC3,prostate,cID_5304,0175029-0000,"10uM,1uM",concordanceLib2,,perturbagen,"0175029-0000_0.00001,0.000001",control,LIB_2,LSM-5805,12.0,4.0,,,CMAP_5304,,,,,,,0175029-0000,,,,,
,MCF7,breast,cID_5307,PHA-00851261E,10uM,concordanceLib2,,perturbagen,PHA-00851261E_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5307,,,,,,,PHA-00851261E,,,,,
,MCF7,breast,cID_531,resveratrol,10uM,concordanceLib2,,perturbagen,resveratrol_0.00001,control,LIB_2,LSM-42917,12.0,2.0,,,CMAP_531,,,,Cytochrome P450 inhibitor|SIRT activator,PTGS1|PTGS2|SIRT1,,resveratrol,,CID445154,445154,,
,MCF7,breast,cID_5316,0317956-0000,10uM,concordanceLib2,,perturbagen,0317956-0000_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5316,,,,,,,0317956-0000,,,,,
,MCF7,breast,cID_5319,0317956-0000,1uM,concordanceLib2,,perturbagen,0317956-0000_0.000001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5319,,,,,,,0317956-0000,,,,,
,MCF7,breast,cID_5321,0317956-0000,"10uM,1uM",concordanceLib2,,perturbagen,"0317956-0000_0.00001,0.000001",control,LIB_2,LSM-5805,11.0,4.0,,,CMAP_5321,,,,,,,0317956-0000,,,,,
,MCF7,breast,cID_534,resveratrol,50uM,concordanceLib2,,perturbagen,resveratrol_0.00005,control,LIB_2,LSM-42917,2.0,2.0,,,CMAP_534,,,,Cytochrome P450 inhibitor|SIRT activator,PTGS1|PTGS2|SIRT1,,resveratrol,,CID445154,445154,,
,MCF7,breast,cID_5355,Prestwick-1080,15uM,concordanceLib2,,perturbagen,Prestwick-1080_0.000015,control,LIB_2,LSM-4894,11.0,2.0,,,CMAP_5355,,,,Anthelmintic agent,,,Prestwick-1080,,CID6604471,6604471,,
,MCF7,breast,cID_536,resveratrol,17.6uM,concordanceLib2,,perturbagen,resveratrol_0.0000176,control,LIB_2,LSM-42917,12.0,2.0,,,CMAP_536,,,,Cytochrome P450 inhibitor|SIRT activator,PTGS1|PTGS2|SIRT1,,resveratrol,,CID445154,445154,,
,MCF7,breast,cID_537,resveratrol,"50uM,10uM,0uM",concordanceLib2,,perturbagen,"resveratrol_0.00005,0.00001,0.0000176",control,LIB_2,LSM-42917,26.0,6.0,,,CMAP_537,,,,Cytochrome P450 inhibitor|SIRT activator,PTGS1|PTGS2|SIRT1,,resveratrol,,CID445154,445154,,
,MCF7,breast,cID_5373,parbendazole,16.2uM,concordanceLib2,,perturbagen,parbendazole_0.0000162,control,LIB_2,LSM-4893,11.0,2.0,,,CMAP_5373,,,,Tubulin inhibitor,TUBB,,parbendazole,,CID26596,26596,,
,PC3,prostate,cID_5374,parbendazole,16.2uM,concordanceLib2,,perturbagen,parbendazole_0.0000162,control,LIB_2,LSM-4893,12.0,2.0,,,CMAP_5374,,,,Tubulin inhibitor,TUBB,,parbendazole,,CID26596,26596,,
,PC3,prostate,cID_538,resveratrol,"50uM,17.6uM",concordanceLib2,,perturbagen,"resveratrol_0.00005,0.0000176",control,LIB_2,LSM-42917,6.0,2.0,,,CMAP_538,,,,Cytochrome P450 inhibitor|SIRT activator,PTGS1|PTGS2|SIRT1,,resveratrol,,CID445154,445154,,
,MCF7,breast,cID_5397,withaferin A,1uM,concordanceLib2,,perturbagen,withaferin A_0.000001,control,LIB_2,LSM-6685,11.0,2.0,,,CMAP_5397,,,,IKK inhibitor,IKBKB|NAMPT,,withaferin A,,CID265237,265237,,
,PC3,prostate,cID_5398,withaferin A,1uM,concordanceLib2,,perturbagen,withaferin A_0.000001,control,LIB_2,LSM-6685,12.0,2.0,,,CMAP_5398,,,,IKK inhibitor,IKBKB|NAMPT,,withaferin A,,CID265237,265237,,
,MCF7,breast,cID_541,nocodazole,13.2uM,concordanceLib2,,perturbagen,nocodazole_0.0000132,control,LIB_2,LSM-2260,11.0,2.0,,,CMAP_541,,,,Tubulin inhibitor,,,nocodazole,,CID4122,4122,,
,MCF7,breast,cID_5415,CP-320650-01,10uM,concordanceLib2,,perturbagen,CP-320650-01_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5415,,,,,,,CP-320650-01,,,,,
,PC3,prostate,cID_5416,CP-320650-01,10uM,concordanceLib2,,perturbagen,CP-320650-01_0.00001,control,LIB_2,LSM-5805,12.0,2.0,,,CMAP_5416,,,,,,,CP-320650-01,,,,,
,MCF7,breast,cID_5418,CP-320650-01,1uM,concordanceLib2,,perturbagen,CP-320650-01_0.000001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5418,,,,,,,CP-320650-01,,,,,
,PC3,prostate,cID_542,nocodazole,13.2uM,concordanceLib2,,perturbagen,nocodazole_0.0000132,control,LIB_2,LSM-2260,12.0,2.0,,,CMAP_542,,,,Tubulin inhibitor,,,nocodazole,,CID4122,4122,,
,MCF7,breast,cID_5420,CP-320650-01,"10uM,1uM",concordanceLib2,,perturbagen,"CP-320650-01_0.00001,0.000001",control,LIB_2,LSM-5805,11.0,4.0,,,CMAP_5420,,,,,,,CP-320650-01,,,,,
,MCF7,breast,cID_5424,CP-690334-01,10uM,concordanceLib2,,perturbagen,CP-690334-01_0.00001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5424,,,,,,,CP-690334-01,,,,,
,PC3,prostate,cID_5425,CP-690334-01,10uM,concordanceLib2,,perturbagen,CP-690334-01_0.00001,control,LIB_2,LSM-5805,12.0,2.0,,,CMAP_5425,,,,,,,CP-690334-01,,,,,
,MCF7,breast,cID_5427,CP-690334-01,1uM,concordanceLib2,,perturbagen,CP-690334-01_0.000001,control,LIB_2,LSM-5805,11.0,2.0,,,CMAP_5427,,,,,,,CP-690334-01,,,,,
,MCF7,breast,cID_5429,CP-690334-01,"10uM,1uM",concordanceLib2,,perturbagen,"CP-690334-01_0.00001,0.000001",control,LIB_2,LSM-5805,11.0,4.0,,,CMAP_5429,,,,,,,CP-690334-01,,,,,
,MCF7,breast,cID_543,nocodazole,"1uM,13.2uM",concordanceLib2,,perturbagen,"nocodazole_0.000001,0.0000132",control,LIB_2,LSM-2260,12.0,3.0,,,CMAP_543,,,,Tubulin inhibitor,,,nocodazole,,CID4122,4122,,
,PC3,prostate,cID_5430,CP-690334-01,"10uM,1uM",concordanceLib2,,perturbagen,"CP-690334-01_0.00001,0.000001",control,LIB_2,LSM-5805,12.0,4.0,,,CMAP_5430,,,,,,,CP-690334-01,,,,,
,MCF7,breast,cID_5442,rifabutin,4.8uM,concordanceLib2,,perturbagen,rifabutin_0.0000048,control,LIB_2,LSM-5004,11.0,2.0,,,CMAP_5442,,,,Protein synthesis inhibitor,,,rifabutin,,CID5482874,5482874,,
,MCF7,breast,cID_5450,clobetasol,8.6uM,concordanceLib2,,perturbagen,clobetasol_0.0000086,control,LIB_2,LSM-5281,12.0,2.0,,,CMAP_5450,,,,Glucocorticoid receptor agonist,NR3C1,,clobetasol,,CID32798,32798,,
,MCF7,breast,cID_5454,phenoxybenzamine,11.8uM,concordanceLib2,,perturbagen,phenoxybenzamine_0.0000118,control,LIB_2,LSM-1729,18.0,3.0,,,CMAP_5454,,,,Adrenergic receptor alpha antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,,phenoxybenzamine,,CID4768,4768,,
,MCF7,breast,cID_5462,daunorubicin,1uM,concordanceLib2,,perturbagen,daunorubicin_0.000001,control,LIB_2,LSM-2962,2.0,2.0,,,CMAP_5462,,,,DNA topoisomerase II alpha inhibitor,TOP2A,,daunorubicin,,CID30323,30323,,
,MCF7,breast,cID_5463,daunorubicin,"7uM,1uM",concordanceLib2,,perturbagen,"daunorubicin_0.000007,0.000001",control,LIB_2,LSM-2962,7.0,3.0,,,CMAP_5463,,,,DNA topoisomerase II alpha inhibitor,TOP2A,,daunorubicin,,CID30323,30323,,
,MCF7,breast,cID_547,colchicine,10uM,concordanceLib2,,perturbagen,colchicine_0.00001,control,LIB_2,LSM-5199,11.0,2.0,,,CMAP_547,,,,Tubulin inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,,colchicine,,CID6167,6167,,
,MCF7,breast,cID_5478,valinomycin,0.1uM,concordanceLib2,,perturbagen,valinomycin_0.0000001,control,LIB_2,LSM-6389,2.0,2.0,,,CMAP_5478,,,,,,,valinomycin,,CID5649,5649,,
,PC3,prostate,cID_5479,valinomycin,0.1uM,concordanceLib2,,perturbagen,valinomycin_0.0000001,control,LIB_2,LSM-6389,2.0,2.0,,,CMAP_5479,,,,,,,valinomycin,,CID5649,5649,,
,MCF7,breast,cID_548,colchicine,"0.1uM,10uM",concordanceLib2,,perturbagen,"colchicine_0.0000001,0.00001",control,LIB_2,LSM-5199,12.0,3.0,,,CMAP_548,,,,Tubulin inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,,colchicine,,CID6167,6167,,
,MCF7,breast,cID_5484,rotenone,1uM,concordanceLib2,,perturbagen,rotenone_0.000001,control,LIB_2,LSM-5260,2.0,2.0,,,CMAP_5484,,,,Mitochondrial complex I inhibitor,MT-ND1,,rotenone,,CID6758,6758,,
,PC3,prostate,cID_5485,rotenone,1uM,concordanceLib2,,perturbagen,rotenone_0.000001,control,LIB_2,LSM-5260,2.0,2.0,,,CMAP_5485,,,,Mitochondrial complex I inhibitor,MT-ND1,,rotenone,,CID6758,6758,,
,MCF7,breast,cID_5490,PF-00562151-00,10uM,concordanceLib2,,perturbagen,PF-00562151-00_0.00001,control,LIB_2,LSM-5805,4.0,4.0,,,CMAP_5490,,,,,,,PF-00562151-00,,,,,
,MCF7,breast,cID_5496,PF-00875133-00,10uM,concordanceLib2,,perturbagen,PF-00875133-00_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5496,,,,,,,PF-00875133-00,,,,,
,PC3,prostate,cID_5501,pioglitazone,10uM,concordanceLib2,,perturbagen,pioglitazone_0.00001,control,LIB_2,LSM-1592,5.0,5.0,,,CMAP_5501,,,,Peroxisome proliferator-activated receptor gamma agonist,PPARG,,pioglitazone,,CID4829,4829,,
,MCF7,breast,cID_5506,H-7,100uM,concordanceLib2,,perturbagen,H-7_0.0001,control,LIB_2,LSM-5082,2.0,2.0,,,CMAP_5506,,,,PKA inhibitor,,,H-7,,CID3542,3542,,
,PC3,prostate,cID_5507,H-7,100uM,concordanceLib2,,perturbagen,H-7_0.0001,control,LIB_2,LSM-5082,2.0,2.0,,,CMAP_5507,,,,PKA inhibitor,,,H-7,,CID3542,3542,,
,MCF7,breast,cID_552,benserazide,13.6uM,concordanceLib2,,perturbagen,benserazide_0.0000136,control,LIB_2,LSM-5097,12.0,2.0,,,CMAP_552,,,,DOPA decarboxylase inhibitor,DDC,,benserazide,,CID2327,2327,,
,MCF7,breast,cID_5556,5707885,50uM,concordanceLib2,,perturbagen,5707885_0.00005,control,LIB_2,LSM-6726,2.0,2.0,,,CMAP_5556,,,,,,,5707885,,CID2863472,2863472,,
,PC3,prostate,cID_5557,5707885,50uM,concordanceLib2,,perturbagen,5707885_0.00005,control,LIB_2,LSM-6726,2.0,2.0,,,CMAP_5557,,,,,,,5707885,,CID2863472,2863472,,
,MCF7,breast,cID_5562,C-75,10uM,concordanceLib2,,perturbagen,C-75_0.00001,control,LIB_2,LSM-6372,2.0,2.0,,,CMAP_5562,,,,,,,C-75,,CID4248455,4248455,,
,MCF7,breast,cID_5568,F0447-0125,10uM,concordanceLib2,,perturbagen,F0447-0125_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5568,,,,,,,F0447-0125,,,,,
,MCF7,breast,cID_5574,5155877,10uM,concordanceLib2,,perturbagen,5155877_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5574,,,,,,,5155877,,,,,
,PC3,prostate,cID_5575,5155877,10uM,concordanceLib2,,perturbagen,5155877_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5575,,,,,,,5155877,,,,,
,MCF7,breast,cID_5580,PHA-00767505E,10uM,concordanceLib2,,perturbagen,PHA-00767505E_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5580,,,,,,,PHA-00767505E,,,,,
,PC3,prostate,cID_5587,dinoprostone,10uM,concordanceLib2,,perturbagen,dinoprostone_0.00001,control,LIB_2,LSM-42919,2.0,2.0,,,CMAP_5587,,,,Prostaglandin E2 receptor agonist,PTGER1|PTGER2|PTGER3|PTGER4,,dinoprostone,,CID5280360,5280360,,
,MCF7,breast,cID_5592,5194442,20uM,concordanceLib2,,perturbagen,5194442_0.00002,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5592,,,,,,,5194442,,,,,
,MCF7,breast,cID_5602,6-bromoindirubin-3'-oxime,0.5uM,concordanceLib2,,perturbagen,6-bromoindirubin-3'-oxime_0.0000005,control,LIB_2,,3.0,3.0,,,CMAP_5602,,,,,,,6-bromoindirubin-3'-oxime,,CID5287844,5287844,,
,PC3,prostate,cID_5603,6-bromoindirubin-3'-oxime,0.5uM,concordanceLib2,,perturbagen,6-bromoindirubin-3'-oxime_0.0000005,control,LIB_2,,4.0,4.0,,,CMAP_5603,,,,,,,6-bromoindirubin-3'-oxime,,CID5287844,5287844,,
,PC3,prostate,cID_5608,Gly-His-Lys,1uM,concordanceLib2,,perturbagen,Gly-His-Lys_0.000001,control,LIB_2,LSM-6466,2.0,2.0,,,CMAP_5608,,,,,,,Gly-His-Lys,,CID22214678,22214678,,
,PC3,prostate,cID_5610,STOCK1N-35874,14uM,concordanceLib2,,perturbagen,STOCK1N-35874_0.000014,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5610,,,,,,,STOCK1N-35874,,,,,
,PC3,prostate,cID_5616,"16,16-dimethylprostaglandin E2",10uM,concordanceLib2,,perturbagen,"16,16-dimethylprostaglandin E2_0.00001",control,LIB_2,LSM-43285,2.0,2.0,,,CMAP_5616,,,,Prostanoid receptor agonist,HPGD,,"16,16-dimethylprostaglandin E2",,CID5283066,5283066,,
,PC3,prostate,cID_5620,PNU-0293363,10uM,concordanceLib2,,perturbagen,PNU-0293363_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5620,,,,,,,PNU-0293363,,,,,
,MCF7,breast,cID_5670,0297417-0002B,10uM,concordanceLib2,,perturbagen,0297417-0002B_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5670,,,,,,,0297417-0002B,,,,,
,PC3,prostate,cID_5674,scriptaid,10uM,concordanceLib2,,perturbagen,scriptaid_0.00001,control,LIB_2,LSM-2499,2.0,2.0,,,CMAP_5674,,,,HDAC inhibitor,HDAC1,,scriptaid,,CID5186,5186,,
,MCF7,breast,cID_5678,lomustine,100uM,concordanceLib2,,perturbagen,lomustine_0.0001,control,LIB_2,,2.0,2.0,,,CMAP_5678,,,,,,,lomustine,,CID3950,3950,,
,PC3,prostate,cID_5679,lomustine,100uM,concordanceLib2,,perturbagen,lomustine_0.0001,control,LIB_2,,2.0,2.0,,,CMAP_5679,,,,,,,lomustine,,CID3950,3950,,
,PC3,prostate,cID_5692,alsterpaullone,10uM,concordanceLib2,,perturbagen,alsterpaullone_0.00001,control,LIB_2,LSM-6558,2.0,2.0,,,CMAP_5692,,,,,,,alsterpaullone,,CID5005498,5005498,,
,MCF7,breast,cID_5702,thapsigargin,0.1uM,concordanceLib2,,perturbagen,thapsigargin_0.0000001,control,LIB_2,LSM-43008,2.0,2.0,,,CMAP_5702,,,,ATPase inhibitor,ATP2A1,,thapsigargin,,CID446378,446378,,
,MCF7,breast,cID_5712,GW-8510,10uM,concordanceLib2,,perturbagen,GW-8510_0.00001,control,LIB_2,LSM-43329,2.0,2.0,,,CMAP_5712,,,,,,,GW-8510,,CID6539118,6539118,,
,PC3,prostate,cID_5713,GW-8510,10uM,concordanceLib2,,perturbagen,GW-8510_0.00001,control,LIB_2,LSM-43329,2.0,2.0,,,CMAP_5713,,,,,,,GW-8510,,CID6539118,6539118,,
,PC3,prostate,cID_5718,MG-262,0.1uM,concordanceLib2,,perturbagen,MG-262_0.0000001,control,LIB_2,,2.0,2.0,,,CMAP_5718,,,,,,,MG-262,,CID490002,490002,,
,PC3,prostate,cID_5728,AR-A014418,10uM,concordanceLib2,,perturbagen,AR-A014418_0.00001,control,LIB_2,LSM-3514,2.0,2.0,,,CMAP_5728,,,,Glycogen synthase kinase inhibitor,GSK3B,,AR-A014418,,CID448014,448014,,
,PC3,prostate,cID_573,colforsin,0.5uM,concordanceLib2,,perturbagen,colforsin_0.0000005,control,LIB_2,LSM-2193,2.0,2.0,,,CMAP_573,,,,Adenylyl cyclase activator,ADCY2,,colforsin,,CID47936,47936,,
,PC3,prostate,cID_5738,MS-275,10uM,concordanceLib2,,perturbagen,MS-275_0.00001,control,LIB_2,LSM-4811,2.0,2.0,,,CMAP_5738,,,,Histone deacetylase inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,MS-275,,CID4261,4261,,
,MCF7,breast,cID_574,colforsin,"50uM,0.5uM",concordanceLib2,,perturbagen,"colforsin_0.00005,0.0000005",control,LIB_2,LSM-2193,7.0,2.0,,,CMAP_574,,,,Adenylyl cyclase activator,ADCY2,,colforsin,,CID47936,47936,,
,MCF7,breast,cID_5744,CP-319743,10uM,concordanceLib2,,perturbagen,CP-319743_0.00001,control,LIB_2,LSM-5805,2.0,2.0,,,CMAP_5744,,,,,,,CP-319743,,,,,
,MCF7,breast,cID_5750,semustine,100uM,concordanceLib2,,perturbagen,semustine_0.0001,control,LIB_2,LSM-6714,2.0,2.0,,,CMAP_5750,,,,,,,semustine,,CID5198,5198,,
,PC3,prostate,cID_5751,semustine,100uM,concordanceLib2,,perturbagen,semustine_0.0001,control,LIB_2,LSM-6714,2.0,2.0,,,CMAP_5751,,,,,,,semustine,,CID5198,5198,,
,MCF7,breast,cID_576,rottlerin,10uM,concordanceLib2,,perturbagen,rottlerin_0.00001,control,LIB_2,LSM-42845,18.0,3.0,,,CMAP_576,,,,MAP kinase inhibitor|Protein kinase inhibitor,,,rottlerin,,CID5281847,5281847,,
,PC3,prostate,cID_5763,15(S)-15-methylprostaglandin E2,10uM,concordanceLib2,,perturbagen,15(S)-15-methylprostaglandin E2_0.00001,control,LIB_2,,2.0,2.0,,,CMAP_5763,,,,,,,15(S)-15-methylprostaglandin E2,,CID20981549,20981549,,
,MCF7,breast,cID_5780,irinotecan,100uM,concordanceLib2,,perturbagen,irinotecan_0.0001,control,LIB_2,LSM-2167,2.0,2.0,,,CMAP_5780,,,,DNA topoisomerase I inhibitor,TOP1,,irinotecan,,CID60838,60838,,
,PC3,prostate,cID_5785,meteneprost,10uM,concordanceLib2,,perturbagen,meteneprost_0.00001,control,LIB_2,,2.0,2.0,,,CMAP_5785,,,,,,,meteneprost,,CID5283060,5283060,,
,MCF7,breast,cID_581,prazosin,10uM,concordanceLib2,,perturbagen,prazosin_0.00001,control,LIB_2,LSM-3079,12.0,2.0,,,CMAP_581,,,,Adrenergic receptor alpha-1 antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,,prazosin,,CID4893,4893,,
,PC3,prostate,cID_5813,"11-deoxy-16,16-dimethylprostaglandin E2",10uM,concordanceLib2,,perturbagen,"11-deoxy-16,16-dimethylprostaglandin E2_0.00001",control,LIB_2,,2.0,2.0,,,CMAP_5813,,,,,,,"11-deoxy-16,16-dimethylprostaglandin E2",,CID5283063,5283063,,
,MCF7,breast,cID_586,5252917,14uM,concordanceLib2,,perturbagen,5252917_0.000014,control,LIB_2,,12.0,2.0,,,CMAP_586,,,,,,,5252917,,CID1376691,1376691,,
,MCF7,breast,cID_603,carbamazepine,0.1uM,concordanceLib2,,perturbagen,carbamazepine_0.0000001,control,LIB_2,LSM-3610,18.0,3.0,,,CMAP_603,,,,Sodium channel alpha subunit blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,carbamazepine,,CID2554,2554,,
,MCF7,breast,cID_608,carbamazepine,"0.1uM,17uM",concordanceLib2,,perturbagen,"carbamazepine_0.0000001,0.000017",control,LIB_2,LSM-3610,30.0,5.0,,,CMAP_608,,,,Sodium channel alpha subunit blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,carbamazepine,,CID2554,2554,,
,MCF7,breast,cID_614,5248896,11uM,concordanceLib2,,perturbagen,5248896_0.000011,control,LIB_2,,12.0,2.0,,,CMAP_614,,,,,,,5248896,,CID23919054,23919054,,
,MCF7,breast,cID_618,5224221,12uM,concordanceLib2,,perturbagen,5224221_0.000012,control,LIB_2,LSM-5805,12.0,2.0,,,CMAP_618,,,,,,,5224221,,,,,
,MCF7,breast,cID_622,5279552,22uM,concordanceLib2,,perturbagen,5279552_0.000022,control,LIB_2,,12.0,2.0,,,CMAP_622,,,,,,,5279552,,CID911462,911462,,
,MCF7,breast,cID_626,5253409,17uM,concordanceLib2,,perturbagen,5253409_0.000017,control,LIB_2,LSM-37000,12.0,2.0,,,CMAP_626,,,,HDAC activator,,,5253409,,CID771910,771910,,
,MCF7,breast,cID_635,oxaprozin,300uM,concordanceLib2,,perturbagen,oxaprozin_0.0003,control,LIB_2,LSM-2553,12.0,2.0,,,CMAP_635,,,,Cyclooxygenase inhibitor,PTGS1|PTGS2,,oxaprozin,,CID4614,4614,,
,MCF7,breast,cID_642,quinostatin,10uM,concordanceLib2,,perturbagen,quinostatin_0.00001,control,LIB_2,,12.0,2.0,,,CMAP_642,,,,,,,quinostatin,,CID6620134,6620134,,
,MCF7,breast,cID_646,ikarugamycin,2uM,concordanceLib2,,perturbagen,ikarugamycin_0.000002,control,LIB_2,LSM-43300,18.0,3.0,,,CMAP_646,,,,,,,ikarugamycin,,CID54680304,54680304,,
,PC3,prostate,cID_65,dexamethasone,9.2uM,concordanceLib2,,perturbagen,dexamethasone_0.0000092,control,LIB_2,LSM-5512,12.0,2.0,,,CMAP_65,,,,Glucocorticoid receptor agonist,NR3C1,,dexamethasone,,CID5743,5743,,
,MCF7,breast,cID_650,5182598,25uM,concordanceLib2,,perturbagen,5182598_0.000025,control,LIB_2,,12.0,2.0,,,CMAP_650,,,,,,,5182598,,CID5718180,5718180,,
,MCF7,breast,cID_655,pyrvinium,1.25uM,concordanceLib2,,perturbagen,pyrvinium_0.00000125,control,LIB_2,LSM-45210,12.0,2.0,,,CMAP_655,,,,,,,pyrvinium,,CID54680693,54680693,,
,MCF7,breast,cID_658,pyrvinium,3.4uM,concordanceLib2,,perturbagen,pyrvinium_0.0000034,control,LIB_2,LSM-45210,11.0,2.0,,,CMAP_658,,,,,,,pyrvinium,,CID54680693,54680693,,
,MCF7,breast,cID_659,pyrvinium,"1.25uM,3.4uM",concordanceLib2,,perturbagen,"pyrvinium_0.00000125,0.0000034",control,LIB_2,LSM-45210,23.0,4.0,,,CMAP_659,,,,,,,pyrvinium,,CID54680693,54680693,,
,MCF7,breast,cID_660,ionomycin,2uM,concordanceLib2,,perturbagen,ionomycin_0.000002,control,LIB_2,LSM-43160,18.0,3.0,,,CMAP_660,,,,Calcium channel modulator,,,ionomycin,,CID73652146,73652146,,
,MCF7,breast,cID_664,depudecin,1uM,concordanceLib2,,perturbagen,depudecin_0.000001,control,LIB_2,LSM-43319,12.0,2.0,,,CMAP_664,,,,,,,depudecin,,CID16219259,16219259,,
,MCF7,breast,cID_670,clotrimazole,11.6uM,concordanceLib2,,perturbagen,clotrimazole_0.0000116,control,LIB_2,LSM-5341,11.0,2.0,,,CMAP_670,,,,Cytochrome P450 51 inhibitor,KCNN4,,clotrimazole,,CID2812,2812,,
,MCF7,breast,cID_671,clotrimazole,"50uM,11.6uM",concordanceLib2,,perturbagen,"clotrimazole_0.00005,0.0000116",control,LIB_2,LSM-5341,17.0,3.0,,,CMAP_671,,,,Cytochrome P450 51 inhibitor,KCNN4,,clotrimazole,,CID2812,2812,,
,MCF7,breast,cID_674,alvespimycin,0.1uM,concordanceLib2,,perturbagen,alvespimycin_0.0000001,control,LIB_2,LSM-43241,42.0,7.0,,,CMAP_674,,,,HSP inhibitor,HSP90AA1,,alvespimycin,,CID5288674,5288674,,
,HL60,haematopoietic and lymphoid tissue,cID_675,alvespimycin,0.1uM,concordanceLib2,,perturbagen,alvespimycin_0.0000001,control,LIB_2,LSM-43241,17.0,3.0,,,CMAP_675,,,,HSP inhibitor,HSP90AA1,,alvespimycin,,CID5288674,5288674,,
,PC3,prostate,cID_676,alvespimycin,0.1uM,concordanceLib2,,perturbagen,alvespimycin_0.0000001,control,LIB_2,LSM-43241,12.0,2.0,,,CMAP_676,,,,HSP inhibitor,HSP90AA1,,alvespimycin,,CID5288674,5288674,,
,MCF7,breast,cID_682,vorinostat,10uM,concordanceLib2,,perturbagen,vorinostat_0.00001,control,LIB_2,LSM-3828,42.0,7.0,,,CMAP_682,,,,Histone deacetylase 1 inhibitor|Histone deacetylase 3 inhibitor|Histone deacetylase 6 inhibitor|Histone deacetylase 2 inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,,vorinostat,,CID5311,5311,,
,HL60,haematopoietic and lymphoid tissue,cID_683,vorinostat,10uM,concordanceLib2,,perturbagen,vorinostat_0.00001,control,LIB_2,LSM-3828,17.0,3.0,,,CMAP_683,,,,Histone deacetylase 1 inhibitor|Histone deacetylase 3 inhibitor|Histone deacetylase 6 inhibitor|Histone deacetylase 2 inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,,vorinostat,,CID5311,5311,,
,PC3,prostate,cID_684,vorinostat,10uM,concordanceLib2,,perturbagen,vorinostat_0.00001,control,LIB_2,LSM-3828,12.0,2.0,,,CMAP_684,,,,Histone deacetylase 1 inhibitor|Histone deacetylase 3 inhibitor|Histone deacetylase 6 inhibitor|Histone deacetylase 2 inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,,vorinostat,,CID5311,5311,,
,MCF7,breast,cID_690,monensin,5.8uM,concordanceLib2,,perturbagen,monensin_0.0000058,control,LIB_2,LSM-5659,12.0,2.0,,,CMAP_690,,,,Bacterial permeability inducer,,,monensin,,CID441145,441145,,
,PC3,prostate,cID_691,monensin,5.8uM,concordanceLib2,,perturbagen,monensin_0.0000058,control,LIB_2,LSM-5659,11.0,2.0,,,CMAP_691,,,,Bacterial permeability inducer,,,monensin,,CID441145,441145,,
,MCF7,breast,cID_692,monensin,"10.9uM,5.8uM",concordanceLib2,,perturbagen,"monensin_0.0000109,0.0000058",control,LIB_2,LSM-5659,18.0,3.0,,,CMAP_692,,,,Bacterial permeability inducer,,,monensin,,CID441145,441145,,
,MCF7,breast,cID_7,metformin,"10uM,0.1uM,0uM",concordanceLib2,,perturbagen,"metformin_0.00001,0.0000001,0.001,0.0000242",control,LIB_2,LSM-4730,14.0,7.0,,,CMAP_7,,,,Mitochondrial complex I (NADH dehydrogenase) inhibitor (Mitochondrial complex I|Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor,GPD2|MT-ND1|ND2|ND3|ND4|ND4L|ND5|ND6|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFAF1|NDUFAF2|NDUFAF3|NDUFAF4|NDUFB1|NDUFB10|NDUFB11|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3,,metformin,,CID4091,4091,,
,MCF7,breast,cID_722,thioguanosine,12.6uM,concordanceLib2,,perturbagen,thioguanosine_0.0000126,control,LIB_2,LSM-5832,11.0,2.0,,,CMAP_722,,,,Purine antagonist,,,thioguanosine,,CID2724387,2724387,,
,MCF7,breast,cID_730,benfluorex,10.4uM,concordanceLib2,,perturbagen,benfluorex_0.0000104,control,LIB_2,LSM-4365,11.0,2.0,,,CMAP_730,,,,Gluconeogenesis inhibitor,HMGCR,,benfluorex,,CID2318,2318,,
,MCF7,breast,cID_742,clomifene,6.6uM,concordanceLib2,,perturbagen,clomifene_0.0000066,control,LIB_2,LSM-42850,11.0,2.0,,,CMAP_742,,,,Estrogen receptor antagonist,ESR1,,clomifene,,CID1548953,1548953,,
,MCF7,breast,cID_750,N6-methyladenosine,14.2uM,concordanceLib2,,perturbagen,N6-methyladenosine_0.0000142,control,LIB_2,LSM-3835,11.0,2.0,,,CMAP_750,,,,,,,N6-methyladenosine,,CID102175,102175,,
,MCF7,breast,cID_754,chlorprothixene,11.4uM,concordanceLib2,,perturbagen,chlorprothixene_0.0000114,control,LIB_2,LSM-42990,11.0,2.0,,,CMAP_754,,,,Dopamine receptor antagonist,DRD2|DRD3|HTR2A|HTR2C,,chlorprothixene,,CID667466,667466,,
,MCF7,breast,cID_76,chlorpropamide,14.4uM,concordanceLib2,,perturbagen,chlorpropamide_0.0000144,control,LIB_2,LSM-6695,11.0,2.0,,,CMAP_76,,,,"Sulfonylurea receptor 1, Kir6.2 blocker",ABCC8|KCNJ11,,chlorpropamide,,CID2727,2727,,
,MCF7,breast,cID_762,bepridil,10uM,concordanceLib2,,perturbagen,bepridil_0.00001,control,LIB_2,LSM-1898,10.0,2.0,,,CMAP_762,,,,Voltage-gated calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8,,bepridil,,CID2351,2351,,
,MCF7,breast,cID_77,chlorpropamide,"100uM,14.4uM",concordanceLib2,,perturbagen,"chlorpropamide_0.0001,0.0000144",control,LIB_2,LSM-6695,12.0,4.0,,,CMAP_77,,,,"Sulfonylurea receptor 1, Kir6.2 blocker",ABCC8|KCNJ11,,chlorpropamide,,CID2727,2727,,
,MCF7,breast,cID_770,dequalinium chloride,7.6uM,concordanceLib2,,perturbagen,dequalinium chloride_0.0000076,control,LIB_2,LSM-5846,10.0,2.0,,,CMAP_770,,,,PKC inhibitor,,,dequalinium chloride,,CID2993,2993,,
,MCF7,breast,cID_806,flupentixol,7.8uM,concordanceLib2,,perturbagen,flupentixol_0.0000078,control,LIB_2,LSM-43011,11.0,2.0,,,CMAP_806,,,,Dopamine receptor antagonist,DRD1|DRD2,,flupentixol,,CID5281881,5281881,,
,MCF7,breast,cID_828,testosterone,11.6uM,concordanceLib2,,perturbagen,testosterone_0.0000116,control,LIB_2,LSM-4025,17.0,3.0,,,CMAP_828,,,,Androgen Receptor agonist,AR,,testosterone,,CID5995,5995,,
,MCF7,breast,cID_836,suloctidil,11.8uM,concordanceLib2,,perturbagen,suloctidil_0.0000118,control,LIB_2,LSM-1469,11.0,2.0,,,CMAP_836,,,,Adrenergic receptor antagonist,,,suloctidil,,CID5354,5354,,
,MCF7,breast,cID_844,domperidone,7.4uM,concordanceLib2,,perturbagen,domperidone_0.0000074,control,LIB_2,LSM-2850,10.0,2.0,,,CMAP_844,,,,Dopamine receptor antagonist,DRD2|DRD3,,domperidone,,CID3151,3151,,
,MCF7,breast,cID_848,ouabain,5.4uM,concordanceLib2,,perturbagen,ouabain_0.0000054,control,LIB_2,LSM-2781,11.0,2.0,,,CMAP_848,,,,ATPase inhibitor,ATP1A1,,ouabain,,CID439501,439501,,
,MCF7,breast,cID_856,anisomycin,15uM,concordanceLib2,,perturbagen,anisomycin_0.000015,control,LIB_2,LSM-4047,11.0,2.0,,,CMAP_856,,,,DNA synthesis inhibitor,,,anisomycin,,CID253602,253602,,
,MCF7,breast,cID_864,corticosterone,11.6uM,concordanceLib2,,perturbagen,corticosterone_0.0000116,control,LIB_2,LSM-5814,11.0,2.0,,,CMAP_864,,,,Mineralocorticoid receptor agonist,HSD11B1|NR3C2,,corticosterone,,CID5753,5753,,
,MCF7,breast,cID_88,tamoxifen,7uM,concordanceLib2,,perturbagen,tamoxifen_0.000007,control,LIB_2,LSM-42959,11.0,2.0,,,CMAP_88,,,,Estrogen receptor alpha modulator,ESR1|ESR2,,tamoxifen,,CID2733526,2733526,,
,MCF7,breast,cID_89,tamoxifen,"1uM,7uM",concordanceLib2,,perturbagen,"tamoxifen_0.000001,0.000007",control,LIB_2,LSM-42959,13.0,4.0,,,CMAP_89,,,,Estrogen receptor alpha modulator,ESR1|ESR2,,tamoxifen,,CID2733526,2733526,,
,MCF7,breast,cID_916,apigenin,14.8uM,concordanceLib2,,perturbagen,apigenin_0.0000148,control,LIB_2,LSM-5206,11.0,2.0,,,CMAP_916,,,,Casein kinase inhibitor|Cell proliferation inhibitor|Cytochrome P450 inhibitor,,,apigenin,,CID5280443,5280443,,
,MCF7,breast,cID_936,N-acetylmuramic acid,13.6uM,concordanceLib2,,perturbagen,N-acetylmuramic acid_0.0000136,control,LIB_2,LSM-6424,11.0,2.0,,,CMAP_936,,,,,,,N-acetylmuramic acid,,CID6713944,6713944,,
,MCF7,breast,cID_984,digitoxigenin,10.6uM,concordanceLib2,,perturbagen,digitoxigenin_0.0000106,control,LIB_2,LSM-2401,11.0,2.0,,,CMAP_984,,,,ATPase inhibitor,,,digitoxigenin,,CID4369270,4369270,,
,MCF7,breast,cID_996,naringenin,14.6uM,concordanceLib2,,perturbagen,naringenin_0.0000146,control,LIB_2,LSM-1927,11.0,2.0,,,CMAP_996,,,,Aromatase inhibitor|TRPV antagonist,CYP19A1|ESR2,,naringenin,,CID932,932,,
,,CTRP cell lines,,CIL55,0.0003 - 10uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1,,,,,,,CIL55,BRD-K46556387,,,,
,,CTRP cell lines,,Thalidomide,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1914,,,,,CTRS_10,,,,TNF production inhibitor,CRBN|CUL4A|DDB1|RBX1|TNF,,Thalidomide,BRD-A93255169,,,,
,,CTRP cell lines,,BAS 02002358,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1843,,,,,CTRS_100,,,,Estrogen receptor antagonist,GPER1,,BAS 02002358,BRD-A83255679,,,,
,,bone cancer,,BRD-K42260513,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1000,,,,,,,BRD-K42260513,BRD-K42260513,,,,
,,bone cancer,,2-(Allylamino)-3-chloronaphthoquinone,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-19709,,,,,CTRS_1001,,,,,,,2-(Allylamino)-3-chloronaphthoquinone,BRD-K45681478,,,,
,,bone cancer,,BRD-K48477130,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1002,,,,,,,BRD-K48477130,BRD-K48477130,,,,
,,bone cancer,,BRD-K50799972,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-11526,,,,,CTRS_1003,,,,,,,BRD-K50799972,BRD-K50799972,,,,
,,bone cancer,,CHEMBL2381520,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-36786,,,,,CTRS_1004,,,,,,,CHEMBL2381520,BRD-K51490254,,,,
,,bone cancer,,BRD-K51831558,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1005,,,,,,,BRD-K51831558,BRD-K51831558,,,,
,,bone cancer,,BRD-K52037352,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-35878,,,,,CTRS_1006,,,,,,,BRD-K52037352,BRD-K52037352,,,,
,,bone cancer,,SCHEMBL12684744,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-40288,,,,,CTRS_1007,,,,,,,SCHEMBL12684744,BRD-K55116708,,,,
,,bone cancer,,BRD-K61166597,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1008,,,,,,,BRD-K61166597,BRD-K61166597,,,,
,,bone cancer,,CHEMBL2355724,0.00091 - 66uM,concordanceLib10,,,,,LIB_10,LSM-7694,,,,,CTRS_1009,,,,,,,CHEMBL2355724,BRD-K63431240,,,,
,,CTRP cell lines,,ML162,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1493,,,,,CTRS_101,,,,,,,ML162,BRD-A36275421,,,,
,,bone cancer,,MLS003179190,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-3441,,,,,CTRS_1010,,,,Caspase inhibitor,CASP3,,MLS003179190,BRD-K64610608,,,,
,,bone cancer,,MLS002473913,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-36022,,,,,CTRS_1011,,,,,,,MLS002473913,BRD-K66453893,,,,
,,bone cancer,,BRD-K66532283,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1012,,,,,,,BRD-K66532283,BRD-K66532283,,,,
,,bone cancer,,BRD-K70511574,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1013,,,,,,,BRD-K70511574,BRD-K62825658,,,,
,,bone cancer,,BRD-K71781559,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1014,,,,,,,BRD-K71781559,BRD-K71781559,,,,
,,bone cancer,,AC1O9BJ3,0.0025 - 83uM,concordanceLib10,,,,,LIB_10,LSM-4717,,,,,CTRS_1015,,,,,,,AC1O9BJ3,BRD-K71935468,,,,
,,bone cancer,,BRD-K80183349,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1016,,,,,,,BRD-K80183349,BRD-K80183349,,,,
,,bone cancer,,Broad-Sai-560,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45991,,,,,CTRS_1017,,,,HDAC inhibitor,,,Broad-Sai-560,BRD-K85133207,,,,
,,bone cancer,,PCI-34051,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4812,,,,,CTRS_1018,,,,HDAC inhibitor,HDAC1|HDAC10|HDAC6|HDAC8,,PCI-34051,BRD-K88742110,,,,
,,bone cancer,,CHEMBL2152368,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-44609,,,,,CTRS_1019,,,,,,,CHEMBL2152368,BRD-K90370028,,,,
,,CTRP cell lines,,CIL41,0.0049 - 160uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_102,,,,,,,CIL41,BRD-K05392795,,,,
,,bone cancer,,BRD-K92856060,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1020,,,,,,,BRD-K92856060,BRD-K92856060,,,,
,,bone cancer,,SPOX1_002925,0.0025 - 83uM,concordanceLib10,,,,,LIB_10,LSM-4769,,,,,CTRS_1021,,,,,,,SPOX1_002925,BRD-K94991378,,,,
,,bone cancer,,BRD-K97651142,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1022,,,,,,,BRD-K97651142,BRD-K97651142,,,,
,,bone cancer,,BRD-K99006945,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1023,,,,,,,BRD-K99006945,BRD-K99006945,,,,
,,bone cancer,,BRD-M00053801,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1024,,,,,,,BRD-M00053801,BRD-M00053801,,,,
,,bone cancer,,ICG-001,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6267,,,,,CTRS_1025,,,,,,,ICG-001,BRD-K73261812,,,,
,,bone cancer,,BRD1835,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1026,,,,,,,BRD1835,BRD-K62801835,,,,
,,bone cancer,,STK178014,0.0049 - 160uM,concordanceLib10,,,,,LIB_10,LSM-43108,,,,,CTRS_1027,,,,,,,STK178014,BRD-K86574132,,,,
,,bone cancer,,ST021200,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4601,,,,,CTRS_1028,,,,,,,ST021200,BRD-K35716340,,,,
,,bone cancer,,BRD-8899,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-29350,,,,,CTRS_1029,,,,Serine/threonine kinase inhibitor,,,BRD-8899,BRD-K22828899,,,,
,,CTRP cell lines,,NSC30930,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_103,,,,,,,NSC30930,BRD-K29711668,,,,
,,bone cancer,,STK219801,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43281,,,,,CTRS_1030,,,,Histone acetyltransferase inhibitor,,,STK219801,BRD-K68548958,,,,
,,bone cancer,,ZINC01050121,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6210,,,,,CTRS_1031,,,,,,,ZINC01050121,BRD-K05649647,,,,
,,bone cancer,,32703-82-5,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-4897,,,,,CTRS_1032,,,,Kinesin inhibitor,KIF11,,32703-82-5,BRD-K89329876,,,,
,,bone cancer,,Brefeldin A,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-42812,,,,,CTRS_1033,,,,Brefeldin A inhibited guanine nucleotide exchange protein inhibitors|Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor|Protein synthesis inhibitor,,,Brefeldin A,BRD-A31107743,,,,
,,bone cancer,,Brivanib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5421,,,,,CTRS_1034,,,,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR,,Brivanib,BRD-K28428262,,,,
,,bone cancer,,Alpelisib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4256,,,,,CTRS_1035,,,,PI3-kinase p110-alpha subunit inhibitor,PIK3CA,,Alpelisib,BRD-K54997624,,,,
,,bone cancer,,C6-ceramide,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1036,,,,,,,C6-ceramide,BRD-K08608874,,,,
,,bone cancer,,Cabozantinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1195,,,,,CTRS_1037,,,,Hepatocyte growth factor receptor inhibitor|Vascular endothelial growth factor receptor 2 inhibitor,KDR|MET,,Cabozantinib,BRD-K51544265,,,,
,,bone cancer,,Idelalisib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1205,,,,,CTRS_1038,,,,PI3K inhibitor,PIK3CD|PIK3CG,,Idelalisib,BRD-K60866521,,,,
,,bone cancer,,Canertinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1120,,,,,CTRS_1039,,,,EGFR inhibitor,EGFR|ERBB2|ERBB4,,Canertinib,BRD-K50168500,,,,
,,CTRP cell lines,,CIL70,0.0012 - 40uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_104,,,,,,,CIL70,BRD-K20215950,,,,
,,bone cancer,,GSK-319347A,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1216,,,,,CTRS_1040,,,,IKK inhibitor,IKBKG,,GSK-319347A,BRD-K51781482,,,,
,,bone cancer,,CAY-10594,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6256,,,,,CTRS_1041,,,,Phospholipase inhibitor,PLD2,,CAY-10594,BRD-K61662457,,,,
,,bone cancer,,CAY10618,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4946,,,,,CTRS_1042,,,,NAMPT inhibitor,NAMPT,,CAY10618,BRD-K83289131,,,,
,,bone cancer,,CBB-1007,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1043,,,,,,,CBB-1007,BRD-K84754008,,,,
,,bone cancer,,CCT036477,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-36860,,,,,CTRS_1044,,,,,,,CCT036477,BRD-A22997170,,,,
,,bone cancer,,CHEMBL1434137,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-6234,,,,,CTRS_1045,,,,Retinoid receptor agonist,RARG,,CHEMBL1434137,BRD-K25737009,,,,
,,bone cancer,,O-Demethylated Adapalene,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6237,,,,,CTRS_1046,,,,Retinoid receptor agonist,RARG,,O-Demethylated Adapalene,BRD-K28907958,,,,
,,bone cancer,,Cediranib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5926,,,,,CTRS_1047,,,,KIT inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,,Cediranib,BRD-K86930074,,,,
,,bone cancer,,ceranib-2,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1048,,,,,,,ceranib-2,BRD-K31514534,,,,
,,bone cancer,,Cerulenin,0.0045 - 150uM,concordanceLib10,,,,,LIB_10,LSM-43210,,,,,CTRS_1049,,,,Fatty acid synthase inhibitor,FASN,,Cerulenin,BRD-K52075040,,,,
,,CTRP cell lines,,MI-1,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_105,,,,,,,MI-1,BRD-K64497429,,,,
,,bone cancer,,Ch-55,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1050,,,,,,,Ch-55,BRD-K71487808,,,,
,,bone cancer,,CHIR-99021,0.0024 - 80uM,concordanceLib10,,,,,LIB_10,LSM-1181,,,,,CTRS_1051,,,,Glycogen synthase kinase inhibitor,,,CHIR-99021,BRD-K16189898,,,,
,,bone cancer,,Chlorambucil,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-2645,,,,,CTRS_1052,,,,DNA inhibitor,,,Chlorambucil,BRD-K29458283,,,,
,,bone cancer,,CHM-1,0.00049 - 16uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1053,,,,,,,CHM-1,BRD-K94145482,,,,
,,bone cancer,,CL-976,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-6282,,,,,CTRS_1054,,,,ACAT inhibitor,ACAT1,,CL-976,BRD-K88544581,,,,
,,bone cancer,,Ciclopirox,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5307,,,,,CTRS_1055,,,,Membrane integrity inhibitor,ATP1A1,,Ciclopirox,BRD-K13044802,CID2749,2749,,
,,bone cancer,,Cyclosporine,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42817,,,,,CTRS_1056,,,,Calcineurin inhibitor,PPIA|PPP3CA,,Cyclosporine,BRD-A38030642,,,,
,,bone cancer,,CID-5951923,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1057,,,,,,,CID-5951923,BRD-A86956638,,,,
,,bone cancer,,CIL41,0.0049 - 160uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1058,,,,,,,CIL41,BRD-K05392795,,,,
,,bone cancer,,CIL55A,0.0024 - 80uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1059,,,,,,,CIL55A,BRD-K69982010,,,,
,,CTRP cell lines,,DBeQ,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_106,,,,,,,DBeQ,BRD-K59204667,,,,
,,bone cancer,,CIL56,0.000076 - 2.50uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1060,,,,,,,CIL56,BRD-K11740178,,,,
,,bone cancer,,CIL70,0.0012 - 40uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1061,,,,,,,CIL70,BRD-K20215950,,,,
,,bone cancer,,Clofarabine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45668,,,,,CTRS_1062,,,,DNA polymerase (alpha/delta/epsilon) inhibitor (DNA polymerase|Ribonucleoside-diphosphate reductase RR1 inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,,Clofarabine,BRD-K34022604,,,,
,,bone cancer,,COL-3,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-36908,,,,,CTRS_1063,,,,Matrix metalloprotease inhibitor,,,COL-3,BRD-A59431241,,,,
,,bone cancer,,Fcodpguefhccia-Uhfffaoysa-N,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-42689,,,,,CTRS_1064,,,,Caspase activator,CASP3,,Fcodpguefhccia-Uhfffaoysa-N,BRD-K30064966,,,,
,,bone cancer,,compound 1B,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1065,,,,,,,compound 1B,BRD-A42556028,,,,
,,bone cancer,,Compound 23 citrate,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1066,,,,,,,Compound 23 citrate,BRD-K67112618,,,,
,,bone cancer,,CHEMBL520231,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43280,,,,,CTRS_1067,,,,Exportin antagonist,XPO1,,CHEMBL520231,BRD-K61829047,,,,
,,bone cancer,,CR-1-31B,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1068,,,,,,,CR-1-31B,BRD-K23547378,,,,
,,bone cancer,,Crizotinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1027,,,,,CTRS_1069,,,,ALK tyrosine kinase receptor inhibitor,ALK|MET,,Crizotinib,BRD-K78431006,,,,
,,CTRP cell lines,,Mdivi-1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_107,,,,,,,Mdivi-1,BRD-K61128465,,,,
,,bone cancer,,Cucurbitacin-I,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43115,,,,,CTRS_1070,,,,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor,JAK2|STAT3,,Cucurbitacin-I,BRD-A28105619,,,,
,,bone cancer,,BSPBIO_001592,0.0051 - 170uM,concordanceLib10,,,,,LIB_10,LSM-43102,,,,,CTRS_1071,,,,Cyclooxygenase inhibitor|Histone acetyltransferase inhibitor|Lipoxygenase inhibitor|NFkB pathway inhibitor,PTGS1|PTGS2,,BSPBIO_001592,BRD-K74148702,,,,
,,bone cancer,,CHEMBL436817,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-6200,,,,,CTRS_1072,,,,Kinase inhibitor,,,CHEMBL436817,BRD-K00088062,,,,
,,bone cancer,,Cyclophosphamide,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-4961,,,,,CTRS_1073,,,,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7,,Cyclophosphamide,BRD-A09722536,,,,
,,bone cancer,,Cytarabine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5470,,,,,CTRS_1074,,,,Ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,,Cytarabine,BRD-K33106058,,,,
,,bone cancer,,Cytochalasin B,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43278,,,,,CTRS_1075,,,,Microtubule inhibitor,ACTB,,Cytochalasin B,BRD-K26664453,,,,
,,bone cancer,,Dabrafenib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6303,,,,,CTRS_1076,,,,RAF inhibitor,BRAF,,Dabrafenib,BRD-K09951645,,,,
,,bone cancer,,Dacarbazine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5487,,,,,CTRS_1077,,,,DNA alkylating agent,,,Dacarbazine,BRD-K35520305,CID5281007,5281007,,
,,bone cancer,,FK 866,0.0000079 - 2uM,concordanceLib10,,,,,LIB_10,LSM-43216,,,,,CTRS_1078,,,,Niacinamide phosphoribosyltransferase inhibitor,NAMPT,,FK 866,BRD-K58550667,,,,
,,bone cancer,,Darinaparsin,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4924,,,,,CTRS_1079,,,,Apoptosis stimulant,,,Darinaparsin,BRD-K35723520,,,,
,,CTRP cell lines,,ASN 05257430,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-2975,,,,,CTRS_108,,,,,,,ASN 05257430,BRD-K44241590,,,,
,,bone cancer,,Dasatinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1020,,,,,CTRS_1080,,,,Bcr-Abl kinase inhibitor|Ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|Src inhibitor|Tyrosine kinase inhibitor,ABL1|BCR|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|YES1,,Dasatinib,BRD-K49328571,,,,
,,bone cancer,,DBeQ,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1081,,,,,,,DBeQ,BRD-K59204667,,,,
,,bone cancer,,Decitabine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5855,,,,,CTRS_1082,,,,DNA methyltransferase inhibitor,DNMT1|DNMT3A,,Decitabine,BRD-K79254416,,,,
,,bone cancer,,"9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4412,,,,,CTRS_1083,,,,Glucocorticoid receptor agonist,NR3C1,,"9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",BRD-A35108200,,,,
,,bone cancer,,Dinaciclib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6306,,,,,CTRS_1084,,,,Cyclin-dependent kinase 1 inhibitor|Cyclin-dependent kinase 2 inhibitor|Cyclin-dependent kinase 5 inhibitor|Cyclin-dependent kinase 9 inhibitor,CDK1|CDK2|CDK5|CDK9,,Dinaciclib,BRD-K13662825,,,,
,,bone cancer,,DOCETAXEL,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45649,,,,,CTRS_1085,,,,,,,DOCETAXEL,BRD-A05821830,,,,
,,bone cancer,,Doxorubicin,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4062,,,,,CTRS_1086,,,,DNA topoisomerase II alpha inhibitor,TOP2A,,Doxorubicin,BRD-K92093830,CID31703,31703,,
,,bone cancer,,ELCPK,0.000012 - 0.400uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1087,,,,,,,ELCPK,BRD-K44847641,,,,
,,bone cancer,,elocalcitol,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1088,,,,,,,elocalcitol,BRD-A04287157,,,,
,,bone cancer,,Entinostat,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4811,,,,,CTRS_1089,,,,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,Entinostat,BRD-K77908580,,,,
,,CTRP cell lines,,CID-5951923,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_109,,,,,,,CID-5951923,BRD-A86956638,,,,
,,bone cancer,,Epigalocatechin Gallate,0.009 - 300uM,concordanceLib10,,,,,LIB_10,LSM-5661,,,,,CTRS_1090,,,,Bacterial DNA gyrase inhibitor,FASN,,Epigalocatechin Gallate,BRD-K55591206,,,,
,,bone cancer,,Erastin,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4914,,,,,CTRS_1091,,,,Ion channel antagonist,VDAC2,,Erastin,BRD-A25004090,,,,
,,bone cancer,,Erismodegib,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4938,,,,,CTRS_1092,,,,Smoothened receptor antagonist,SMO,,Erismodegib,BRD-K19796430,,,,
,,bone cancer,,Erlotinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1097,,,,,CTRS_1093,,,,EGFR inhibitor,EGFR,,Erlotinib,BRD-K70401845,,,,
,,bone cancer,,etomoxir,0.009 - 300uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1094,,,,,,,etomoxir,BRD-K81335284,,,,
,,bone cancer,,Etoposide,0.00086 - 28uM,concordanceLib10,,,,,LIB_10,LSM-6348,,,,,CTRS_1095,,,,DNA topoisomerase II inhibitor,TOP2A|TOP2B,,Etoposide,BRD-K37798499,CID36462,36462,,
,,bone cancer,,ETP-46464,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1096,,,,,,,ETP-46464,BRD-K24556407,,,,
,,bone cancer,,848193-68-0,0.0024 - 80uM,concordanceLib10,,,,,LIB_10,LSM-6271,,,,,CTRS_1097,,,,SIRT inhibitor,SIRT1,,848193-68-0,BRD-K76964878,,,,
,,bone cancer,,Fingolimod (FTY720) HCl,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45416,,,,,CTRS_1098,,,,Sphingosine 1-phosphate receptor agonist,S1PR1|S1PR2|S1PR3|S1PR4|S1PR5,,Fingolimod (FTY720) HCl,BRD-K88025533,,,,
,,bone cancer,,Fluorouracil,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-4261,,,,,CTRS_1099,,,,RNA synthesis inhibitor|Thymidylate synthase inhibitor,DPYD|TYMS,,Fluorouracil,BRD-K24844714,,,,
,,CTRP cell lines,,Gossypol,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6229,,,,,CTRS_11,,,,BCL inhibitor|MCL1 inhibitor,BCL2|BCL2L1|MCL1,,Gossypol,BRD-K19295594,CID3503,3503,,
,,CTRP cell lines,,IU1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_110,,,,,,,IU1,BRD-K45841694,,,,
,,bone cancer,,fluvastatin,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1100,,,,,,,fluvastatin,BRD-A52530402,,,,
,,bone cancer,,Foretinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1158,,,,,CTRS_1101,,,,VEGFR inhibitor,FLT1|FLT3|FLT4|KDR|KIT|MET|PDGFRA|PDGFRB|TEK,,Foretinib,BRD-K03449891,,,,
,,bone cancer,,FQI-1,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1102,,,,,,,FQI-1,BRD-A91658086,,,,
,,bone cancer,,FQI-2,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1103,,,,,,,FQI-2,BRD-K35498412,,,,
,,bone cancer,,Fumonisin-B1,0.015 - 500uM,concordanceLib10,,,,,LIB_10,LSM-6190,,,,,CTRS_1104,,,,Sphingosine N acyltransferase inhibitor,CERS1,,Fumonisin-B1,BRD-A63646118,,,,
,,bone cancer,,GANT-61,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4903,,,,,CTRS_1105,,,,GLI antagonist,GLI1|GLI2,,GANT-61,BRD-K09485525,,,,
,,bone cancer,,MLS006011051,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42801,,,,,CTRS_1106,,,,RAF inhibitor,BRAF,,MLS006011051,BRD-K67578145,,,,
,,bone cancer,,Pictilisib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1047,,,,,CTRS_1107,,,,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PIK3R1|PIK3R2|PIK3R3|PIK3R5,,Pictilisib,BRD-K52911425,,,,
,,bone cancer,,Gefitinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1098,,,,,CTRS_1108,,,,EGFR inhibitor,EGFR,,Gefitinib,BRD-K64052750,,,,
,,bone cancer,,Gemcitabine,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-5333,,,,,CTRS_1109,,,,Ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,,Gemcitabine,BRD-K15108141,,,,
,,CTRP cell lines,,"9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4412,,,,,CTRS_111,,,,Glucocorticoid receptor agonist,NR3C1,,"9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",BRD-A35108200,,,,
,,bone cancer,,GMX1778,0.0000087 - 0.300uM,concordanceLib10,,,,,LIB_10,LSM-6247,,,,,CTRS_1110,,,,NAMPT inhibitor,NAMPT,,GMX1778,BRD-K47335880,,,,
,,bone cancer,,Gossypol,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6229,,,,,CTRS_1111,,,,BCL inhibitor|MCL1 inhibitor,BCL2|BCL2L1|MCL1,,Gossypol,BRD-K19295594,CID3503,3503,,
,,bone cancer,,GSK-3 Inhibitor IX,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42780,,,,,CTRS_1112,,,,Glycogen synthase kinase inhibitor|Lipoxygenase inhibitor,GSK3A|GSK3B,,GSK-3 Inhibitor IX,BRD-K04923131,,,,
,,bone cancer,,GSK J4,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6328,,,,,CTRS_1113,,,,,,,GSK J4,BRD-K98203492,,,,
,,bone cancer,,GSK-1059615,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42798,,,,,CTRS_1114,,,,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PIK3R1|PIK3R2|PIK3R3|PIK3R5,,GSK-1059615,BRD-K06750613,,,,
,,bone cancer,,GSK2636771,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45667,,,,,CTRS_1115,,,,PI3-kinase p110-beta subunit inhibitor,PIK3CB,,GSK2636771,BRD-K49215523,,,,
,,bone cancer,,GSK4112,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1116,,,,,,,GSK4112,BRD-K78667050,,,,
,,bone cancer,,GSK-461364,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1013,,,,,CTRS_1117,,,,PLK inhibitor,PLK1,,GSK-461364,BRD-K92428232,,,,
,,bone cancer,,GSK 525762A,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6334,,,,,CTRS_1118,,,,,,,GSK 525762A,BRD-K08109215,,,,
,,bone cancer,,GW 405833,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-2217,,,,,CTRS_1119,,,,Cannabinoid receptor agonist,CNR2,,GW 405833,BRD-K10705233,,,,
,,CTRP cell lines,,ML311,0.001 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_112,,,,,,,ML311,BRD-A40802033,,,,
,,bone cancer,,GW843682X,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1014,,,,,CTRS_1120,,,,PLK inhibitor,PLK1|PLK3,,GW843682X,BRD-K90382497,,,,
,,bone cancer,,HBX-41108,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1121,,,,,,,HBX-41108,BRD-K50501969,,,,
,,bone cancer,,HC-067047,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1122,,,,,,,HC-067047,BRD-K03391209,,,,
,,bone cancer,,HLI-373,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6225,,,,,CTRS_1123,,,,MDM inhibitor,MDM2,,HLI-373,BRD-K17349619,,,,
,,bone cancer,,hyperforin,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1124,,,,,,,hyperforin,BRD-A30032852,,,,
,,bone cancer,,I-BET151,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6335,,,,,CTRS_1125,,,,,,,I-BET151,BRD-K36363294,,,,
,,bone cancer,,Ibrutinib (PCI-32765),0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45830,,,,,CTRS_1126,,,,Tyrosine-protein kinase BTK inhibitor,BTK,,Ibrutinib (PCI-32765),BRD-K70301465,,,,
,,bone cancer,,IC-87114,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5829,,,,,CTRS_1127,,,,PI3K inhibitor,PIK3CD,,IC-87114,BRD-K75430629,,,,
,,bone cancer,,Ifosfamide,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5118,,,,,CTRS_1128,,,,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,,Ifosfamide,BRD-A67097164,,,,
,,bone cancer,,Imatinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1023,,,,,CTRS_1129,,,,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|CSF1R|KIT|PDGFRA|PDGFRB,,Imatinib,BRD-K92723993,,,,
,,CTRP cell lines,,Tozasertib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1021,,,,,CTRS_113,,,,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2,,Tozasertib,BRD-K59369769,,,,
,,bone cancer,,SMR000075319,0.0061 - 200uM,concordanceLib10,,,,,LIB_10,LSM-6371,,,,,CTRS_1130,,,,Importin-beta transport receptor inhibitor,KPNB1,,SMR000075319,BRD-A02481876,,,,
,,bone cancer,,indisulam,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1131,,,,,,,indisulam,BRD-K17610631,,,,
,,bone cancer,,IPR-456,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1132,,,,,,,IPR-456,BRD-A76527075,,,,
,,bone cancer,,Evodiamine,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6483,,,,,CTRS_1133,,,,ATPase inhibitor|TRPV agonist,TRPV1,,Evodiamine,BRD-A68631409,,,,
,,bone cancer,,Isonicotinohydroxamic acid,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-36788,,,,,CTRS_1134,,,,,,,Isonicotinohydroxamic acid,BRD-K55478147,,,,
,,bone cancer,,CAY10603,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4941,,,,,CTRS_1135,,,,HDAC inhibitor,HDAC6,,CAY10603,BRD-K69840642,,,,
,,bone cancer,,istradefylline,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1136,,,,,,,istradefylline,BRD-K87774949,,,,
,,bone cancer,,Itrazole,0.00051 - 17uM,concordanceLib10,,,,,LIB_10,LSM-5032,,,,,CTRS_1137,,,,Cytochrome P450 inhibitor,,,Itrazole,BRD-A34817987,,,,
,,bone cancer,,IU1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1138,,,,,,,IU1,BRD-K45841694,,,,
,,bone cancer,,1268524-70-4,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6332,,,,,CTRS_1139,,,,,,,1268524-70-4,BRD-K54606188,,,,
,,CTRP cell lines,,Imatinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1023,,,,,CTRS_114,,,,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|CSF1R|KIT|PDGFRA|PDGFRB,,Imatinib,BRD-K92723993,,,,
,,bone cancer,,JW-480,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1140,,,,,,,JW-480,BRD-K99655327,,,,
,,bone cancer,,JW-74,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1141,,,,,,,JW-74,BRD-K75664313,,,,
,,bone cancer,,KH-CB19,0.00051 - 17uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1142,,,,,,,KH-CB19,BRD-K66430217,,,,
,,bone cancer,,KHS101,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1143,,,,,,,KHS101,BRD-K78978711,,,,
,,bone cancer,,KI8751,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-3040,,,,,CTRS_1144,,,,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,,KI8751,BRD-K47150025,,,,
,,bone cancer,,KO143,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-6260,,,,,CTRS_1145,,,,Breast cancer resistance protein inhibitor,ABCG2,,KO143,BRD-K64642496,,,,
,,bone cancer,,KPT185,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1146,,,,,,,KPT185,BRD-K71467466,,,,
,,bone cancer,,KU0060648,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4935,,,,,CTRS_1147,,,,DNA dependent protein kinase inhibitor|PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PRKDC,,KU0060648,BRD-K09499853,,,,
,,bone cancer,,AZD-2014,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5754,,,,,CTRS_1148,,,,MTOR inhibitor,MTOR,,AZD-2014,BRD-K67566344,,,,
,,bone cancer,,KU-55933,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1074,,,,,CTRS_1149,,,,ATM kinase inhibitor,ATM,,KU-55933,BRD-K25311561,,,,
,,CTRP cell lines,,,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45743,,,,,CTRS_115,,,,,,,,BRD-K92041145,,,,
,,bone cancer,,KU-60019,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1150,,,,,,,KU-60019,BRD-K36016295,,,,
,,bone cancer,,KW-2449,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42803,,,,,CTRS_1151,,,,Serine/threonine-protein kinase Aurora-A inhibitor|Serine/threonine-protein kinase Aurora-B inhibitor|Tyrosine-protein kinase ABL inhibitor|Tyrosine-protein kinase receptor FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,,KW-2449,BRD-K21718444,,,,
,,bone cancer,,KX2-391,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45890,,,,,CTRS_1152,,,,Tyrosine-protein kinase SRC inhibitor,SRC,,KX2-391,BRD-K29968218,,,,
,,bone cancer,,L-685458,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1153,,,,,,,L-685458,BRD-K87317732,,,,
,,bone cancer,,Lapatinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1051,,,,,CTRS_1154,,,,EGFR inhibitor|ErbB2 inhibitor,EGFR|ERBB2,,Lapatinib,BRD-K19687926,,,,
,,bone cancer,,Panobinostat,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43059,,,,,CTRS_1155,,,,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,Panobinostat,BRD-K02130563,,,,
,,bone cancer,,LE-135,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-2127,,,,,CTRS_1156,,,,Retinoid receptor agonist,RARB,,LE-135,BRD-K06593056,,,,
,,bone cancer,,Lenvatinib (E7080),0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45581,,,,,CTRS_1157,,,,Vascular endothelial growth factor receptor inhibitor,FLT1|FLT4|KDR,,Lenvatinib (E7080),BRD-K39974922,,,,
,,bone cancer,,leptomycin B,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1158,,,,,,,leptomycin B,BRD-K27624156,,,,
,,bone cancer,,Linifanib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1183,,,,,CTRS_1159,,,,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|PDGFRA|PDGFRB,,Linifanib,BRD-K99749624,,,,
,,CTRP cell lines,,Decitabine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5855,,,,,CTRS_116,,,,DNA methyltransferase inhibitor,DNMT1|DNMT3A,,Decitabine,BRD-K79254416,,,,
,,bone cancer,,CHEMBL3186197,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6215,,,,,CTRS_1160,,,,IGF-1 inhibitor,IGF1R|INSR,,CHEMBL3186197,BRD-K08589866,,,,
,,bone cancer,,Lomeguatrib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45635,,,,,CTRS_1161,,,,,,,Lomeguatrib,BRD-K27955832,,,,
,,bone cancer,,AC1MSUFC,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-6191,,,,,CTRS_1162,,,,HMGCR inhibitor,HMGCR,,AC1MSUFC,BRD-A70155556,,,,
,,bone cancer,,LRRK2-IN-1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1086,,,,,CTRS_1163,,,,Leucine rich repeat kinase inhibitor,LRRK2,,LRRK2-IN-1,BRD-K01436366,,,,
,,bone cancer,,LY2157299,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45601,,,,,CTRS_1164,,,,TGF-beta receptor type I inhibitor,TGFBR1,,LY2157299,BRD-K78118466,,,,
,,bone cancer,,LY 2183240,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-2839,,,,,CTRS_1165,,,,FAAH inhibitor|FAAH reuptake inhibitor,FAAH,,LY 2183240,BRD-K37865504,,,,
,,bone cancer,,BDBM50127227,0.00092 - 30uM,concordanceLib10,,,,,LIB_10,LSM-43025,,,,,CTRS_1166,,,,Farnesyltransferase inhibitor|NFkB pathway inhibitor,FNTA|IKBKB,,BDBM50127227,BRD-K78599730,,,,
,,bone cancer,,marinopyrrole A,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1167,,,,,,,marinopyrrole A,BRD-K57261999,,,,
,,bone cancer,,Masitinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1130,,,,,CTRS_1168,,,,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|Src inhibitor,FGFR3|KIT|LYN|PDGFRA|PDGFRB,,Masitinib,BRD-K71035033,,,,
,,bone cancer,,Mdivi-1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1169,,,,,,,Mdivi-1,BRD-K61128465,,,,
,,CTRP cell lines,,CHIR-99021,0.0024 - 80uM,concordanceLib10,,,,,LIB_10,LSM-1181,,,,,CTRS_117,,,,Glycogen synthase kinase inhibitor,,,CHIR-99021,BRD-K16189898,,,,
,,bone cancer,,4LY1,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6529,,,,,CTRS_1170,,,,HDAC inhibitor,HDAC1|HDAC2,,4LY1,BRD-K04466929,,,,
,,bone cancer,,Methotrexate,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5690,,,,,CTRS_1171,,,,Dihydrofolate reductase inhibitor,DHFR,,Methotrexate,BRD-K59456551,CID126941,126941,,
,,bone cancer,,CHEMBL3347630,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43292,,,,,CTRS_1172,,,,,,,CHEMBL3347630,BRD-K52560704,,,,
,,bone cancer,,MG-132,0.00061 - 20uM,concordanceLib10,,,,,LIB_10,LSM-1107,,,,,CTRS_1173,,,,Proteasome inhibitor,PSMB1,,MG-132,BRD-K60230970,,,,
,,bone cancer,,MGCD-265,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1124,,,,,CTRS_1174,,,,VEGFR inhibitor,AXL|FLT1|FLT4|KDR|MET|MST1R|TEK,,MGCD-265,BRD-K56277358,,,,
,,bone cancer,,MI-1,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1175,,,,,,,MI-1,BRD-K64497429,,,,
,,bone cancer,,MI-2,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-36369,,,,,CTRS_1176,,,,,,,MI-2,BRD-K90860366,,,,
,,bone cancer,,mitomycin,0.0015 - 50uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1177,,,,,,,mitomycin,BRD-K59670716,,,,
,,bone cancer,,MK-0752,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45266,,,,,CTRS_1178,,,,,,,MK-0752,BRD-K18850819,,,,
,,bone cancer,,AZD-1775,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1153,,,,,CTRS_1179,,,,WEE1 kinase inhibitor,WEE1,,AZD-1775,BRD-K54256913,,,,
,,CTRP cell lines,,BI-2536,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1041,,,,,CTRS_118,,,,PLK inhibitor,PLK1,,BI-2536,BRD-K64890080,,,,
,,bone cancer,,MK-2206,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1057,,,,,CTRS_1180,,,,AKT inhibitor,AKT1|AKT2|AKT3,,MK-2206,BRD-K68065987,,,,
,,bone cancer,,MLS000106215,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-4009,,,,,CTRS_1181,,,,,,,MLS000106215,BRD-K89692698,,,,
,,bone cancer,,CID-2858522,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-3337,,,,,CTRS_1182,,,,NFkB pathway inhibitor,,,CID-2858522,BRD-K59962020,,,,
,,bone cancer,,SMR000068650,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-2859,,,,,CTRS_1183,,,,,,,SMR000068650,BRD-K38985961,,,,
,,bone cancer,,BAS 02002358,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1843,,,,,CTRS_1184,,,,Estrogen receptor antagonist,GPER1,,BAS 02002358,BRD-A83255679,,,,
,,bone cancer,,ASN 05257430,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-2975,,,,,CTRS_1185,,,,,,,ASN 05257430,BRD-K44241590,,,,
,,bone cancer,,ML162,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1493,,,,,CTRS_1186,,,,,,,ML162,BRD-A36275421,,,,
,,bone cancer,,DASA-58,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-3813,,,,,CTRS_1187,,,,Pyruvate kinase isozyme activator,PKM,,DASA-58,BRD-K80672993,,,,
,,bone cancer,,TL_HRAS26,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-2013,,,,,CTRS_1188,,,,,,,TL_HRAS26,BRD-K01877528,,,,
,,bone cancer,,ML239,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-3882,,,,,CTRS_1189,,,,,,,ML239,BRD-K01121114,,,,
,,CTRP cell lines,,BRD-K61166597,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_119,,,,,,,BRD-K61166597,BRD-K61166597,,,,
,,bone cancer,,ML258,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1190,,,,,,,ML258,BRD-A82720512,,,,
,,bone cancer,,ML311,0.001 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1191,,,,,,,ML311,BRD-A40802033,,,,
,,bone cancer,,ML320,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1192,,,,,,,ML320,BRD-K81491172,,,,
,,bone cancer,,MLS004683642,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-36755,,,,,CTRS_1193,,,,Kelch-like ECH-associated protein ligand,KEAP1,,MLS004683642,BRD-K93367411,,,,
,,bone cancer,,MLN 2238,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4944,,,,,CTRS_1194,,,,Proteasome inhibitor,PSMB1,,MLN 2238,BRD-K78659596,,,,
,,bone cancer,,MLN 2480,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45644,,,,,CTRS_1195,,,,RAF serine/threonine protein kinase inhibitor,ARAF|BRAF|RAF1,,MLN 2480,BRD-K43410529,,,,
,,bone cancer,,Momelotinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1141,,,,,CTRS_1196,,,,Tyrosine-protein kinase JAK1  inhibitor|Tyrosine-protein kinase JAK2 inhibitor,JAK1|JAK2,,Momelotinib,BRD-K87737963,,,,
,,bone cancer,,MST-312,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6230,,,,,CTRS_1197,,,,Telomerase inhibitor,TERT,,MST-312,BRD-K19894101,,,,
,,bone cancer,,Myricetin,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-2957,,,,,CTRS_1198,,,,Androgen receptor agonist|Cytochrome P450 inhibitor,PIK3CG,,Myricetin,BRD-K43149758,,,,
,,bone cancer,,N9-Isopropylolomoucine,0.012 - 400uM,concordanceLib10,,,,,LIB_10,LSM-3607,,,,,CTRS_1199,,,,CDK inhibitor,CDK1|CDK5,,N9-Isopropylolomoucine,BRD-K71726959,,,,
,,CTRP cell lines,,Chlorambucil,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-2645,,,,,CTRS_12,,,,DNA inhibitor,,,Chlorambucil,BRD-K29458283,,,,
,,CTRP cell lines,,Axitinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43191,,,,,CTRS_120,,,,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR,,Axitinib,BRD-K29905972,,,,
,,bone cancer,,nakiterpiosin,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1200,,,,,,,nakiterpiosin,BRD-K38264551,,,,
,,bone cancer,,Narciclasine,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4934,,,,,CTRS_1201,,,,Coflilin signaling pathway activator|LIM kinase activator|Rho associated kinase activator,RHOA,,Narciclasine,BRD-K06792661,,,,
,,bone cancer,,Navitoclax,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4738,,,,,CTRS_1202,,,,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,Navitoclax,BRD-K82746043,,,,
,,bone cancer,,Necrostatin,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-1494,,,,,CTRS_1203,,,,RIPK inhibitor,RIPK1,,Necrostatin,BRD-A36318220,,,,
,,bone cancer,,necrostatin-7,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1204,,,,,,,necrostatin-7,BRD-K50145167,,,,
,,bone cancer,,necrosulfonamide,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1205,,,,,,,necrosulfonamide,BRD-K64117221,,,,
,,bone cancer,,Nelarabine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45931,,,,,CTRS_1206,,,,,,,Nelarabine,BRD-K84466663,,,,
,,bone cancer,,Neratinib,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42778,,,,,CTRS_1207,,,,EGFR inhibitor,EGFR|ERBB2|ERBB4,,Neratinib,BRD-K85606544,,,,
,,bone cancer,,CHEMBL1222381,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-6252,,,,,CTRS_1208,,,,,,,CHEMBL1222381,BRD-K53903639,,,,
,,bone cancer,,Niclosamide,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-2787,,,,,CTRS_1209,,,,DNA replication inhibitor|STAT inhibitor,STAT3,,Niclosamide,BRD-K35960502,CID4477,4477,,
,,CTRP cell lines,,Selumetinib,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-1056,,,,,CTRS_121,,,,MEK inhibitor,MAP2K1|MAP2K2,,Selumetinib,BRD-K57080016,,,,
,,bone cancer,,Nilotinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1099,,,,,CTRS_1210,,,,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|BCR|KIT,,Nilotinib,BRD-K81528515,,,,
,,bone cancer,,CHEMBL2136735,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1152,,,,,CTRS_1211,,,,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR3|FLT1|FLT4|KDR|PDGFRA|PDGFRB,,CHEMBL2136735,BRD-K49075727,,,,
,,bone cancer,,NPC-26,0.0012 - 40uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1212,,,,,,,NPC-26,BRD-K36852164,,,,
,,bone cancer,,501919-59-1,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-6243,,,,,CTRS_1213,,,,STAT inhibitor,STAT3,,501919-59-1,BRD-K40853697,,,,
,,bone cancer,,NSC19630,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1214,,,,,,,NSC19630,BRD-K39706510,,,,
,,bone cancer,,NSC23766,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-1818,,,,,CTRS_1215,,,,Ras GTPase inhibitor,,,NSC23766,BRD-A80213327,,,,
,,bone cancer,,NSC30930,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1216,,,,,,,NSC30930,BRD-K29711668,,,,
,,bone cancer,,NSC48300,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1217,,,,,,,NSC48300,BRD-K45748132,,,,
,,bone cancer,,"3,5-Bis(4-methylbenzylidene)piperidin-4-one",33uM,concordanceLib10,,,,,LIB_10,LSM-2827,,,,,CTRS_1218,,,,Ubiquitin specific protease inhibitor,SENP2|USP1|USP2|USP7,,"3,5-Bis(4-methylbenzylidene)piperidin-4-one",BRD-K37392901,,,,
,,bone cancer,,NSC95397,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-3521,,,,,CTRS_1219,,,,CDC inhibitor,,,NSC95397,BRD-K68143200,,,,
,,CTRP cell lines,,Dactolisib,0.00051 - 17uM,concordanceLib10,,,,,LIB_10,LSM-4255,,,,,CTRS_122,,,,MTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PIK3R1|PIK3R2|PIK3R3|PIK3R5,,Dactolisib,BRD-K12184916,,,,
,,bone cancer,,NUTLIN 3,0.0045 - 150uM,concordanceLib10,,,,,LIB_10,LSM-4288,,,,,CTRS_1220,,,,MDM inhibitor,MDM2,,NUTLIN 3,BRD-A12230535,,,,
,,bone cancer,,NVP-231,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1221,,,,,,,NVP-231,BRD-A12571627,,,,
,,bone cancer,,NVP-ADW742,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1222,,,,,,,NVP-ADW742,BRD-K15179513,,,,
,,bone cancer,,Dactolisib,0.00051 - 17uM,concordanceLib10,,,,,LIB_10,LSM-4255,,,,,CTRS_1223,,,,MTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PIK3R1|PIK3R2|PIK3R3|PIK3R5,,Dactolisib,BRD-K12184916,,,,
,,bone cancer,,NVP-BSK805,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1224,,,,,,,NVP-BSK805,BRD-K02017404,,,,
,,bone cancer,,TAE-684,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1024,,,,,CTRS_1225,,,,ALK tyrosine kinase receptor inhibitor,ALK,,TAE-684,BRD-K50140147,,,,
,,bone cancer,,,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45743,,,,,CTRS_1226,,,,,,,,BRD-K92041145,,,,
,,bone cancer,,Obatoclax,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43178,,,,,CTRS_1227,,,,BCL inhibitor,BCL2,,Obatoclax,BRD-K15600710,,,,
,,bone cancer,,Olaparib,0.0045 - 150uM,concordanceLib10,,,,,LIB_10,LSM-1145,,,,,CTRS_1228,,,,PARP inhibitor,PARP1|PARP2|PARP3,,Olaparib,BRD-K02113016,,,,
,,bone cancer,,Oligomycin A,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43272,,,,,CTRS_1229,,,,ATPase inhibitor|ATP synthase inhibitor,ATP5A1,,Oligomycin A,BRD-A81541225,,,,
,,CTRP cell lines,,GW843682X,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1014,,,,,CTRS_123,,,,PLK inhibitor,PLK1|PLK3,,GW843682X,BRD-K90382497,,,,
,,bone cancer,,Omacetaxine Mepesuccinate,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-3716,,,,,CTRS_1230,,,,Protein synthesis inhibitor,,,Omacetaxine Mepesuccinate,BRD-K76674262,,,,
,,bone cancer,,OSI-027,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45146,,,,,CTRS_1231,,,,Serine/threonine-protein kinase mTOR inhibitor,MTOR,,OSI-027,BRD-K87124298,,,,
,,bone cancer,,OSI-930,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1179,,,,,CTRS_1232,,,,KIT inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT,,OSI-930,BRD-K25340465,,,,
,,bone cancer,,Ouabain,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-2781,,,,,CTRS_1233,,,,ATPase inhibitor,ATP1A1,,Ouabain,BRD-K35708212,CID439501,439501,,
,,bone cancer,,PAC-1,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-3119,,,,,CTRS_1234,,,,Caspase activator,CASP3,,PAC-1,BRD-K92991072,,,,
,,bone cancer,,BRD-A28746609,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1102,,,,,CTRS_1235,,,,Tubulin inhibitor,NR1I2|TUBB,,BRD-A28746609,BRD-A28746609,,,,
,,bone cancer,,palmostatin B,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1236,,,,,,,palmostatin B,BRD-K42137908,,,,
,,bone cancer,,pandacostat,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1237,,,,,,,pandacostat,BRD-K44741158,,,,
,,bone cancer,,Parbendazole,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4893,,,,,CTRS_1238,,,,Tubulin inhibitor,TUBB,,Parbendazole,BRD-K02407574,CID26596,26596,,
,,bone cancer,,"(1Ar,7as,10as,10br)-1a,5-Dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1ah)-one",0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43089,,,,,CTRS_1239,,,,NFkB pathway inhibitor,,,"(1Ar,7as,10as,10br)-1a,5-Dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1ah)-one",BRD-K81651477,,,,
,,CTRP cell lines,,Vandetanib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1199,,,,,CTRS_124,,,,Ephrin receptor inhibitor|Epidermal growth factor receptor inhibitor|Tyrosine-protein kinase BRK inhibitor|Tyrosine-protein kinase receptor RET inhibitor|Tyrosine-protein kinase SRC inhibitor|Tyrosine-protein kinase TIE-2 inhibitor|Vascular endothelial growth factor receptor inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK,,Vandetanib,BRD-K77625799,,,,
,,bone cancer,,Pazopanib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1114,,,,,CTRS_1240,,,,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|LCK|PDGFRA|PDGFRB,,Pazopanib,BRD-K74514084,,,,
,,bone cancer,,PD153035 (Hydrochloride),0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-45421,,,,,CTRS_1241,,,,,,,PD153035 (Hydrochloride),BRD-K26603252,,,,
,,bone cancer,,PD318088,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1242,,,,,,,PD318088,BRD-A57798112,,,,
,,bone cancer,,CHEMBL416418,0.0065 - 210uM,concordanceLib10,,,,,LIB_10,LSM-6211,,,,,CTRS_1243,,,,Glucosyltransferase inhibitor,ASAH1|UGCG,,CHEMBL416418,BRD-K05653692,,,,
,,bone cancer,,Pevonedistat,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6263,,,,,CTRS_1244,,,,Nedd activating enzyme inhibitor,NAE1|UBA3,,Pevonedistat,BRD-K67844266,,,,
,,bone cancer,,PF-184,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1245,,,,,,,PF-184,BRD-K11593101,,,,
,,bone cancer,,PF-03758309,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-4254,,,,,CTRS_1246,,,,Serine/threonine-protein kinase PAK 4 inhibitor,PAK4,,PF-03758309,BRD-K37764012,,,,
,,bone cancer,,PF-4800567 hydrochloride,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1247,,,,,,,PF-4800567 hydrochloride,BRD-K43428468,,,,
,,bone cancer,,PF 543,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42693,,,,,CTRS_1248,,,,Sphingosine kinase inhibitor,SPHK1,,PF 543,BRD-K79877282,,,,
,,bone cancer,,869288-64-2,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1200,,,,,CTRS_1249,,,,,,,869288-64-2,BRD-K79239947,,,,
,,CTRP cell lines,,Sorafenib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1008,,,,,CTRS_125,,,,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,,Sorafenib,BRD-K23984367,,,,
,,bone cancer,,PF750,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-6277,,,,,CTRS_1250,,,,FAAH inhibitor,FAAH,,PF750,BRD-K83213911,,,,
,,bone cancer,,PHA-793887,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1073,,,,,CTRS_1251,,,,CDK inhibitor,CDK1|CDK10|CDK11B|CDK12|CDK13|CDK14|CDK15|CDK16|CDK17|CDK18|CDK19|CDK2|CDK20|CDK3|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9,,PHA-793887,BRD-K64800655,,,,
,,bone cancer,,Phloretin,0.018 - 590uM,concordanceLib10,,,,,LIB_10,LSM-6221,,,,,CTRS_1252,,,,Sodium/glucose cotransporter inhibitor,,,Phloretin,BRD-K15563106,,,,
,,bone cancer,,PI-103,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-1126,,,,,CTRS_1253,,,,MTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,,PI-103,BRD-K67868012,,,,
,,bone cancer,,Pifithrin,0.0071 - 230uM,concordanceLib10,,,,,LIB_10,LSM-3485,,,,,CTRS_1254,,,,TP53 inhibitor,TP53,,Pifithrin,BRD-K66874953,,,,
,,bone cancer,,Pifithrin MU,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4188,,,,,CTRS_1255,,,,HSP inhibitor,HSPA1A|TP53,,Pifithrin MU,BRD-K96799727,,,,
,,bone cancer,,PIK-93,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1191,,,,,CTRS_1256,,,,,,,PIK-93,BRD-K29395450,,,,
,,bone cancer,,Piplartine,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42914,,,,,CTRS_1257,,,,Glutathione transferase inhibitor,,,Piplartine,BRD-K24132293,,,,
,,bone cancer,,pitstop2,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1258,,,,,,,pitstop2,BRD-K90570971,,,,
,,bone cancer,,SCHEMBL15444220,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43124,,,,,CTRS_1259,,,,,,,SCHEMBL15444220,BRD-K83336168,,,,
,,CTRP cell lines,,CID-2858522,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-3337,,,,,CTRS_126,,,,NFkB pathway inhibitor,,,CID-2858522,BRD-K59962020,,,,
,,bone cancer,,pluripotin,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1260,,,,,,,pluripotin,BRD-K98538768,,,,
,,bone cancer,,Vemurafenib,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1068,,,,,CTRS_1261,,,,RAF inhibitor,BRAF,,Vemurafenib,BRD-K56343971,,,,
,,bone cancer,,PLX-4720,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1049,,,,,CTRS_1262,,,,RAF inhibitor,BRAF,,PLX-4720,BRD-K16478699,,,,
,,bone cancer,,PRIMA 1,0.0051 - 170uM,concordanceLib10,,,,,LIB_10,LSM-6220,,,,,CTRS_1263,,,,TP53 inhibitor,ACHE,,PRIMA 1,BRD-K15318909,,,,
,,bone cancer,,ZINC68199948,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6249,,,,,CTRS_1264,,,,Thioredoxin inhibitor,TP53,,ZINC68199948,BRD-K49456190,,,,
,,bone cancer,,PRL-3InhibitorI,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-43277,,,,,CTRS_1265,,,,Tyrosine phosphatase inhibitor,PTP4A3,,PRL-3InhibitorI,BRD-K09907482,,,,
,,bone cancer,,Procarbazine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-2272,,,,,CTRS_1266,,,,Monoamine oxidase inhibitor,,,Procarbazine,BRD-K13032584,CID4915,4915,,
,,bone cancer,,Prochlorperazine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-2436,,,,,CTRS_1267,,,,Dopamine D2 receptor antagonist,DRD2,,Prochlorperazine,BRD-K19352500,CID4917,4917,,
,,bone cancer,,Purmorphamine,0.0046 - 150uM,concordanceLib10,,,,,LIB_10,LSM-3649,,,,,CTRS_1268,,,,Smoothened receptor agonist,SMO,,Purmorphamine,BRD-K73397362,,,,
,,bone cancer,,PX 12,0.003 - 100uM,concordanceLib10,,,,,LIB_10,LSM-4918,,,,,CTRS_1269,,,,Thioredoxin inhibitor,TXN|TXNRD1,,PX 12,BRD-A56592690,,,,
,,CTRP cell lines,,temozolomide,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_127,,,,,,,temozolomide,BRD-A94153989,,,,
,,bone cancer,,PYR-41,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1270,,,,,,,PYR-41,BRD-K60750172,,,,
,,bone cancer,,Pyrazolanthrone,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1163,,,,,CTRS_1271,,,,JNK inhibitor,MAPK10|MAPK8|MAPK9|TTK,,Pyrazolanthrone,BRD-K01567962,,,,
,,bone cancer,,Quizartinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1037,,,,,CTRS_1272,,,,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,,Quizartinib,BRD-K93918653,,,,
,,bone cancer,,R428,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45574,,,,,CTRS_1273,,,,,,,R428,BRD-K14870255,,,,
,,bone cancer,,CHIR-265,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1207,,,,,CTRS_1274,,,,Serine/threonine-protein kinase B-raf inhibitor|Vascular endothelial growth factor receptor 2 inhibitor,BRAF|KDR,,CHIR-265,BRD-K93123848,,,,
,,bone cancer,,Regorafenib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1226,,,,,CTRS_1275,,,,Discoidin domain-containing receptor 2 inhibitor|Fibroblast growth factor receptor 1 inhibitor|Fibroblast growth factor receptor 2 inhibitor|MAP kinase p38 beta inhibitor|Platelet-derived growth factor receptor inhibitor|Serine/threonine-protein kinase B-raf inhibitor|Serine/threonine-protein kinase RAF inhibitor|Stem cell growth factor receptor inhibitor|Tyrosine-protein kinase ABL inhibitor|Tyrosine-protein kinase FRK inhibitor|Tyrosine-protein kinase receptor RET inhibitor|Tyrosine-protein kinase TIE-2 inhibitor|Vascular endothelial growth factor receptor inhibitor,ABL1|BRAF|DDR2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|PDGFRA|PDGFRB|RAF1|RET|TEK,,Regorafenib,BRD-K16730910,,,,
,,bone cancer,,BL003-049-HDAC3,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-36785,,,,,CTRS_1276,,,,,,,BL003-049-HDAC3,BRD-K47503321,,,,
,,bone cancer,,RG 108,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-6283,,,,,CTRS_1277,,,,DNA methyltransferase inhibitor,DNMT1,,RG 108,BRD-K89391146,,,,
,,bone cancer,,Rigosertib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-44531,,,,,CTRS_1278,,,,PLK inhibitor,CDK1|F2R|FLT1|FYN|PDGFRA|PLK1|PLK2|SRC,,Rigosertib,BRD-K55187425,,,,
,,bone cancer,,Rita,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6201,,,,,CTRS_1279,,,,MDM inhibitor,MDM2,,Rita,BRD-K00317371,,,,
,,CTRP cell lines,,BRD4770,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42692,,,,,CTRS_128,,,,Histone lysine methyltransferase inhibitor,EHMT2,,BRD4770,BRD-K72264770,,,,
,,bone cancer,,RO4929097,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42762,,,,,CTRS_1280,,,,,,,RO4929097,BRD-K22024824,,,,
,,bone cancer,,Ruxolitinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1139,,,,,CTRS_1281,,,,JAK inhibitor,JAK1|JAK2|TYK2,,Ruxolitinib,BRD-K53972329,,,,
,,bone cancer,,Salermide,0.012 - 400uM,concordanceLib10,,,,,LIB_10,LSM-5123,,,,,CTRS_1282,,,,SIRT inhibitor,SIRT1|SIRT2,,Salermide,BRD-A67788537,,,,
,,bone cancer,,Saracatinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1032,,,,,CTRS_1283,,,,Src inhibitor,ABL1|SRC,,Saracatinib,BRD-K19540840,,,,
,,bone cancer,,SB225002,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-3367,,,,,CTRS_1284,,,,CC chemokine receptor antagonist,CXCR2,,SB225002,BRD-K61323504,,,,
,,bone cancer,,SB-431542,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-3498,,,,,CTRS_1285,,,,TGF beta receptor inhibitor,ACVR1C|TGFBR1,,SB-431542,BRD-K67298865,,,,
,,bone cancer,,SB525334,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1121,,,,,CTRS_1286,,,,TGF beta receptor inhibitor,TGFBR1,,SB525334,BRD-K37720887,,,,
,,bone cancer,,SB-743921,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1287,,,,,,,SB-743921,BRD-K62358710,,,,
,,bone cancer,,SCH-529074,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1288,,,,,,,SCH-529074,BRD-K24376488,,,,
,,bone cancer,,SCH-79797,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6224,,,,,CTRS_1289,,,,Proteasome inhibitor,F2R,,SCH-79797,BRD-K17140735,,,,
,,CTRP cell lines,,CHEMBL2152368,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-44609,,,,,CTRS_129,,,,,,,CHEMBL2152368,BRD-K90370028,,,,
,,bone cancer,,Selumetinib,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-1056,,,,,CTRS_1290,,,,MEK inhibitor,MAP2K1|MAP2K2,,Selumetinib,BRD-K57080016,,,,
,,bone cancer,,Semagacestat,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42753,,,,,CTRS_1291,,,,Gamma-secretase inhibitor,APH1A|APH1B|NCSTN|PSEN1|PSEN2|PSENEN,,Semagacestat,BRD-K65592642,,,,
,,bone cancer,,ZINC77024257,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1171,,,,,CTRS_1292,,,,MDM inhibitor,MDM2,,ZINC77024257,BRD-K60219430,,,,
,,bone cancer,,SGX-523,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1123,,,,,CTRS_1293,,,,Hepatocyte growth factor receptor inhibitor,MET,,SGX-523,BRD-K19477839,,,,
,,bone cancer,,CHEMBL258148,0.009 - 300uM,concordanceLib10,,,,,LIB_10,LSM-6214,,,,,CTRS_1294,,,,Cathepsin inhibitor,CTSL,,CHEMBL258148,BRD-K08417745,,,,
,,bone cancer,,Sildenafil,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-3797,,,,,CTRS_1295,,,,Phosphodiesterase inhibitor,PDE5A,,Sildenafil,BRD-K50128260,,,,
,,bone cancer,,CX-4945 (Silmitasertib),0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45467,,,,,CTRS_1296,,,,Casein kinase II alpha inhibitor,CSNK2A1,,CX-4945 (Silmitasertib),BRD-K81458380,,,,
,,bone cancer,,Simvastatin,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-2492,,,,,CTRS_1297,,,,HMG-CoA reductase inhibitor,HMGCR,,Simvastatin,BRD-K22134346,CID54454,54454,,
,,bone cancer,,Sirolimus,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42782,,,,,CTRS_1298,,,,FK506-binding protein 1A inhibitor,FKBP1A|MTOR,,Sirolimus,BRD-K84937637,CID5284616,5284616,,
,,bone cancer,,SJ 172550,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43286,,,,,CTRS_1299,,,,MDM inhibitor,MDM4,,SJ 172550,BRD-K93095519,,,,
,,CTRP cell lines,,Fluorouracil,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-4261,,,,,CTRS_13,,,,RNA synthesis inhibitor|Thymidylate synthase inhibitor,DPYD|TYMS,,Fluorouracil,BRD-K24844714,,,,
,,CTRP cell lines,,SNX-2112 (PF-04928473),0.001 - 37uM,concordanceLib10,,,,,LIB_10,LSM-45259,,,,,CTRS_130,,,,,,,SNX-2112 (PF-04928473),BRD-K71281111,,,,
,,bone cancer,,skepinone-L,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1300,,,,,,,skepinone-L,BRD-K83607951,,,,
,,bone cancer,,Skiii,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-2462,,,,,CTRS_1301,,,,Sphingosine kinase inhibitor,SPHK1,,Skiii,BRD-K20755323,,,,
,,bone cancer,,67200-34-4,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42773,,,,,CTRS_1302,,,,,,,67200-34-4,BRD-K92960067,,,,
,,bone cancer,,"4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione",0.000041 - 1.30uM,concordanceLib10,,,,,LIB_10,LSM-6189,,,,,CTRS_1303,,,,Topoisomerase inhibitor,TOP1,,"4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione",BRD-A36630025,,,,
,,bone cancer,,BMS-387032,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1132,,,,,CTRS_1304,,,,CDK inhibitor|Cell cycle inhibitor|MCL1 inhibitor,CDK2|CDK7|CDK9,,BMS-387032,BRD-K43389698,,,,
,,bone cancer,,SNX-2112 (PF-04928473),0.001 - 37uM,concordanceLib10,,,,,LIB_10,LSM-45259,,,,,CTRS_1305,,,,,,,SNX-2112 (PF-04928473),BRD-K71281111,,,,
,,bone cancer,,Sorafenib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1008,,,,,CTRS_1306,,,,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,,Sorafenib,BRD-K23984367,,,,
,,bone cancer,,Sotrastaurin,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42761,,,,,CTRS_1307,,,,Protein kinase C (PKC) inhibitor (Protein kinase C,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCH|PRKCI|PRKCQ|PRKCZ|PRKD1|PRKD3,,Sotrastaurin,BRD-K16761703,,,,
,,bone cancer,,spautin-1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1308,,,,,,,spautin-1,BRD-K84964099,,,,
,,bone cancer,,SR-II-138A,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1309,,,,,,,SR-II-138A,BRD-K11172604,,,,
,,CTRP cell lines,,Navitoclax,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4738,,,,,CTRS_131,,,,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,Navitoclax,BRD-K82746043,,,,
,,bone cancer,,SR1001,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1310,,,,,,,SR1001,BRD-K47981327,,,,
,,bone cancer,,SR8278,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1311,,,,,,,SR8278,BRD-A02904414,,,,
,,bone cancer,,SRT-1720,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-42691,,,,,CTRS_1312,,,,SIRT activator,SIRT1,,SRT-1720,BRD-K53855319,,,,
,,bone cancer,,StemRegenin 1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1313,,,,,,,StemRegenin 1,BRD-K36739687,,,,
,,bone cancer,,STF-31,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1314,,,,,,,STF-31,BRD-K22477529,,,,
,,bone cancer,,SU 11274,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42792,,,,,CTRS_1315,,,,Hepatocyte growth factor receptor inhibitor|Tyrosine kinase inhibitor,MET,,SU 11274,BRD-K02965346,,,,
,,bone cancer,,Sunitinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42800,,,,,CTRS_1316,,,,Macrophage colony stimulating factor  receptor  inhibitor|Platelet-derived growth factor receptor inhibitor|Stem cell growth factor receptor inhibitor|Tyrosine-protein kinase receptor FLT3 inhibitor|Tyrosine-protein kinase receptor RET inhibitor|Vascular endothelial growth factor receptor inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,,Sunitinib,BRD-K42828737,,,,
,,bone cancer,,SZ4TA2,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1317,,,,,,,SZ4TA2,BRD-K55125219,,,,
,,bone cancer,,Tacedinaline,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-19036,,,,,CTRS_1318,,,,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,Tacedinaline,BRD-K52313696,,,,
,,bone cancer,,Tacrolimus,0.0023 - 74uM,concordanceLib10,,,,,LIB_10,LSM-43009,,,,,CTRS_1319,,,,Calcineurin inhibitor,FKBP1A,,Tacrolimus,BRD-K69608737,,,,
,,CTRP cell lines,,Bexarotene,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45378,,,,,CTRS_132,,,,Retinoid X receptor agonist,RXRA|RXRB|RXRG,,Bexarotene,BRD-K92441787,,,,
,,bone cancer,,Tamatinib,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1040,,,,,CTRS_1320,,,,SYK inhibitor,SYK,,Tamatinib,BRD-K20285085,,,,
,,bone cancer,,Tamoxifen,0.003 - 100uM,concordanceLib10,,,,,LIB_10,LSM-42959,,,,,CTRS_1321,,,,Estrogen receptor alpha modulator,ESR1|ESR2,,Tamoxifen,BRD-K93754473,CID2733526,2733526,,
,,bone cancer,,Tandutinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5949,,,,,CTRS_1322,,,,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,FLT3|KIT|PDGFRA|PDGFRB,,Tandutinib,BRD-K89162000,,,,
,,bone cancer,,Tanespimycin,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43238,,,,,CTRS_1323,,,,Heat shock protein HSP90 inhibitor,HSP90AA1|HSP90AB1,,Tanespimycin,BRD-K81473043,CID6505803,6505803,,
,,bone cancer,,temozolomide,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1324,,,,,,,temozolomide,BRD-A94153989,,,,
,,bone cancer,,temsirolimus,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1325,,,,,,,temsirolimus,BRD-K08177763,,,,
,,bone cancer,,Teniposide,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1483,,,,,CTRS_1326,,,,Topoisomerase inhibitor,TOP2A,,Teniposide,BRD-A35588707,,,,
,,bone cancer,,TG100-115,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5731,,,,,CTRS_1327,,,,PI3-kinase p110-delta subunit inhibitor|PI3-kinase p110-gamma subunit inhibitor,PIK3CD|PIK3CG,,TG100-115,BRD-K64785675,,,,
,,bone cancer,,Fedratinib,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-1142,,,,,CTRS_1328,,,,FLT3 inhibitor|JAK inhibitor,FLT3|JAK2,,Fedratinib,BRD-K12502280,,,,
,,bone cancer,,TGX 221,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1172,,,,,CTRS_1329,,,,PI3K inhibitor,PIK3CB,,TGX 221,BRD-A41692738,,,,
,,CTRP cell lines,,Nilotinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1099,,,,,CTRS_133,,,,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|BCR|KIT,,Nilotinib,BRD-K81528515,,,,
,,bone cancer,,Thalidomide,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1914,,,,,CTRS_1330,,,,TNF production inhibitor,CRBN|CUL4A|DDB1|RBX1|TNF,,Thalidomide,BRD-A93255169,,,,
,,bone cancer,,Tigecycline,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-36875,,,,,CTRS_1331,,,,Bacterial 30S ribosomal subunit inhibitor,,,Tigecycline,BRD-A34462049,,,,
,,bone cancer,,(S)-Tipifarnib,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6259,,,,,CTRS_1332,,,,Farnesyltransferase inhibitor,,,(S)-Tipifarnib,BRD-K63195589,,,,
,,bone cancer,,Tipifarnib,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6258,,,,,CTRS_1333,,,,Farnesyltransferase inhibitor,CHURC1-FNTB|FNTA|FNTB,,Tipifarnib,BRD-K62965247,,,,
,,bone cancer,,Tivantinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1131,,,,,CTRS_1334,,,,Tyrosine kinase inhibitor,MET,,Tivantinib,BRD-K33379087,,,,
,,bone cancer,,Tivozanib,0.00041 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1005,,,,,CTRS_1335,,,,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,,Tivozanib,BRD-K53414658,,,,
,,bone cancer,,Topotecan,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5662,,,,,CTRS_1336,,,,Topoisomerase inhibitor,TOP1|TOP1MT,,Topotecan,BRD-K55696337,,,,
,,bone cancer,,Tosedostat,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-6286,,,,,CTRS_1337,,,,Peptidase inhibitor,ANPEP|C9orf3|DNPEP|ENPEP|ERAP1|ERAP2|LAP3|LNPEP|LVRN|METAP1|METAP1D|METAP2|NPEPL1|NPEPPS|RNPEP|RNPEPL1|XPNPEP1|XPNPEP2|XPNPEP3,,Tosedostat,BRD-K92241597,,,,
,,bone cancer,,TPCA-1,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1136,,,,,CTRS_1338,,,,IKK inhibitor,IKBKB,,TPCA-1,BRD-K51575138,,,,
,,bone cancer,,Trametinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1143,,,,,CTRS_1339,,,,MEK inhibitor,MAP2K1|MAP2K2,,Trametinib,BRD-K12343256,,,,
,,CTRP cell lines,,Sunitinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42800,,,,,CTRS_134,,,,Macrophage colony stimulating factor  receptor  inhibitor|Platelet-derived growth factor receptor inhibitor|Stem cell growth factor receptor inhibitor|Tyrosine-protein kinase receptor FLT3 inhibitor|Tyrosine-protein kinase receptor RET inhibitor|Vascular endothelial growth factor receptor inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,,Sunitinib,BRD-K42828737,,,,
,,bone cancer,,9-Cis retinol,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-5317,,,,,CTRS_1340,,,,Retinoid receptor agonist|Retinoid receptor ligand,RARA|RARB|RARG|RORB,,9-Cis retinol,BRD-K64634304,,,,
,,bone cancer,,SMR001317659,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-2094,,,,,CTRS_1341,,,,,,,SMR001317659,BRD-K05402890,,,,
,,bone cancer,,Trifluoperazine,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4010,,,,,CTRS_1342,,,,Serotonin 2a (5-HT2a) receptor antagonist (Serotonin 2a|Serotonin 2c (5-HT2c) receptor antagonist (Serotonin 2c|D2-like dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|HTR2C,,Trifluoperazine,BRD-K89732114,CID5566,5566,,
,,bone cancer,,PG 490,0.0000087 - 0.300uM,concordanceLib10,,,,,LIB_10,LSM-6185,,,,,CTRS_1343,,,,RNA polymerase inhibitor,,,PG 490,BRD-A13122391,,,,
,,bone cancer,,Tubastatin A,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4806,,,,,CTRS_1344,,,,HDAC inhibitor,HDAC6,,Tubastatin A,BRD-K00627859,,,,
,,bone cancer,,TW 37,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6236,,,,,CTRS_1345,,,,BCL inhibitor,BCL2|BCL2L1|MCL1,,TW 37,BRD-K28360340,,,,
,,bone cancer,,UNC-0321,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4942,,,,,CTRS_1346,,,,Histone lysine methyltransferase inhibitor,EHMT2,,UNC-0321,BRD-K74236984,,,,
,,bone cancer,,UNC0638,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6325,,,,,CTRS_1347,,,,,,,UNC0638,BRD-K86856088,,,,
,,bone cancer,,VAF-347,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1348,,,,,,,VAF-347,BRD-K96335988,,,,
,,bone cancer,,Valdecoxib,0.018 - 600uM,concordanceLib10,,,,,LIB_10,LSM-5305,,,,,CTRS_1349,,,,Cyclooxygenase inhibitor,PTGS2,,Valdecoxib,BRD-K12994359,,,,
,,CTRP cell lines,,Bendamustine HCl,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45554,,,,,CTRS_135,,,,,,,Bendamustine HCl,BRD-K17068645,,,,
,,bone cancer,,Vandetanib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1199,,,,,CTRS_1350,,,,Ephrin receptor inhibitor|Epidermal growth factor receptor inhibitor|Tyrosine-protein kinase BRK inhibitor|Tyrosine-protein kinase receptor RET inhibitor|Tyrosine-protein kinase SRC inhibitor|Tyrosine-protein kinase TIE-2 inhibitor|Vascular endothelial growth factor receptor inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK,,Vandetanib,BRD-K77625799,,,,
,,bone cancer,,Veliparib,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1146,,,,,CTRS_1351,,,,PARP inhibitor,PARP1|PARP2,,Veliparib,BRD-K87142802,,,,
,,bone cancer,,VER 155008,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6239,,,,,CTRS_1352,,,,HSP inhibitor,HSPA1A,,VER 155008,BRD-K32330832,,,,
,,bone cancer,,UNII-5J49Q6B70F,0.004 - 130uM,concordanceLib10,,,,,LIB_10,LSM-5877,,,,,CTRS_1353,,,,Tubulin inhibitor,TUBB,,UNII-5J49Q6B70F,BRD-K82109576,,,,
,,bone cancer,,vorapaxar,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1354,,,,,,,vorapaxar,BRD-K93442924,,,,
,,bone cancer,,Vorinostat,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-3828,,,,,CTRS_1355,,,,Histone deacetylase 1 inhibitor|Histone deacetylase 3 inhibitor|Histone deacetylase 6 inhibitor|Histone deacetylase 2 inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,,Vorinostat,BRD-K81418486,CID5311,5311,,
,,bone cancer,,CHEMBL492797,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-42752,,,,,CTRS_1356,,,,,,,CHEMBL492797,BRD-K31406481,,,,
,,bone cancer,,Tozasertib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1021,,,,,CTRS_1357,,,,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,ABL1|AURKA|AURKB|AURKC|BCR|FLT3|JAK2,,Tozasertib,BRD-K59369769,,,,
,,bone cancer,,XL335,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45859,,,,,CTRS_1358,,,,Bile acid receptor FXR agonist,NR1H4,,XL335,BRD-K54640016,,,,
,,bone cancer,,WP1130,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1359,,,,,,,WP1130,BRD-K43644456,,,,
,,CTRP cell lines,,Omacetaxine Mepesuccinate,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-3716,,,,,CTRS_136,,,,Protein synthesis inhibitor,,,Omacetaxine Mepesuccinate,BRD-K76674262,,,,
,,bone cancer,,WZ 4002,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1085,,,,,CTRS_1360,,,,EGFR inhibitor,EGFR|ERBB2,,WZ 4002,BRD-K72420232,,,,
,,bone cancer,,WZ8040,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1361,,,,,,,WZ8040,BRD-K81728688,,,,
,,bone cancer,,SAR245409,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1174,,,,,CTRS_1362,,,,PI3K inhibitor,,,SAR245409,BRD-K75308783,,,,
,,bone cancer,,YK 4-279,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4933,,,,,CTRS_1363,,,,Apoptosis stimulant|Binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor,DHX9|FLI1,,YK 4-279,BRD-A62182663,,,,
,,bone cancer,,Sepantronium,0.000031 - 1uM,concordanceLib10,,,,,LIB_10,LSM-5399,,,,,CTRS_1364,,,,Survivin inhibitor,BIRC5,,Sepantronium,BRD-K76703230,,,,
,,bone cancer,,4-Deoxyuridine,0.018 - 590uM,concordanceLib10,,,,,LIB_10,LSM-6181,,,,,CTRS_1365,,,,DNA methyltransferase inhibitor,CDA|DNMT1,,4-Deoxyuridine,BRD-A01145011,,,,
,,bone cancer,,ZSTK 474,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1053,,,,,CTRS_1366,,,,PI3K inhibitor,PIK3CG,,ZSTK 474,BRD-K63068307,,,,
,,breast cancer,,16Beta-bromoandrosterone,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6294,,,,,CTRS_1367,,,,Glucose 6-phosphate dehydrogenase inhibitor,G6PD,,16Beta-bromoandrosterone,BRD-K98404142,,,,
,,breast cancer,,"1S,3R-RSL-3",0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1368,,,,,,,"1S,3R-RSL-3",BRD-K23853216,,,,
,,breast cancer,,3-Cl-AHPC,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1369,,,,,,,3-Cl-AHPC,BRD-A09890259,,,,
,,CTRP cell lines,,O-Demethylated Adapalene,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6237,,,,,CTRS_137,,,,Retinoid receptor agonist,RARG,,O-Demethylated Adapalene,BRD-K28907958,,,,
,,breast cancer,,968,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1370,,,,,,,968,BRD-A43210826,,,,
,,breast cancer,,A-804598,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1371,,,,,,,A-804598,BRD-K76894955,,,,
,,breast cancer,,Arachidonyl Trifluoromethylketone,0.001 - 270uM,concordanceLib10,,,,,LIB_10,LSM-43275,,,,,CTRS_1372,,,,Cytosolic phospholipase inhibitor,PLA2G4A,,Arachidonyl Trifluoromethylketone,BRD-K07303502,,,,
,,breast cancer,,abiraterone,0.00051 - 17uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1373,,,,,,,abiraterone,BRD-K50071428,,,,
,,breast cancer,,ABT-199 (GDC-0199),0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45468,,,,,CTRS_1374,,,,Apoptosis regulator Bcl-2 inhibitor,BCL2,,ABT-199 (GDC-0199),BRD-K62391742,,,,
,,breast cancer,,ABT737,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-1180,,,,,CTRS_1375,,,,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,ABT737,BRD-K56301217,,,,
,,breast cancer,,AC55649,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6290,,,,,CTRS_1376,,,,Retinoid receptor agonist,RARA|RARB,,AC55649,BRD-K93176058,,,,
,,breast cancer,,Afatinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43226,,,,,CTRS_1377,,,,EGFR inhibitor,EGFR|ERBB2|ERBB4,,Afatinib,BRD-K66175015,,,,
,,breast cancer,,AGK 2,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43196,,,,,CTRS_1378,,,,SIRT inhibitor,SIRT2,,AGK 2,BRD-K32536677,,,,
,,breast cancer,,Alisertib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-37184,,,,,CTRS_1379,,,,Aurora kinase inhibitor,AURKA,,Alisertib,BRD-K75295174,,,,
,,CTRP cell lines,,SCH-79797,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-6224,,,,,CTRS_138,,,,Proteasome inhibitor,F2R,,SCH-79797,BRD-K17140735,,,,
,,breast cancer,,alvocidib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1380,,,,,,,alvocidib,BRD-K68682020,,,,
,,breast cancer,,AM-580,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-2132,,,,,CTRS_1381,,,,Retinoid receptor agonist,RARA,,AM-580,BRD-K06854232,,,,
,,breast cancer,,Apatinib Hydrochloride,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4810,,,,,CTRS_1382,,,,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,Apatinib Hydrochloride,BRD-K64606589,,,,
,,breast cancer,,AT-406,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1383,,,,,,,AT-406,BRD-K02834582,,,,
,,breast cancer,,AT13387,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45514,,,,,CTRS_1384,,,,,,,AT13387,BRD-K58435339,,,,
,,breast cancer,,AT 7867,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1155,,,,,CTRS_1385,,,,,,,AT 7867,BRD-K12040459,,,,
,,breast cancer,,austocystin D,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1386,,,,,,,austocystin D,BRD-K25987073,,,,
,,breast cancer,,Avicin-D,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-44620,,,,,CTRS_1387,,,,NFkB pathway inhibitor,,,Avicin-D,BRD-A15100685,,,,
,,breast cancer,,Avrainvillamide,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-42688,,,,,CTRS_1388,,,,Nucleophosmin inhibitor,,,Avrainvillamide,BRD-K10466330,,,,
,,breast cancer,,Axitinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43191,,,,,CTRS_1389,,,,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR,,Axitinib,BRD-K29905972,,,,
,,CTRP cell lines,,LE-135,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-2127,,,,,CTRS_139,,,,Retinoid receptor agonist,RARB,,LE-135,BRD-K06593056,,,,
,,breast cancer,,AZ-3146,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1390,,,,,,,AZ-3146,BRD-K59146805,,,,
,,breast cancer,,Azacitidine,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-5218,,,,,CTRS_1391,,,,DNA (cytosine-5)-methyltransferase 3A inhibitor (DNA|DNA (cytosine-5)-methyltransferase 1 inhibitor (DNA,DNMT1|DNMT3A,,Azacitidine,BRD-K03406345,CID9444,9444,,
,,breast cancer,,AZD-1480,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45764,,,,,CTRS_1392,,,,,,,AZD-1480,BRD-K65928735,,,,
,,breast cancer,,AZD4547,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-6308,,,,,CTRS_1393,,,,,,,AZD4547,BRD-K28392481,,,,
,,breast cancer,,AZD-6482,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1059,,,,,CTRS_1394,,,,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PIK3R1|PIK3R2|PIK3R3|PIK3R5,,AZD-6482,BRD-K58772419,,,,
,,breast cancer,,AZD7545,0.0023 - 74uM,concordanceLib10,,,,,LIB_10,LSM-6250,,,,,CTRS_1395,,,,Pyruvate dehydrogenase kinase inhibitor,,,AZD7545,BRD-K52836380,,,,
,,breast cancer,,AZD7762,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45536,,,,,CTRS_1396,,,,Serine/threonine-protein kinase Chk1  inhibitor,CHEK1,,AZD7762,BRD-K86525559,,,,
,,breast cancer,,AZD-8055,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1007,,,,,CTRS_1397,,,,MTOR inhibitor,MTOR,,AZD-8055,BRD-K69932463,,,,
,,breast cancer,,MLS000709026,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-43139,,,,,CTRS_1398,,,,RAD51 inhibitor,RAD51,,MLS000709026,BRD-K10882151,,,,
,,breast cancer,,HMS1361J12,0.00001 - 0.330uM,concordanceLib10,,,,,LIB_10,LSM-45145,,,,,CTRS_1399,,,,,,,HMS1361J12,BRD-K86787118,,,,
,,CTRP cell lines,,Isoliquiritigenin,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-43093,,,,,CTRS_14,,,,Guanylate cyclase activator,GABBR1,,Isoliquiritigenin,BRD-K33583600,,,,
,,CTRP cell lines,,Skiii,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-2462,,,,,CTRS_140,,,,Sphingosine kinase inhibitor,SPHK1,,Skiii,BRD-K20755323,,,,
,,breast cancer,,AZD-1152-HQPA,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1067,,,,,CTRS_1400,,,,Aurora kinase inhibitor,AURKA|AURKB,,AZD-1152-HQPA,BRD-K63923597,,,,
,,breast cancer,,bardoxolone methyl,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1401,,,,,,,bardoxolone methyl,BRD-K59437938,,,,
,,breast cancer,,CYTO7H11,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4351,,,,,CTRS_1402,,,,Cytochrome C release inhibitor,BAX,,CYTO7H11,BRD-A18763547,,,,
,,breast cancer,,BCL-LZH-4,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1403,,,,,,,BCL-LZH-4,BRD-A68258842,,,,
,,breast cancer,,HSCI1_000314,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-6251,,,,,CTRS_1404,,,,Arginase inhibitor,ARG1|ARG2,,HSCI1_000314,BRD-K53792571,,,,
,,breast cancer,,Belinostat,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-43181,,,,,CTRS_1405,,,,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,Belinostat,BRD-K17743125,,,,
,,breast cancer,,Bendamustine HCl,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45554,,,,,CTRS_1406,,,,,,,Bendamustine HCl,BRD-K17068645,,,,
,,breast cancer,,Betulinic acid,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-3004,,,,,CTRS_1407,,,,Apoptosis stimulant|Caspase activator|Diacylglycerol O acyltransferase inhibitor|HIV integrase inhibitor|NFkB pathway activator|SARS coronavirus 3C-like protease inhibitor|Topoisomerase inhibitor,GPBAR1,,Betulinic acid,BRD-K45401373,,,,
,,breast cancer,,Bexarotene,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-45378,,,,,CTRS_1408,,,,Retinoid X receptor agonist,RXRA|RXRB|RXRG,,Bexarotene,BRD-K92441787,,,,
,,breast cancer,,BI-2536,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-1041,,,,,CTRS_1409,,,,PLK inhibitor,PLK1,,BI-2536,BRD-K64890080,,,,
,,CTRP cell lines,,CL-976,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-6282,,,,,CTRS_141,,,,ACAT inhibitor,ACAT1,,CL-976,BRD-K88544581,,,,
,,breast cancer,,BIBR-1532,0.0081 - 270uM,concordanceLib10,,,,,LIB_10,LSM-43274,,,,,CTRS_1410,,,,Telomerase inhibitor,TERT,,BIBR-1532,BRD-K04623885,,,,
,,breast cancer,,Doramapimod,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1170,,,,,CTRS_1411,,,,P38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,,Doramapimod,BRD-K74065929,,,,
,,breast cancer,,birinapant,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1412,,,,,,,birinapant,BRD-K18589165,,,,
,,breast cancer,,BIX01294,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-4571,,,,,CTRS_1413,,,,DNA methyltransferase inhibitor|Histone lysine methyltransferase inhibitor,EHMT2,,BIX01294,BRD-K26818574,,,,
,,breast cancer,,Blebbistatin,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-6195,,,,,CTRS_1414,,,,ATPase inhibitor,MYH2,,Blebbistatin,BRD-A75817871,,,,
,,breast cancer,,bleomycin A2,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1415,,,,,,,bleomycin A2,BRD-A42083487,,,,
,,breast cancer,,BMS-195614,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1416,,,,,,,BMS-195614,BRD-K45935533,,,,
,,breast cancer,,BMS-270394,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1417,,,,,,,BMS-270394,BRD-K04905989,,,,
,,breast cancer,,BMS-345541,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-1028,,,,,CTRS_1418,,,,IKK inhibitor,IKBKB,,BMS-345541,BRD-K13566078,,,,
,,breast cancer,,BMS-536924,0.0011 - 37uM,concordanceLib10,,,,,LIB_10,LSM-1210,,,,,CTRS_1419,,,,IGF-1 inhibitor,IGF1R,,BMS-536924,BRD-K34581968,,,,
,,CTRP cell lines,,Necrostatin,0.016 - 530uM,concordanceLib10,,,,,LIB_10,LSM-1494,,,,,CTRS_142,,,,RIPK inhibitor,RIPK1,,Necrostatin,BRD-A36318220,,,,
,,breast cancer,,BMS-754807,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-6218,,,,,CTRS_1420,,,,IGF-1 inhibitor,IGF1R|INSR,,BMS-754807,BRD-K13049116,,,,
,,breast cancer,,179324-69-7,0.000004 - 0.130uM,concordanceLib10,,,,,LIB_10,LSM-6281,,,,,CTRS_1421,,,,NFkB pathway inhibitor|Proteasome inhibitor,ADRM1|PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMC1|PSMC2|PSMC3|PSMC4|PSMC5|PSMC6|PSMD1|PSMD11|PSMD12|PSMD13|PSMD14|PSMD2|PSMD3|PSMD4|PSMD6|PSMD7|PSMD8|SEM1,,179324-69-7,BRD-K88510285,,,,
,,breast cancer,,bosutinib,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1422,,,,,,,bosutinib,BRD-K90746395,,,,
,,breast cancer,,BRD-A02303741,0.0017 - 55uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1423,,,,,,,BRD-A02303741,BRD-A02303741,,,,
,,breast cancer,,BRD-A05715709,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1424,,,,,,,BRD-A05715709,BRD-A05715709,,,,
,,breast cancer,,BRD-A71883111,0.001 - 33uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1425,,,,,,,BRD-A71883111,BRD-A71883111,,,,
,,breast cancer,,BRD-A86708339,0.002 - 66uM,concordanceLib10,,,,,LIB_10,,,,,,CTRS_1426,,,,,,,BRD-A86708339,BRD-A86708339,,,,
,,breast cancer,,Merck-Ketone,0.001 - 33uM,concordanceLib10,,,,,LIB_10,LSM-36779,,,,,CTRS_1427,,,,,,,Merck-Ketone,BRD-A94377914,,,,
,,breast cancer,,CHEMBL3183436,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-15092,,,,,CTRS_1428,,,,,,,CHEMBL3183436,BRD-K01737880,,,,
,,breast cancer,,BRD-K02251932,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-23124,,,,,CTRS_1429,,,,,,,BRD-K02251932,BRD-K02251932,,,,
,,CTRP cell lines,,GW 405833,0.0041 - 130uM,concordanceLib10,,,,,LIB_10,LSM-2217,,,,,CTRS_143,,,,Cannabinoid receptor agonist,CNR2,,GW 405833,BRD-K10705233,,,,
,,breast cancer,,BRD-K02492147,0.002 - 66uM,concordanceLib10,,,,,LIB_10,LSM-8589,,,,,CTRS_1430,,,,,,,BRD-K02492147,BRD-K02492147,,,,
